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ABSTRACT
COMPOSITE NETWORK OF ACTIN AND MICROTUBULE FILAMENTS,
SELF-ORGANIZATION AND STEADY-STATE DYNAMICS
September 2020
LEILA FARHADI
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Jennifer Ross
Actin and microtubule filaments, with their auxiliary proteins, enable the cytoskeleton to
perform vital processes in the cell by tuning the organizational, mechanical properties
and dynamics of the network. Despite their critical importance and interactions in cells,
we are only beginning to uncover information about the composite network. Here, I use
florescence microscopy to explore the role of filaments characteristics, interactions and
activities in the self-organization and steady-state dynamics of the composite network of
filaments. First, I discuss active self-organization of semiflexible actin and rigid
microtubule filaments in the 2D composite network while myosin II and kinesin-1 motor
proteins propel actin and microtubule filaments, respectively. Second, I studied the
steady-state mobility of the 3D composite network is studied when the interactions of
filaments are regulated by the varying amount of crosslinkers. In a composite network
where only actin filaments crosslinked using biotin-NeutrAvidin molecules, microtubule
mobility is tuned by actin crosslinking and displays non-monotonic dependence on the
amount of actin crosslinkers. Third, I included antiparallel microtubule crosslinkers,
MAP65, as well as biotin-NeutrAvidin actin crosslinkers to reveal the different roles of
these crosslinkers in the structure and mobility of the composite network. While actin
crosslinkers dictated the mobility, microtubule crosslinkers control the co-localization of
filaments. Finally, I worked on an active composite network of actin, microtubule, and
myosin II motor proteins. The structural changes in the contractile composite network is
characterized using correlation length measurements. These results provide a valuable
insight into the cytoskeletal filaments interactions and their vital roles in various
biological processes in cells. Furthermore, this knowledge could enable us to design
autonomous bioinspired materials with tunable mechanical properties.
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Figure 1. 1 Phase diagram parameters for studying composite network of actin and
microtubule filaments. Particle properties in the composite network of filaments,
such as stiffness and the length of the filaments could tune the characteristics of the
network. Interaction of filaments could be regulated by the type and amount of
crosslinkers and crowding agent used for imaging. Activity of the composite could
be controlled by the type and amount of the crosslinkers, while ATP concentration
could also affect the activity of motor proteins and the composite network. .............3
Figure 1. 2 (A) Structure of an actin filament: Actin is a double helix filament that is made of
globular actin monomers. This biofilament has the diameter of 5-9 nm when the
length of the half a period is around 37 nm. (B) Structure of a microtubule filament:
Microtubule is a hollow cylinder with the inner diameter of 17 nm and outer
diameter of 25 nm. Tubulin dimers are subunits of a microtubule filament...............7
Figure 1. 3 Structure of (A) Myosin II: Myosin motor protein bind to actin filaments and
generate movement by ATP hydrolysis. It consists of head, neck and tail parts. The
head domains bind to the actin filament (2012 Pearson Education). (B) Kinesin- 1:
It is the associate motor protein of microtubule filaments. Kinesin also has head,
neck, and tail parts. The head binds to microtubule and generate force by
hydrolyzing ATP 39. ..................................................................................................10

Figure 2. 1 Composite driven active rod experiments. (A) The drive rods are composed of
microtubule and actin filaments, which are polymerized from tubulin dimers and
globular actin monomers, respectively. (B) Microtuules are driven by the ATP turnover of kinesin-1 motor proteins. Actin filaments are driven by the ATP turn-over
of myosin II motor proteins. Both motors are truncated forms. Kinesin-1 is
truncated at amino acid 560 and expressed in bacteria. Myosin-II is enzymatically
cleaved to make heavy meromyosin (HMM) and purified from chick muscles. (C)
Active rod experiments performed in a filament gliding assay. Kinesin-1 and
myosin II are both adhered to the cover glass. Microtubules and actin filaments are
added to the chamber where they bind to the motors and are propelled via ATP.
Methylcellulose is added to keep actin and microtubule filaments crowded to the
surface. ......................................................................................................................22
Figure 2. 2 Filament characterization. (A) Filament contour lengths were measured for actin
filaments and microtubule filaments. (i) Probability distribution functions (PDFs) of
actin filaments (red circles, N = 1070) and microtubules (blue squares, N = 865)
were binned with 0.25 μm sized bins and normalized. Data was fit to a lognormal
function for actin (dark red line) and microtubules (dark blue line). See
supplemental information for fit equation and supplemental table 1 for all fit
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parameters with uncertainty and goodness of fits. (ii) Cumulative distribution
functions (CDFs) of the same data for actin filaments (red circles, N = 1070), and
microtubules (blue squares, N = 865). CDFs were normalized and fit with the error
function appropriate for lognormally distributed data for actin filaments (dark red
line) and microtubules (dark blue line). See supplemental information for fit
equation and supplemental table 2 for all fit parameters with uncertainty and
goodness of fits. (iii) Using the fit parameters from the CDF data, I found the
median contour lengths for both actin filaments (red bars) and microtubules (blue
bars). Error bars represent the uncertainty of the fits parameter for the median. (B)
Filament velocities were measured for actin and microtubule filaments separately.
(i) PDFs of actin filament velocities (red circles, N = 276) and microtubules (blue
squares, N = 167) were binned with 0.05 μm/s sized bins and normalized. Data was
fit to a lognormal function for actin (dark red line) and microtubules (dark blue
line). See supplemental information for fit equation and supplemental table 3 for all
fit parameters with uncertainty and goodness of fits. (ii) Cumulative distribution
functions (CDFs) of the same data for actin filaments (red circles, N = 276), and
microtubules (blue squares, N = 167). CDFs were normalized and fit with the error
function appropriate for lognormally distributed data for actin filaments (dark red
line) and microtubules (dark blue line). See supplemental information for fit
equation and supplemental table 4 for all fit parameters with uncertainty and
goodness of fits. (iii) Using the fit parameters from the CDF data, we found the
median filament velocities for both actin filaments (red bars) and microtubules
(blue bars). Error bars represent the uncertainty of the fits parameter for the
median……………………………………………………………………………...25
Figure 2. 3 Example images and angle analysis using Directionality plugin in ImageJ/Fiji.
(A) Filaments that were well-aligned (nematic or polar) for (i) microtubules or (ii)
actin are displayed as a standard deviation compression over movie. The angular
distribution for (iii) microtubules and (iv) actin of the images in (i) and (ii),
respectively. Nematic or polar alignment results in an asymmetric distribution
peaked at one angle. (B) Filaments that are not well-aligned (isotropic) for (i) or (ii)
actin are displayed as a standard deviation compression over the time series of the
movie. The angular distribution for (iii) microtubules and (iv) actin of the images in
(i) and (ii), respectively. Isotropic alignment results in an almost flat distribution,
which some edge effects. Some of the angle distributions were more ambiguous,
and visual inspection was more reliable. ..................................................................31
Figure 2. 4 Example images and correlation analysis for nematic/polar organization of
filaments. (i, ii) Nematic organization for microtubule (i) and actin (ii) filaments
displayed as an intensity compression over movie. Each image is 1429×1429 pixel
or 154.81 μm×154.81 μm. Scale bar is 20 μm and applies to both images. (iii, iv)
2D spatial correlation g(r,θ) is displayed for microtubule (iii) and actin (iv)
filaments versus pixels. (v, vi) 1D spatial correlation is plotted versus short range
distance, r(μm), for microtubules (v) and actin filaments (vi). The results calculated
after angular averaging of g(r,θ) and then normalization. Correlation values 1 and 0
correspond to high correlation and no correlation, respectively. ..............................32
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Figure 2. 5 Example images and correlation analysis for isotropic organization of filaments.
(i, ii) Isotropic organization for microtubule (i) and actin (ii) filaments displayed as
an intensity compression over movie. Each image is 1429×1429 pixel or 154.81
μm×154.81 μm. Scale bar is 20 μm and applies to both images. (iii, iv) 2D spatial
correlation g(r,θ) is displayed for microtubule (iii) and actin (iv) filaments versus
pixels. (v, vi) 1D spatial correlation is plotted versus short range distance, r(μm), for
microtubules (v) and actin filaments (vi). The results calculated after angular
averaging of g(r,θ) and then normalization. Correlation values 1 and 0 correspond
to high correlation and no correlation, respectively..................................................33
Figure 2. 6 Methylcellulose increases microtubule interactions. (A) Time series of gliding
microtubules in a chamber with kinesin-1 motors only without methylcellulose.
Microtubules do not exhibit long-range interaction. Microtubules do create small
loops. Time between frames is 100 s. (B) Time series of gliding microtubules in a
chamber with kinesin motors and 0.3% methylcellulose, as used in our composite
assays. Microtubules begin in a nematic phase, which is aligned and transition to a
polar phase. Time between frames is 100 s. For all images, the scale bar is 10
μm...... .......................................................................................................................38
Figure 2. 7 Steady states of microtubule organization as a function of increasing microtubule
filament density. (A) Color time overlays where each frame of a time series is
overlaid as a different color, as indicated by the color scale bar. (i) Lowest
concentrations of microtubules display an isotropic phase with filaments pointing in
all directions. The concentration (c) is 0.5 μM tubulin dimers. The filament density
(ρ) is 0.0267 filaments per μm2. The surface area fraction of filaments (ϕ) is 0.033.
The color time scale for this image is from 0 to 180 s. (ii) The intermediate
concentration of microtubules displays a nematic phase with filaments co-aligning
locally and moving in antiparallel directions within the high density regions. The c
is 2.5 μM tubulin dimers. The ρ is 0.133 filaments per μm2. The ϕ is 0.0167. The
color time scale for this image is from 0 to 40 s. (iii) The highest concentration of
microtubules displays a polar phase with filaments co-aligning globally and moving
in the same directions within the high density regions. The c is 5 μM tubulin
dimers. The ρ is 0.267 filaments per μm2. The ϕ is 0.033. The color time scale for
this image is from 0 to 120 s. (B) In order to determine the direction of the
filaments within the high-density regions of the images, I created kymographs
where the image along the linear region of interest is sequentially layered for each
time step. The time dimension is portrayed on the y-axis. The space dimension
along the filament is portrayed along the x-direction. (i) For the lowest density of
filaments, visible tracks in the color time overlays were used to create kymographs.
These tracks were deposited by single filaments, as evidenced by the single trail of
intensity in the kymographs. (ii) For intermediate densities of filaments, the dense
regions of the color-time overlay were used to create kymographs. The filaments
moving in the high density regions were moving in both directions, as evidenced by
the diagonal lines in both directions. (iii) For high density filaments, the high
density regions of the color-time overlays were used to create the kymograph. All
the filaments appear to move in the same direction implying that the high density
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region has polar-aligned filaments. All scale bars in the x-direction are 5 μm for all
images. All scale bars in the y-direction were 1 min in time for all kymographs. ...40
Figure 2. 8 Steady states of actin filament organization as a function of increasing actin
filament density. (A) Color time overlays where each frame of a time series is
overlaid as a different color, as indicated by the color scale bar. (i) Lowest
concentrations of actin filaments display an isotropic phase with filaments pointing
in all directions. The concentration (c) is 0.5 μM actin monomers. The filament
density (ρ) is 0.2 filaments per μm2. The surface area fraction of filaments (ϕ) is
0.0008. The color time scale for this image is from 0 to 120 s. (ii) The highest
concentration of actin filaments displays a nematic phase with filaments co-aligning
globally and moving in antiparallel directions throughout the space. The c is 10 μM
tubulin dimers. The ρ is 3.0 filaments per μm2. The ϕ is 0.015. Filament alignment
occurs rapidly, but the local density of the aligned filaments changes over time.
Early images of these samples do not show density fluctuations – only global
alignment. Later imaging of the same sample shows the accumulation of highdensity regions. The color time scale for these time series are from 0 to 120 s. (B) In
order to determine the direction of the filaments within the high-density regions of
the images, I created kymographs where the image along the linear region of
interest is sequentially layered for each time step. The time dimension is portrayed
on the y-axis. The space dimension along the filament is portrayed along the xdirection. (i) For the lowest density of filaments, visible tracks in the color time
overlays were used to create kymographs. These tracks were deposited by single
filaments, as evidenced by the single trail of intensity in the kymographs. Some
filaments were observed to pause because of interactions with some dead myosins
(top). When unlabeled actin filaments were also included, all filaments were
observed to move without pausing (bottom). (ii) For high densities of filaments, the
denser regions of the color-time overlay were used to create kymographs. For early
time movies, a single diffraction-limited region used for the kymograph still
displayed filaments moving in both directions, even though the density was not as
high. For the late time movies, the regions of high density show motion in both
directions and a significantly higher number of filaments passing parallel to the
diffraction-limited region. All scale bars in the x-direction are 5 μm for all images.
All scale bars in the y-direction were 1 min in time for all kymographs. .................44
Figure 2. 9 Velocity of actin filaments increases with polymer concentration. (A) Actin
velocities with crowding. (i) Probability distribution functions of the velocity of
trackable actin filaments gliding in the myosin and kinesin gliding assay at 0.5 µM
without microtubules (red filled circles), 10 µM without microtubules (blue filled
circles), or 10 µM with 5 µM microtubules (green filled circles). Fits to the data are
lognormal fit equation (Equation 2.1) for 0.5 µM without microtubules (dark red
line), 10 µM without microtubules (dark blue line), or 10 µM with 5 µM
microtubules (dark green line). (ii) Cumulative probability distribution functions of
the velocity of trackable actin filaments gliding in the myosin and kinesin gliding
assay at 0.5 µM without microtubules (red filled circles), 10 µM without
microtubules (blue filled circles), or 10 µM with 5 µM microtubules (green filled
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circles). Fits to the data are lognormal fit equation (Equation 2.2) for 0.5 µM
without microtubules (dark red line), 10 µM without microtubules (dark blue line),
or 10 µM with 5 µM microtubules (dark green line). (B) Microtubules velocities
with crowding. (i) Probability distribution functions of the velocity of trackable
microtubule filaments gliding in the myosin and kinesin gliding assay at 0.5 µM
without actin (red filled squares), 5 µM without actin (blue filled squares), or 5 µM
with 10 µM actin (green filled squares). Fits to the data are lognormal fit equation
(Equation 2.1) for 0.5 µM without actin (dark red line), 5 µM without actin (dark
blue line), or 5 µM with 10 µM actin (dark green line). (ii) Cumulative probability
distribution functions of the velocity of trackable microtubule filaments gliding in
the myosin and kinesin gliding assay at 0.5 µM without actin (red filled squares), 5
µM without actin (blue filled squares), or 5 µM with 10 µM actin (green filled
squares). Fits to the data are lognormal fit equation (Equation 2.2) for 0.5 µM
without actin (dark red line), 5 µM without actin (dark blue line), or 5 µM with 10
µM actin (dark green line). (C) Median velocities from the fits to the cumulative
distribution functions for actin (filled bars) and microtubules (outlined bars). Actin
data from 0.5 µM without microtubules (red filled bar), 10 µM without
microtubules (blue filled bar), or 10 µM with 5 µM microtubules (green filled bar).
Microtubule data from 0.5 µM without actin (red filled bar), 5 µM without actin
(blue filled bar), or 5 µM with 10 µM actin (green filled bar). Error bars represent
the uncertainty of the median velocity fit parameter from Equation 2.2. See Tables
2.5–2.8 for all fit parameters with uncertainty and goodness of fits.........................49
Figure 2. 10 State diagram for actin and microtubule composite gliding assays. (A) The actin
filaments (red markers) were used at five different concentrations: 0.5 μM, 5 μM,
6.7 μM, 8.8 μM, and 10 μM corresponding to the following filament densities
(filaments per μm2): 0.2, 1.5, 2.0, 2.7, 3.0 and the following dimensionless area
fractions: 0.0008, 0.008, 0.010, 0.013, 0.015. The microtubules (blue markers)
where used at three different concentrations: 0.5 μM, 2.5 μM, and 5 μM
corresponding to the following filament densities (filaments/μm2): 0.03, 0.17, 0.34
and the following dimensionless area fractions: 0.004, 0.02, 0.04. For each
concentration pair observed, I used the definitions of isotropic, nematic, and polar
described in figure 2.7 and 2.8 to describe the organization of actin filaments or
microtubules. Isotropic organizations are denoted with a filled circle. Polar
organizations are denoted with a single-headed arrow. Nematic organizations are
denoted with a double headed arrow. Some organizational states were difficult to
determine or showed different organizations in different chambers. These were
mixed between isotropic and nematic and are denoted with a double headed wide
arrow. For each location on the state diagram, 2-5 different chambers were made
and 4-9 different 2-5 minute movies were recorded over one hour, as described. (B)
Example alignment of actin and microtubules. (i) Images from a time series of actin
gliding at 10 µM in the presence of (ii) 5 µM microtubules. (iii) Images are overlaid
with actin in red and microtubules in cyan. Short actin filaments that glide along
microtubule bundles are highlighted with an arrow head. Microtubule channel can
be seen through the actin channel due to high signal and imperfect dichroic glass.
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Time between frames in second is given under the images, approximately 3 s apart.
Scale bar is 10 µm. ....................................................................................................52

Figure 3. 1 Schematic of experiments to probe the role that crosslinking plays in the
mechanics and mobility of crosslinked actin-microtubule composites. (A) Cartoon
of molecular components comprising actin-microtubule composites with varying
crosslinker motifs (None, Actin, Microtubule, Both, Co-linked, Both 2x) described
in the text. The calculated length between crosslinkers for each motif is listed under
each cartoon, where lc,a is the length between crosslinkers along an actin filament,
lc,m is the length between crosslinkers along a microtubule, and lc is the length
between crosslinkers when actin and microtubules are linked to each other.
(B)Two-color laser scanning confocal micrograph of 5.8 μM Co-linked actinmicrotubule composite with ~3% of microtubules and actin labeled with rhodamine
(red) and Alexa-488 (green), respectively. Standard deviation projections of a 60 s
video taken at 1 fps for the microtubule (red) and actin (green) channels. Scale bar
is 20 μm. ....................................................................................................................66
Figure 3. 2 Schematic of experiments to probe the role that crosslinking plays in the
mechanics and mobility of actin crosslinked actin-microtubule composites. (A)
Cartoon of composites of microtubules (red) and actin (green) with increasing
concentrations of actin crosslinkers (blue) defined as the crosslinker:actin ratio R.
(B) Two-color laser scanning confocal image of 5.8 μM total actin-microtubule
composite with R = 0.08. For visualization of filaments, ~3% of tubulin and actin
are labeled with rhodamine (red channel) and Alexa-488 (green), respectively.
Standard deviation projections of a 60 s time series taken at 1 fps for the
microtubule (red) and actin (green) channels. Scale bar is 20 µm. ..........................69
Figure 3. 3 Differences between crosslinking motifs have minimal impact on the steady-state
filament mobility in actin-microtubule composites. (A) For each composite,
a 128×128 image shows the standard deviation of intensity values for each pixel
over time for actin (green) and microtubules (red) in a 60 s time series. Scale bar is
10 µm and applies to all images. (B) Box-whisker plot of the steady-state mobility,
determined by computing the average standard deviation of pixel intensities <>
normalized by the overall average pixel intensity <I> for each time series (as
described in Methods). For each composite type, <>/<I> is calculated separately
for actin (cross-hatched) and microtubules (solid) and each data point is computed
from 10-12 time series each collected in different regions of the sample chambers of
two different samples. As shown, microtubules are less mobile than actin filaments
in all composites. Further, while crosslinking reduces the mobility of both
filaments, the specific crosslinking motif has little effect. .......................................73
Figure 3. 4 Mobility analysis from time series with 62.5 ms time windows. Box-whisker plot
of the steady-state mobility determined by computing the average standard
deviation of pixel intensities <δ> normalized by the overall average pixel intensity
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<I> for each time series. Here, we use a time resolution of 62.5 ms (1 frame)
compared to 1 s (16 frames averaged together) shown in Fig 3.3. As shown, the
dependence of the mobility of both actin and microtubules on crosslinking motif is
robust to varying time windows used for analysis. However, for smaller time
windows the mobility values and spread in the mobility distributions for both actin
and microtubules are enhanced due to noise.............................................................74
Figure 3. 5 Microtubule mobility is tuned by actin crosslinking and dictates the nonmonotonic mechanics of composites. (A) Projection images of the standard
deviation of pixel intensity values in actin (green) and microtubules (red) channels
for a 60 s time series. Time series are acquired using a Nikon A1R laser scanning
confocal microscope with 60 - 1.4 NA objective. Numbers in bottom left of each
image correspond to crosslinking ratio R. Colors outlining images match color
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CHAPTER 1
INTRODUCTION

1.1 Introduction

Biophysics is a bridging field that employs physics and mathematics concepts and
methods to explore complex biological systems. Many physical and chemical principals
could be applied directly to understand and quantify the governing behavior of biological
organization in the cell and molecular scales. In addition, new methods and techniques
have been developed using physical principles and engineering. Various types of imaging
techniques, like fluorescence imaging that have extensively been used in this thesis,
enable us to visualize biological structures and perform quantitative measurements.
Biological systems could be studied through observation, measurements, and
manipulation of its component in vivo (performed in a living organism) as well as in vitro
(performed outside of a living organism). Molecular biophysicists often examine
biological processes as systems of interacting subcomponents. To reveal the underlying
mechanism that govern these complex systems, it is essential to determine which features
and subcomponents have a key role in a certain biological process. Then, proper
experiments are designed to study these phenomena in living cells or in reconstituted
systems that are assembled from biological building blocks. Reconstitution experiments
provide a powerful platform to determine minimal requirements for a certain biological
system. Hence, the role of individual components and the interplay between them could
be explored systematically.
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This thesis focuses on reconstituted composite networks of cytoskeletal filaments,
actin and microtubules, in vitro. This minimal system enables us to investigate the
organization and dynamics of this composite network while other well-defined
components could be introduced in a controlled manner. Figure 1.1 shows the three main
control parameters in the present work that contribute to the crosstalk of actin and
microtubule filaments.
The stiffness of actin and microtubule filaments is their key characteristic that has
a significant role in their various biological functions. To regulate the mechanical
properties of the composite network, we used filaments with different stiffnesses and
lengths. Here, the persistence length (rigidity) of the filaments remained fixed.
Microtubules are more rigid compared to actin filaments. In chapter 2, the length of the
pre-polymerized actin and microtubule filaments were controlled, while filament length
was not controlled in other chapters where filaments were copolymerized.
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Figure 1. 1 Phase diagram parameters for studying composite network of actin and
microtubule filaments. Particle properties in the composite network of filaments,
such as stiffness and the length of the filaments could tune the characteristics of the
network. Interaction of filaments could be regulated by the type and amount of
crosslinkers and crowding agent used for imaging. Activity of the composite could
be controlled by the type and amount of the crosslinkers, while ATP concentration
could also affect the activity of motor proteins and the composite network.

To tune the interaction of actin and microtubule filaments, different types of
crosslinkers and crowding agents could be employed. The structure and organization of
the network of filaments could be determined by various types of crosslinkers that bind to
them and form higher order structures. In chapter 3, biotin-Neutravidin molecules create
isotopically crosslinked networks of actin and microtubules. In other studies, in chapter 3
and 4, these molecules bind to actin filaments to link them while MAP65 molecules form
bundles of microtubules. Another interesting work in chapter 2 indicates that crowding
agents that are used to facilitate imaging near a surface in a sample could also affect the
way that filaments “talk” to each other.
Activity of the composite network could be provided by different kinds of motor
proteins that constantly consume energy and generate force in the system. In chapter 2, I
used kinesin-1 and myosin II motors to observe the self-organization of filaments in the
2D composite network. Chapters 3 and 4 explore the steady-state dynamics of the
composite network where no motor protein has been used. Myosin II motor activities in a
3D composite network of actin and microtubule are discussed in chapter 5. This active
composite network undergoes contraction motion that leads to structural changes in the
network of filaments.
The actin-microtubule composite networks were examined systematically while
the interaction and dynamics of the filaments were regulated by the control parameters.
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The amount and the type of each factor, such as the amount of crosslinker or motor
protein, enable us to study the phase diagram at these limits. To visualize the formed
composite network at each data point, I used epi-fluorescence (chapter 2, 4) or scanning
confocal (chapter 3, 5) microscopy. The results of each study are discussed and analyzed
accordingly.

1.2 Biological background
Cells organize their interior and interact effectively with their environment. A
complex interacting network of filaments, the cytoskeleton, empower the cell to carry out
vital functions. The essential roles of the cytoskeleton are to facilitate morphological
changes in cell division and migration. It shapes the cell and enables it to maintain its
integrity while responding to stress caused by changing environment. The cytoskeleton is
composed of three different types of protein filaments: microtubules, actin filaments, and
intermediate filaments. Each of them has certain mechanical properties, dynamics, and
biological roles. Each of these filaments has a large set of specific accessory proteins as
well as motor proteins. To execute key processes, cell requires effective cooperation and
interaction between these filaments and accessory proteins.
Here, the biological background of two main cytoskeletal filaments actin and
microtubules will be reviewed. The characteristics of some of their associate motor
proteins, myosin II and kinesin-1 as well as crosslinkers such as MAP65 and biotinNeutrAvidin will be discussed.
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1.2.2 Cytoskeletal filaments
1.2.2.1 Actin filaments

Actin filaments are helical biopolymers with the diameter of 5-9 nm while the
helix repeats every 37 nm (Fig 1.2.A). Filamentous actin, also known as F-actin,
polymerizes from noncovalently bound globular actin monomers, G-actin that has a
molecular mass of 42 kDa. These weak noncovalent bonds between subunits enable the
actin filaments to assemble and disassemble rapidly with no need of forming or breaking
covalent bonds 1. X-ray crystallography shows that globular actin consists of two lopes
separated by a cleft. This cleft is a binding site for adenosine triphosphate (ATP)
or adenosine diphosphate (ADP) associated with a Mg2+ ion 2,3. These G-actin monomers
assemble head-to-tail to generate actin filaments.
The actin filament is called a polar structure because the orientation of the
asymmetric subunits forms a filament with two distinct ends that have different structure
and dynamics. Hence, actin filament has a fast-growing end, the “plus end”, and slow a
growing end, the “minus end”. These ends are also called the barbed and pointed ends,
respectively. The latter terminology refers to the electron microscopic images of actin
filaments decorated with myosin motors that show arrowhead configuration, where the
shaft is the actin and the fletching is the myosin. The end of the filament without any
protruding myosin is called pointed end and the other end is barbed end 4–6. In the steady
state, the net assembly rate at the plus end equals the net disassembly rate at the minus
end. This phenomenon is called treadmilling that maintains the length of actin filaments
constant in steady-state condition, although there is a flux of G-actin monomers along the
filament 1,4,7.
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Actin polymerization is a non-equilibrium process due to constant energy
consumption. ATP hydrolysis process starts shortly after an ATP-bound monomer
incorporates to a filament. Thus, ADP-bound actin monomers are formed and remained
trapped in the filaments, while the free phosphate group, Pi, releases slowly from each
monomer. Consequently, two different ATP-bound and ADP-bound G-actin could be
found in the filament structure. At fast elongation rates of actin filaments, a transient cap
of ATP-bound subunits exists at the plus end, while at steady state, it turns to stabilizing
ADP-Pi cap at the fast-growing end of actin polymer. However, phosphate release leads
to conformational changes of the actin subunit that destabilize the intermolecular bounds
between the monomers and result in structural and dynamics changes 8–10.
Actin is a relatively flexible filament, as quantified by persistence length
measurements carried out both on in vitro and in vivo such as thermal fluctuation analysis
11–14

and mechanical properties studies with optical tweezers 15. The results indicate the

persistence length in the order of 10 - 20 μm 14,16–18. In vitro F-actin polymerization can
form filaments in range of 1-20 μm, while the distribution of filament length depends on
the initial G-actin concentration 19,20. As the results, in most of the in vitro studies, F-actin
could be considered a semiflexible polymer due to its comparable length distribution to
the persistence length.
Actin filaments form higher order structures using accessory proteins that regulate
their mechanics and dynamics 21–23. In muscle cells, aligned actin filaments and myosin
motor proteins generate force and ultimately muscle contraction. During cell mitosis,
actin cables facilitate intracellular organelles transport to the daughter cells. Also, it
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provides structural support to the cell interior during mitosis. It allows the cell motility by
generating protrusive and retractive forces at the front and rear of the cell 1.

Figure 1. 2 (A) Structure of an actin filament: Actin is a double helix filament that is
made of globular actin monomers. This biofilament has the diameter of 5-9 nm
when the length of the half a period is around 37 nm. (B) Structure of a microtubule
filament: Microtubule is a hollow cylinder with the inner diameter of 17 nm and
outer diameter of 25 nm. Tubulin dimers are subunits of a microtubule filament.

1.2.2.2 Microtubule filaments
Microtubules are formed from protein subunits called tubulin. Each tubulin is a
heterodimer that is made of two globular proteins, α and β tubulin that are tightly bound
noncovalently. Each α and β subunit weights 55 kDa and has a binding site for a GTP
molecule. The GTP that is bound to α tubulin is physically trapped and never hydrolyzed
or exchanged. In contrast, the GTP in the β tubulin could be hydrolyzed to GDP, and it is
exchangeable. That hydrolysis cause conformational changes in the microtubule subunits
and has an important effect on the filament dynamics 24.
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Tubulins assemble into a hollow cylinder structure with inner diameter of 17 and
outer diameter of 25 nm, that is composed of 13 protofilaments 25 (Fig 1.2.B). The
longitudinal contact occurs between α and β subunit while lateral contacts are between α α and β - β subunits 26. All of the subunits in a protofilaments point in a same direction,
while the protofilaments are aligned in parallel along the microtubule polymer. As a
result, microtubule filaments have two distinct ends with different polymerization
dynamics. They have fast-growing “plus end” and slow-growing “minus ends” where the
β tubulins and α tubulins are exposed, respectively 27,28.
Tubulins bind and hydrolyze GTP to GDP. This process is important in
microtubule polymerization dynamics as well as stability. The GTP hydrolysis only
occurs at the β tubulin, while the GTP that binds to α tubulin is never hydrolyzed. The
hydrolysis causes conformational changes within the tubulin as it leads to compaction
that rearranges and tilts the interaction between α and β tubulins 29,30.
Microtubules go through a stochastic process of switching between growing and
shrinking called dynamic instability. This phenomenon allows the microtubules to form
new structures and rearrange the interior of the cell accordingly. When the rate of
assembly of subunits is faster than the hydrolysis of the GTP, a stabilizing GTP cap
forms on the microtubule end that tends to grow fast. However, if hydrolysis proceeds
faster than the subunit addition, the cap is lost and depolymerization happens. The
transition from growth to rapid shrinking is called catastrophe, while the change to
growth is called rescue 1,27.
The structure of the microtubule forms a stiff filament that withstands mechanical
stress in the cell. To measure their flexural rigidity, various methods were employed such
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as thermal fluctuation measurements 31, flow 32,33, or optical tweezers 33–35. The
persistence length of the microtubule corresponds to 1 mm 14,18,36,37 which is larger than
the average size of eukaryotic cell (5 – 15 μm) 38. This explains how these filaments
maintain the structure of the cell. Microtubules provide a platform for intracellular
transport by making tracks for cargo-carrying motor proteins. Microtubules also have a
vital role in forming the mitotic spindle while the dynamic instability allows
reorganization of these filaments during cell division.

1.2.3 Motor proteins
One of the important associated proteins of the cytoskeleton are motor proteins.
Each type of filament has specific motor proteins that can bind, hydrolyze ATP, and
move along these structurally polarized polymers. A superfamily of myosin motors with
different structures bind to actin filaments and generate motion. For microtubules, more
that fourteen families of kinesin in the kinesin superfamily were found that can bind to
microtubules. Each type of motor protein walks along in certain direction of filaments.
Using these polar tracks, they carry organelles, such as Golgi complexes and secretory
vesicles, to various locations in the cell. Motor proteins also can generate force by sliding
filaments against each other and exerting tension in the cell that facilitate muscle
contraction and ciliary beating.
The immobilized motor proteins can propel their associate filaments in a gliding
assay experiment. In chapter 3, I use both myosin and kinesin to simultaneously drive
actin and microtubule filaments in a gliding assay. In the last chapter, I explore the
organization of a 3D contractile actin-microtubule composite network when myosin II
motors provide activity by generating force between actin filaments.
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Figure 1. 3 Structure of (A) Myosin II: Myosin motor protein bind to actin filaments
and generate movement by ATP hydrolysis. It consists of head, neck and tail parts.
The head domains bind to the actin filament (2012 Pearson Education). (B) Kinesin1: It is the associate motor protein of microtubule filaments. Kinesin also has head,
neck, and tail parts. The head binds to microtubule and generate force by
hydrolyzing ATP 39.

1.2.3.1 Myosin motor
Myosin is a superfamily of motor proteins that walks along actin filament and
could be found in almost all eukaryotes. Myosin protein is composed of head domain,
neck and elongated tail part. The head domain is the force generative machinery that
binds to actin filaments (Fig 1.3.A). Each myosin head binds and hydrolyzes ATP to
move toward the plus end of the actin filaments.
Skeletal muscle myosin was the first identified motor protein, called conventional
myosin or myosin II due to its two head domains. Myosin II motors generate force and
displacement through a power stroke mechanism empowered by ATP hydrolysis. The
power stroke occurs after the release of phosphate molecule, produced by ATP
10

hydrolysis, while myosin is tightly binding to actin. This release results in conformational
change in myosin motor and generates force. Then, the head of myosin loses its bound
ADP molecule while locked tightly to actin filament in rigor configuration. Binding to a
new ATP, reduces the affinity of the head to actin, hence the myosin motor releases the
actin filament. The hydrolysis of a new ATP molecule followed by phosphate releasing
leads to myosin binding to actin again and repeating this cycle 40–42.
Myosin II plays an important role in contractile activities in both muscle and nonmuscle cells. In muscle cells, individual myosin II motors joint together and form the
thick filament of sarcomere, which is a vital structure for muscle contraction 1. In nonmuscle cells, myosin II motors and actin filaments build stress fibers. These actin bundles
facilitate cell contractility by providing force during various cell functions such as cell
adhesion, migration and morphogenesis 42,43.

1.2.3.2 Kinesin motor
Kinesin is a microtubule-associate motor protein powered by ATP hydrolysis and
walks along the microtubule toward the plus end (Fig 1.3.B). Kinesin is structurally
similar to myosin II and consists of two globular head motor domains, an elongated tail,
and a neck. These head domains work in a coordinated manner that enable the kinesin to
step forward. Once a head domain is bound to the microtubule, ATP binding causes
conformational changes in the neck linker part of the motor that leads to movement
toward the plus end of microtubule. After hydrolyzing ATP and releasing the phosphate,
the head detaches from the microtubule. By exchanging the ADP for a new ATP, the
head domain is ready to repeat the cycle 42,44.
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Like myosin, kinesin belongs to a large superfamily. Kinesin motors transport
large cargos to desire destination in the cell by their unidirectional movement along
microtubules. They have been known for fast movement of mitochondria and fast axonal
transport. Additionally, many types of kinesin motors are in charge of mitotic and meiotic
spindle formation as well as chromosome separation during cell division 1.

1.2.4 Crosslinkers
Cells regulate their morphology, dynamics, and mechanics of the cytoskeletal. To
control higher order structures of actin and microtubules, the cell accurately adjusts the
interaction between the cytoskeletal filaments in different positions. A wide range of
accessory proteins for each type of filament, governs filament bundling and crosslinking.
I discuss in chapter 3 that in in vitro studies the presence of crowding agents could also
modify the interaction of microtubule-microtubule filaments, as well as actin-actin and
actin-microtubule filaments. In this thesis, I employed two different types of crosslinkers,
MAP65 and biotin-NeutrAvidin molecules.

1.2.4.1 Biotin-NeutrAvidin
NeutrAvidin is a tetramer that weighs around 60 kDa. It has a strong affinity to
biotin, KD = 10 -15 M. Biotin-NeutrAvidin complex molecules are generic and strong
crosslinkers that are employed to form isotropic crosslinked network of filaments 45.
Different desirable crosslinking motifs could be made using preassembled NeutrAvidin
with biotinylated actin and/or tubulin. In addition, different amounts of these crosslinkers
could determine the degree to which the network of filaments is crosslinked.
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1.2.4.2 MAP65 molecules
Proteins that bind along the side of microtubule filaments are called microtubuleassociated proteins or MAPs. Various types of MAPs are identified to be responsible for
different functions such as stabilizing and crosslinking microtubules. MAP65 molecules,
are a family of MAPs that weight 65 kDa and form antiparallel crosslinked microtubules.
They could be found in plants, and are analogous to PRC1 in animal cells and Asep1 in
yeast cells 46. It has been shown that purified MAP65 forms microtubule bundling in vitro
while the spacing between adjacent microtubules is around 25 nm 46–49. MAP65
molecules have a binding affinity of KD = 1.2 μM 50. Hence, they weakly crosslink
microtubules in vitro. However, great number of these transient crosslinkers can
guarantee the formation of more stable bundles of microtubule filaments.
In this thesis, I explore the composite network of actin and microtubule filaments.
To control the interaction of these filaments, different types of crosslinkers or crowding
agents were employed. The steady-state dynamics of the composite network due to
thermal fluctuations were measured. The mobility of the active composite networks was
quantified while motor proteins actively organize the structure of the networks.
Investigating the active self-organization and dynamics of the composite network of
filaments could reveal the underlying mechanism that leads to crosstalk between actin
and microtubule filaments in the cytoskeleton in the presence of their numerous auxiliary
proteins. Furthermore, it could provide valuable prospective to design artificial smart
materials.
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CHAPTER 2

ACTIVE SELF-ORGANIZATION OF THE 2D COMPOSITE NETWORK OF
ACTIN AND MICROTUBULES

2.1 Abstract
Spontaneous self-organization of active matter has been demonstrated in a
number of biological systems including bacteria, cells, and cytoskeletal filaments.
Cytoskeletal filaments act as active polar rods when they are propelled along a glass
surface via motor proteins. Actin has previously been shown to display polar or nematic
ordering, whereas microtubules have been shown to create large vortices. For the first
time, I combine both the actin and microtubule gliding into a composite active system. In
the absence of actin filaments, microtubule filament organization transitions from
isotropic to nematic to polar as a function of filament density. I find that the presence of a
crowder, methylcellulose, is essential for this transition. In the absence of actin,
microtubules transition from isotropic to nematic. In combination, microtubules are
affected by the presence of actin and the overall density of the filaments, becoming
entrained with the nematic alignment of actin. Actin filaments are not as affected by the
presence of microtubules. These results serve as a first step in exploring the rich
emergent behavior that can result from composite active matter system with tunable
particle properties, self-propulsion speeds, and interparticle interactions.
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2.2 Introduction
Active materials are a recently demarcated class of non-equilibrium systems that
are characterized by energy input at the microscale that results in emergent steady states
at long length scales. Being inherently out of equilibrium due to the microscopic drive,
the basic mechanisms that lead to emergent behavior provide a pathway to design
materials that have properties prohibited thermodynamically in traditional systems 51 and
identify design principles for directed self-assembly 52. Further, active materials serve as
a useful theoretical paradigm to understand biochemomechanical functionality in
biological systems ranging from sub-cellular 53–55 to tissues 56–58.
From a fundamental point of view, it is useful to categorize active materials based
on the symmetry of the active drive and the interactions among particles 59,60. The most
common realization of activity is self-propulsion, a self-replenishing velocity along one
direction of the body axis of the particles that compose the material. This could arise
either due to flagellar swimming in the case of bacteria 61,62 or due to cytoskeletal
motility as in the case of epithelial cells 63,64, due to chemical catalysis in the case of
synthetic systems 65,66 or due to the activity of a motor protein carpet as in the case of
motility assays 67–69. The symmetry of this form of drive is called “polar” in that there is a
specific direction in the particle coordinates in which the driving acts. The emergent
properties of self-propelled particle systems are determined by the symmetry of the
interaction. The most well studied case is that of isotropic (non-aligning) excluded
volume interactions. Isotropic active fluids have proved fruitful to describe synthetic selfpropelled particle systems 70,71 and have led to our understanding of such phenomena as
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athermal phase separation 71, rectification in the presence of barriers 72, and boundary
effects 73.
Another realization of interactions among self-propelled particles is nematic
alignment, where the body axes of two interacting particles along which their selfpropulsion axes are equally likely to be aligned parallel or anti-parallel with respect to
each other. This is a well-studied model theoretically, using microscopic 74–78, statistical
mechanics 79–81, and continuum theory 82–85. Spectacular phenomenology predicted from
the theoretical investigations include the existence of anomalous Giant Number
fluctuations and phase separation into bands, and instability of the bands leading to a
chaotic inhomogeneous steady state. The experimental investigations into this rich
parameter space have been more limited. A vibrated monolayer of granular rods have
been used as an experimental test bed for some of these ideas 86,87 while this theoretical
paradigm has been used to understand some emergent behavior in B. Subtilis 61,62,88 and
myxobacteria colonies 89–91. Further, to date, most active matter systems explored
experimentally, have been composed of a single species of active particle, while
theoretical work on self-propelled particles with varying motility has shown segregation
behavior in bulk 92 and under confinement 93.
In this work, I create a new, composite system composed of both microtubules
and actin filaments as rods propelled by their respective motor proteins, kinesin-1 and
myosin II. I build upon past work with actin systems 51,67,94,95 and our research group’s
prior work with microtubule systems 96–98. The theory above describes actin ordering
from isotropic to nematic, but prior experimental reports have shown that actin can also
transition to global polar order, where all the filaments are propelled in the same direction
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67,99

. The same theories apply to microtubule systems, but microtubule ordering has often

been difficult to observe, especially in kinesin-driven filament gliding assays. In our
previously published works, I used microtubule-gliding assays with kinesin-1 motors to
examine the effects of both filament density and crosslinkers on self-organization of
microtubules 96–98. I found that two microtubules do not interact at low concentration 96,97,
often crossing each other as if the other filament was not in the path. When taken to
higher filament densities, I found that there was no long-range order, instead small, single
microtubule loops form (46). Other microtubule motors, such as axonemal dynein, have
been shown to create arrays of large vortices of gliding microtubules 68. In this
manuscript, I report a method for creating microtubule self-organization for the first time.
Microtubules are capable of nematic and polar order at high densities. Interesting, the
same experimental parameters cause actin filaments to lose their polar order, although
they can still exhibit nematic ordering.
In this work, I take self-organization a step forward by creating a new, composite
system composed of both microtubules and actin filaments as self-propelled rods. This
system can serve as a model to explore the emergent behavior of composite selfpropelled particles with aligning interactions and variable motility and particle properties.
The actin and microtubule composite is also biologically interesting because
microtubules and actin filaments make up part of the essential cytoskeletal network of
cells. Microtubules serve as long-range support structures and the long-distance highway
system for intracellular transport in the cell 100. Actin filaments serve as active force
generators for cell motility and cellular contraction, as well as the short-range, local road
system for intracellular transport 100. Each of these cytoskeletal networks self-organize
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into important architectures within cells, and are presumed to interact, yet little is known
about those interactions. Recent work has illustrated that microtubule-associated proteins
and actin binding proteins can serve as the intermediary between these two networks to
drive co-organization during simultaneous co-polymerization 101,102. The cytoskeletal
structure is active, using the energy of ATP (actin) or GTP (microtubules) hydrolysis to
rearrange itself as needed based on the cell’s life cycle state, cell cycle state, or local
environment. The cell has no internal intelligence prescribing the cytoskeletal
architecture. Instead, the microtubule and actin networks must self-organize using
physical and chemical cues. The work presented here is an important step in
understanding how actin and microtubules could self-organize and coordinate in the cell
using only physical (steric) interactions.
In the experiments reported here, I find that actin alone changes from isotropic to
nematic organizations with increasing filament density while microtubules exhibit
isotropic, nematic, and polar ordering. When mixed together, I find that the actin can
inhibit microtubule polar order, and the filaments can affect each other to cause
entrainment. I find that the effect is stronger for actin affecting microtubule organization,
but not as effective for microtubules on actin alignment. These results serve as a first step
in exploring the rich emergent behavior that can result from this composite active matter
system with tunable particle properties, self-propulsion speeds, and interparticle
interactions.
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2.3 Materials and Method
2.3.1 Actin Polymerization
Actin was purified from acetone powder of chicken pectoralis muscle as
previously described 103. Briefly, G-actin was extracted from the actetone powder in a
low salt buffer (2 mM Tris base, 0.2 mM CaCl2, 0.005% NaN3, at pH 8.0) on ice in a cold
room (4°C). Actin filaments were then polymerized in a solution including 1 mM ATP,
10 mM imidazole, 50 mM KCl, 1 mM MgCl2, and 1 mM DTT, pH 7.5. Labeled actin
filaments were polymerized in the same buffer from a combination of rhodamine-labeled
globular actin (Cytoskeleton) and unlabeled actin at a ratio of 1:2. To polymerize
filaments, actin solution was incubated on ice for 30 minutes and then at room
temperature for another 30 minutes. Unlabeled phalloidin (Thermo Fisher Science) in
methanol was added to stabilize the actin filaments with a final concentration of 16 µM.
After the addition of phalloidin, filaments were incubated on ice for another hour.

2.3.2 Microtubule Polymerization
Microtubules were polymerized from 5 mg/ml tubulin dimers (Cytoskeleton) in
adding PEM-100 (100 mM PIPES, 1 mM EGTA, 1 mM MgSO4, pH 6.8). Labeled
microtubules were polymerized by mixing Dylight-650 tubulin (Cytoskeleton) or Alexa647 tubulin (PUR Solutions) at a 1:8 ratio tubulin with unlabeled tubulin. After mixing
tubulin in PEM-100, dimers were centrifuged at 360,000xg at 4°C for 10 minutes to
pellet aggregated dimers. The supernatant was removed and used for polymerization.
GTP was added to the solution at 1 mM. Tubulin was incubated at 37°C for 20 minutes.
After polymerization, paclitaxel (Taxol) was added to a final concentration of 50 μM to
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stabilize microtubules. The Taxol binding was equilibrated by incubating at 37°C for
another 20 minutes.

2.3.3 Myosin II preparation
Whole skeletal muscle myosin (myosin II) was purified from chicken pectoralis
muscle as previously described 104. It was subsequently cut by chymotryptic digestion
into heavy meromyosin (HMM) and further purified as described 104. HMM was stored in
-20°C in 50% glycerol and a low salt myosin buffer (25 mM imidazole, 300 mM KCl, 1
mM EGTA, 10 mM DTT, 4 mM MgCl2 at pH 7.4.) for up to 4 weeks when being used in
gliding assays. Prior to use in filament gliding assays, the final purification steps for
HMM were performed to remove any enzymatically dead myosin motors. Myosin stock
is diluted in myosin buffer to final concentration of 180 µg/ml myosin, 100 µg /ml
unlabeled F-actin, and 1 mM ATP. The myosin and actin were centrifuged for 20 minutes
at 95,000 rpm and 4°C. Enzymatically dead myosins bind and do not release from actin
filaments, and therefore pellet during centrifugation. Use of myosin remaining in the
supernatant ensures the best activity of the motors and the removal of dead motors
reduces additional drag on these active motors in these motility assays.

2.3.4 Kinesin-1 Preparation
Truncated kinesin-1, 560 amino acids in length, with a 6x His tag and GFP at the
amino terminus (AddGene) was transfected into BL21 bacteria cells for protein
expression and purification, as previously described 105,106. Kinesin was aliquoted and
drop frozen in 30% sucrose in PEM-100 for use over 6-9 months. Prior to use in filament
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gliding assays, kinesin-1 was clarified by centrifugation at 360,000 xg for 10 minutes at
4°C.

2.3.5 Filament Gliding Assay
Filament gliding assays to accommodate both actin and microtubule gliding were
modified from microtubule and actin gliding assays (Fig 2.1). Coverslips were coated
with 0.1% nitrocellulose diluted in amylacetate using a spin coater at 3,500 rpm for 30
seconds. Coverslips were used to create experimental chambers using double stick tape to
create a flow path between a slide and the coverslip. Chambers were 10 μl in volume.
Myosin (530 nM) and kinesin (58 nM) motors were mixed, added to the chamber, and
incubated for 5 minutes to allow them to adhere to the surface. The surfaces were blocked
by adding 0.5 mg/ml BSA in actin buffer (25 mM imidazole, 25 mM KCl, 1 mM EGTA,
10 mM DTT, 4 mM MgCl2 at pH 7.4). Cytoskeletal filaments were added to the chamber
and allowed to adhere. Actin filaments were diluted in actin buffer with oxygen
scavenging system (0.016 μM glucose oxidase, 0.12 mg/ml catalase) and microtubule
filaments were diluted in PEM-100 and 20 μM Taxol with the same oxygen scavenging
system. Finally, motility solution (50 mM KCl, 2.5 mM ATP, 10 mM DTT, 30 μM
Taxol, 0.6% methylcellulose in actin buffer) is added to initiate the gliding activity.
In order to vary the density of the cytoskeletal filaments for each experiment, I
adjusted the concentration of the filaments that were added to the chamber. The
concentration was described by the concentration of the tubulin or G-actin subunits
added. The density of the filaments was estimated from the concentration of subunits
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Figure 2. 1 Composite driven active rod experiments. (A) The drive rods are
composed of microtubule and actin filaments, which are polymerized from tubulin
dimers and globular actin monomers, respectively. (B) Microtuules are driven by
the ATP turn-over of kinesin-1 motor proteins. Actin filaments are driven by the
ATP turn-over of myosin II motor proteins. Both motors are truncated forms.
Kinesin-1 is truncated at amino acid 560 and expressed in bacteria. Myosin-II is
enzymatically cleaved to make heavy meromyosin (HMM) and purified from chick
muscles. (C) Active rod experiments performed in a filament gliding assay. Kinesin1 and myosin II are both adhered to the cover glass. Microtubules and actin
filaments are added to the chamber where they bind to the motors and are propelled
via ATP. Methylcellulose is added to keep actin and microtubule filaments crowded
to the surface.
using the median length measurement (Fig 2.2) of each filament, assuming that all the
filaments were this median contour length, Lc. The contour length was used to find the
number of subunits per filament and the approximate surface area projection of each
22

filament. For microtubules, the number of subunits per filaments was approximated by
assuming that the microtubules had 13 protofilaments around and a dimer was 8 nm in
length. For an actin filament, there were two protofilaments and each monomer was 5 nm
in length. The molar concentration was converted to the number of filaments using the
estimation of the number of subunits per filament. The contour length was also used to
find the volume of an individual filament, and the volume was converted to the surface
area of the filament by raising it to the 2/3rds power. These estimations were used to
change the concentration of tubulin or G-actin subunits into the number of filaments in
the chamber and the surface density of filaments in the chamber, as reported. Because
actin and microtubules are filaments, and they are polymerized at high density, they have
the ability to be entangled networks in the test tube. This filament entanglement was the
largest source of variation in our experimental system because the local filament density
could change when entangled. When pipetting the filaments to dilute them, the entangled
filaments could result in pulling out more or fewer filaments than expected. Further, the
final chamber wash, which included methylcellulose had to be pipetted gently to prevent
disruption or breakage of the methylcellulose.
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Figure 2. 2 Filament characterization. (A) Filament contour lengths were measured
for actin filaments and microtubule filaments. (i) Probability distribution functions
(PDFs) of actin filaments (red circles, N = 1070) and microtubules (blue squares, N =
865) were binned with 0.25 μm sized bins and normalized. Data was fit to a
lognormal function for actin (dark red line) and microtubules (dark blue line). See
supplemental information for fit equation and supplemental table 1 for all fit
parameters with uncertainty and goodness of fits. (ii) Cumulative distribution
functions (CDFs) of the same data for actin filaments (red circles, N = 1070), and
microtubules (blue squares, N = 865). CDFs were normalized and fit with the error
function appropriate for lognormally distributed data for actin filaments (dark red
line) and microtubules (dark blue line). See supplemental information for fit
equation and supplemental table 2 for all fit parameters with uncertainty and
goodness of fits. (iii) Using the fit parameters from the CDF data, I found the
median contour lengths for both actin filaments (red bars) and microtubules (blue
bars). Error bars represent the uncertainty of the fits parameter for the median. (B)
Filament velocities were measured for actin and microtubule filaments separately.
(i) PDFs of actin filament velocities (red circles, N = 276) and microtubules (blue
squares, N = 167) were binned with 0.05 μm/s sized bins and normalized. Data was
fit to a lognormal function for actin (dark red line) and microtubules (dark blue
line). See supplemental information for fit equation and supplemental table 3 for all
fit parameters with uncertainty and goodness of fits. (ii) Cumulative distribution
functions (CDFs) of the same data for actin filaments (red circles, N = 276), and
microtubules (blue squares, N = 167). CDFs were normalized and fit with the error
function appropriate for lognormally distributed data for actin filaments (dark red
line) and microtubules (dark blue line). See supplemental information for fit
equation and supplemental table 4 for all fit parameters with uncertainty and
goodness of fits. (iii) Using the fit parameters from the CDF data, we found the
median filament velocities for both actin filaments (red bars) and microtubules
(blue bars). Error bars represent the uncertainty of the fits parameter for the
median.

In order to mitigate these issues and increase the reproducibility of our
experiments, I performed the following steps for each experiment. First, microtubules
were sheared 3 times using a Hamilton syringe to purposely break up entangled networks
and to create microtubules that were relatively short (Lc ~ 5 µm, Fig 2.2). Actin filaments
were polymerized to be short (Lc ~ 1 µm, Fig 2.2), but they were still entangled at high
concentration. In order to mix the labeled with unlabeled actin filaments, labeled
filaments were added to the unlabeled filaments and were mixed by stirring with the
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pipette tip. The actin filaments were never pipetted excessively nor were they vortexed to
mix, as this would cause shearing and reduction of the length of the filaments. All
chambers were visually inspected to determine if the filament density was similar from
chamber to chamber for the same experimental parameters. If a chamber did not appear
to have a similar or expected density or either actin or microtubules, it was not used for
analysis.
Another source of uncertainty of the experiments was the labile nature of the
isolated kinesin-1 or myosin II motors. These motors were fairly stable when stored but
would sometimes prematurely expire and no longer function. If either the microtubules or
actin filaments did not bind to the surface or did not glide, the chamber was discarded,
and a new preparation of kinesin-1 or myosin II was purified. During this study, two
different myosin II preparations from chicken and three different kinesin-1 preparations
from bacteria were prepared. The majority of the data reported was from a single
preparation of both kinesin-1 and myosin II.
As described above, the final purification step for myosin II motors was
performed each day prior to using the myosin II motors to remove myosin II motors that
may have expired in storage. In this step, the myosin was bound to actin filaments and
released using a high concentration of ATP. Despite all these procedures, I still had some
enzymatically dead myosin II motors bound to the surface in the experiment. In typical
actin gliding assays, one would add in unlabeled actin filaments to block these dead
motors in the chamber. In this work, such additional filaments would increase the
concentration at the lowest densities of filaments, so I could not include them. Thus, I had
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some labeled filaments at the lowest actin concentration that would bind to dead myosinII molecules and be immobile.

2.4 Imaging and Image analysis
For all assays, gliding filaments were visualized using epi-fluorescence imaging
on a Nikon Ti-E inverted microscope with either a 60x water immersion objective (NA =
1.38) or a 60x oil-immersion objective (NA = 1.49). Rhodamine actin (excitation: 530
nm, emission: 560 nm) and Dylight 650 (excitation: 650 nm, emission: 700 nm) or
rhodamine microtubules (emission: 530 nm, excitation 560 nm) were imaged using
sequential imaging for 2 minutes to 60 minutes and recorded using Nikon Elements.
Images were projected onto the detector of a Scientific-CMOS camera (Zyla, Andor),
recorded, and saved as .nd2 files (compressionless tif files) with the metadata. Image data
was imported into ImageJ/Fiji using the Bioformats Imager. The pixel size was 108
nm/pixel. The diffraction limit for the fluorescence image was approximately 300 nm,
which corresponded to about 3 pixels. All experiments were performed at room
temperature (23°C) in a temperature-controlled room with year-round heating and air
conditioning.
Determination of the state of the filament gliding system were performed by
creating standard deviation z-projections of the time series movie data using ImageJ/Fiji.
The standard deviation images were inspected manually and classified initially in that
manner. In order to reduce human bias, I also used two different ImageJ/FIJI plugins to
characterize the global organization of the filaments. The programs were “Directionality”
107

or “OrientationJ” 108. Both of these systems can use either a nearest neighbor approach

or fast Fourier Transforms to detect the local gradient in the intensity of an image. The
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gradient of the intensity in a local vicinity corresponds to the local orientation. I found
that both of these systems worked well for identifying the regions where filaments were
aligned and the orientation of the aligned regions. Global alignment could be visually
inspected using a color-coding. Histograms of the angles represented within the image
were plotted (Fig 2.3). When the image was globally isotropic, the angles were evenly
distributed, with no or very little peak at the alignment angle. For aligned images, there
was one dominant or characteristic angle in the histogram between -90 and 90 degrees, as
would be expected for aligned filaments. Using this analysis, I could verify in a nonbiased way, when the standard deviation images revealed alignment for most of the data
(Fig 2.3 A).
I found that the ImageJ/FIJI plugins or programs had some difficulty with certain
data sets. I show two difficult data sets in the supplement (Fig 2.3 B). The reasons for the
uncertainty were sometimes due to the fact that there were very few filaments, such as in
the most dilute regimes. Other times, the images had non-motile, background aggregates
that showed up in fluorescence. Although these aggregates should be round, if the movie
displayed thermal drift, the points would be analyzed as orientation in the data. I
attempted to correct this using drift correction plugin (StackReg) but was not able to drift
correct all the data sets. Finally, sometimes the data appeared isotropic to our eyes, but
appeared to have some overall orientation. This may have been due to the fact that the
goal of the program is to seek out and report orientation based on intensity gradients.
Samples with low signal-to-noise, which some of our data had due to photobleaching,
may have appeared to have some orientation. For completeness, I show examples of

28

when the Directionality or OrientationJ analysis did not report the overall arrangement of
the filaments as clearly (Fig 2.3 B).
Another analysis that could be employed to characterize the type of alignment in
the network is spatial correlation measurements. Briefly, I used a MATLAB code that
uses Fast Fourier Transform, FFT, to compute pair autocorrelation function 109. The 2D
correlation function map 𝑔(𝑟, 𝜃) =

𝐹𝐹𝑇 −1 ( |𝐹𝐹𝑇 (𝐼)|2 )
𝐹𝐹𝑇 −1 ( |𝐹𝐹𝑇 (𝑊)|2 )

was calculated for an image, I.

Here, FFT-1 is a revers Fast Fourie Transform, while r and θ are distance and angle,
respectively. Also, W is a mask that has the same size as the image where all pixels have
a value of 1 inside the measurement area and was used for normalization purposes. The
2D correlation map of example images with nematic and isotropic organization for actin
and microtubule channels are displayed in Fig 2.4 and Fig 2.5. To calculate the 1D
correlation function G(r) for an image, g(r,θ) was averaged over all the angels θ for
different r values. Then, 1D correlation function,

G(r) − 1
𝐺𝑚𝑎𝑥 (𝑟)−1

, was plotted versus r (μm)

while Gmax(r) has the greatest value of the 1D correlation function (Fig 2.4 v, vi and Fig
2.4 v,vi). The 2D correlation map of the nematic microtubule and actin images (Fig 2.4
iii, iv) indicates that g(r,θ) map highly depends on θ angles, where the repetitive
structures are formed along the alignment axes for filaments. However, isotropic
microtubule and actin images (Fig 2.5 iii, iv) display radially symmetric g(r,θ) maps as
predicted 110. However, although the 2D correlation maps show angular dependent
patterns for nematically ordered filaments, it seems that it is not the optimum method to
quantify the state of alignment in the intermediate cases where isotropic to nematic/polar
transition occurs.
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After all, in order to assess if bundles of microtubules or actin filaments were
displaying nematic or polar alignment, I used kymographs (space-time plots). The
location of the linear region of interest for the kymograph was determined using the
standard deviation z-projections of the movies, which represented the tracks of filaments
over time. The linear region of interest was moved to the movie and created using the
MultiKymograph plugin in ImageJ/FIJI. The linear region of interest was expanded to
three pixels, which is a diffraction-limited region for our microscope. Kymographs
displayed the number of filaments and the direction of the filaments that moved along the
same track within a diffraction-limited region over the entire movie.
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Figure 2. 3 Example images and angle analysis using Directionality plugin in
ImageJ/Fiji. (A) Filaments that were well-aligned (nematic or polar) for (i)
microtubules or (ii) actin are displayed as a standard deviation compression over
movie. The angular distribution for (iii) microtubules and (iv) actin of the images in
(i) and (ii), respectively. Nematic or polar alignment results in an asymmetric
distribution peaked at one angle. (B) Filaments that are not well-aligned (isotropic)
for (i) or (ii) actin are displayed as a standard deviation compression over the time
series of the movie. The angular distribution for (iii) microtubules and (iv) actin of
the images in (i) and (ii), respectively. Isotropic alignment results in an almost flat
distribution, which some edge effects. Some of the angle distributions were more
ambiguous, and visual inspection was more reliable.
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Figure 2. 4 Example images and correlation analysis for nematic/polar organization
of filaments. (i, ii) Nematic organization for microtubule (i) and actin (ii) filaments
displayed as an intensity compression over movie. Each image is 1429×1429 pixel or
154.81 μm×154.81 μm. Scale bar is 20 μm and applies to both images. (iii, iv) 2D
spatial correlation g(r,θ) is displayed for microtubule (iii) and actin (iv) filaments
versus pixels. (v, vi) 1D spatial correlation is plotted versus short range distance,
r(μm), for microtubules (v) and actin filaments (vi). The results calculated after
angular averaging of g(r,θ) and then normalization. Correlation values 1 and 0
correspond to high correlation and no correlation, respectively.
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Figure 2. 5 Example images and correlation analysis for isotropic organization of
filaments. (i, ii) Isotropic organization for microtubule (i) and actin (ii) filaments
displayed as an intensity compression over movie. Each image is 1429×1429 pixel or
154.81 μm×154.81 μm. Scale bar is 20 μm and applies to both images. (iii, iv) 2D
spatial correlation g(r,θ) is displayed for microtubule (iii) and actin (iv) filaments
versus pixels. (v, vi) 1D spatial correlation is plotted versus short range distance,
r(μm), for microtubules (v) and actin filaments (vi). The results calculated after
angular averaging of g(r,θ) and then normalization. Correlation values 1 and 0
correspond to high correlation and no correlation, respectively.
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2.5 Results
2.5.1 Filament and gliding characteristics
I systematically studied active matter composite systems of actin and microtubule
filaments propelled by myosin II and kinesin-1 motors, respectively. Immobilized myosin
and kinesin proteins adhered to a nitrocellulose-coated coverslip through non-specific
interaction as it was described previously 69. Methylcellulose, a macromolecular
crowding agent routinely used in actin gliding assays was added (0.6%, 88,000 MW) to
keep the filaments close to the surface 100,111 (Fig 2.1).
Actin and microtubule filaments have different bending stiffnesses that make their
composite networks a unique and interesting system to study. The persistence length of
actin filaments is around 16 μm 14, and microtubules are more rigid with the persistence
length of 1 mm 14,36,37. I measured the counter length of actin and microtubule filaments
to assure they were in a regime that act as rigid rods. I found that their contour length
distributions were log normal as it was expected for polymerization reactions 112. I plotted
the probability distribution function (PDF) and cumulative distribution function (CDF)
for contour lengths of both filaments (Fig 2.2.A).
Normalized probability distributions were fit to lognormal distributions of the
form:
𝑃𝐷𝐹(𝑥) =

𝐴
𝜎𝑥

exp (−

(ln(𝑥)− 𝑥0 )2
2𝜎2

)

Eq 2.1

Where A is an amplitude, x0 and σ are the mean and standard deviation of the normal
distribution of log(x). For normalized data, the amplitude should equal the inverse of the
square root of 2π, but we cannot discount the possibility of undercounting the data. I found
the data was better fit with an amplitude to help correct for systematic measurement errors.
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The best fit parameters for the filament contour length probability distribution functions
can be found in Table 2.1.

Table 2. 1 Best fit parameters for filament contour length probability distribution
functions
Data Set
A
x0
σ
R2
Actin

0.101 ± 0.004

-0.09 ± 0.02

0.65 ± 0.02

0.989

Microtubules

0.099 ± 0.002

1.59 ± 0.02

0.79 ± 0.02

0.969

Normalized cumulative distributions were fit to the error function very well,
which is the expected fit for a cumulative distribution function of a lognormal
distribution of the form:
𝐶𝐷𝐹(𝑥) =

1
2

+

1
2

erf (

ln (𝑥)− 𝑥0
√2𝜎

)

Eq 2.2

When x0 and σ are as mentioned above. Here, an amplitude is not required, so it has one
less fitting parameter. The best fit parameters for the filament contour length cumulative
distribution functions can be found in Table 2.2.
Table 2. 2 Best fit parameters for filament contour length cumulative distribution
functions
Data Set
x0
σ
R2
Actin

-0.2045 ± 0.0005

0.5403 ± 0.0009

0.999

Microtubules

1.6196 ± 0.0008

0.778 ± 0.001

0.999

I found the median contour length for the actin filaments was 0.980 ± 0.001 μm
and for microtubules was 5.05 ± 0.008 μm (Fig 2.2.A).
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Another important characteristic in a gliding assay is the propulsion speed of the
filaments (Fig 2.2.B). First, I directly measured the velocity of self-propelled filaments at
low densities of actin and microtubule filaments. Normalized probability distributions
were fit to lognormal distributions using equation 2.1. The best fit parameters for the
propulsion speed probability distribution functions can be found in Table 2.3.
Table 2. 3 Best fit parameters for propulsion speed probability distribution
functions
Data Set
A
x0
σ
R2
Actin

0.021 ± 0.001

-1.07 ± 0.07

0.94 ± 0.05

0.961

Microtubules

0.025 ± 0.004

-0.9 ± 0.2

1.0 ± 0.1

0.840

Also, normalized cumulative distributions were fit to equation 2.2. The best fit
parameters for the propulsion speed probability distribution functions can be found in
Table 2.4.
Table 2. 4 Best fit parameters for propulsion speed cumulative distribution
functions
Data Set
x0
σ
R2
Actin

-1.077 ± 0.001

0.805 ± 0.002

0.999

Microtubules

-1.131 ± 0.005

0.726 ± 0.009

0.995

I find that the velocity distributions are almost identical when plotted as
probability distribution histograms (Fig. 2.2.B i). Using the Kolmogorov-Smirnov
statistical test, I find that the probability that these two distributions are distinct is 16% (p
= 0.161), so I conclude that the distributions are identical to our ability to measure it.
Median velocities, determined from error function fits to the cumulative distribution
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functions (Fig 2.B ii) are very similar for actin (0.341 ± 0.001 μm/s) and microtubules
(0.323 ± 0.004 μm/s) (Fig 2.2.B iii).

2.5.2 Methylcellulose enhances microtubule-microtubule interactions
Given our past results and long-time experience with microtubule gliding 96–98, we were
surprised to see that microtubules became well-ordered at high density when we
performed experiments as described here. The buffers and protein constituents are
different in the current assays compared to prior work, so we examined what might cause
the difference. We discovered that the presence of methylcellulose in the experiment was
capable of inducing microtubule-microtubule interactions that result in the formation of
large-scale bundles (Fig. 2.6.B). Methylcellulose is a crowding agent used in both actin
gliding and microtubule dynamic instability assays to force the filaments to stay close to
the surface during the assay. We added it here in the attempt to create a composite assay
between microtubule and actin gliding. Excitingly, it enhanced the microtubule
interactions, such that they were able to form self-organized bundles during gliding.
Further, these bundles appear to be polar – all moving in the same direction. Thus, not
only is the methylcellulose allowing the microtubules to sterically interact with each
other, the microtubules are likely engaged closely and without lubrication, as has been
reported when using poly-ethylene glycol 113.
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Figure 2. 6 Methylcellulose increases microtubule interactions. (A) Time series of
gliding microtubules in a chamber with kinesin-1 motors only without
methylcellulose. Microtubules do not exhibit long-range interaction. Microtubules
do create small loops. Time between frames is 100 s. (B) Time series of gliding
microtubules in a chamber with kinesin motors and 0.3% methylcellulose, as used
in our composite assays. Microtubules begin in a nematic phase, which is aligned
and transition to a polar phase. Time between frames is 100 s. For all images, the
scale bar is 10 μm.

2.5.3 Microtubules exhibit Isotropic, Nematic, and Polar states
Using the composite experimental system including kinesin, myosin, and
methylcellulose, I observed microtubules alone can alter their self-organization as a
function of filament density. At low filament density, the organization of microtubules in
the chamber is isotropic. I displayed the motion of individual filaments by overlaying
images of microtubules as different colors to represent different times (Fig 2.7.A). The
tracks were isotropically distributed, revealing the polar
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Figure 2. 7 Steady states of microtubule organization as a function of increasing
microtubule filament density. (A) Color time overlays where each frame of a time
series is overlaid as a different color, as indicated by the color scale bar. (i) Lowest
concentrations of microtubules display an isotropic phase with filaments pointing in
all directions. The concentration (c) is 0.5 μM tubulin dimers. The filament density
(ρ) is 0.0267 filaments per μm2. The surface area fraction of filaments (ϕ) is 0.033.
The color time scale for this image is from 0 to 180 s. (ii) The intermediate
concentration of microtubules displays a nematic phase with filaments co-aligning
locally and moving in antiparallel directions within the high density regions. The c
is 2.5 μM tubulin dimers. The ρ is 0.133 filaments per μm2. The ϕ is 0.0167. The
color time scale for this image is from 0 to 40 s. (iii) The highest concentration of
microtubules displays a polar phase with filaments co-aligning globally and moving
in the same directions within the high density regions. The c is 5 μM tubulin
dimers. The ρ is 0.267 filaments per μm2. The ϕ is 0.033. The color time scale for this
image is from 0 to 120 s. (B) In order to determine the direction of the filaments
within the high-density regions of the images, I created kymographs where the
image along the linear region of interest is sequentially layered for each time step.
The time dimension is portrayed on the y-axis. The space dimension along the
filament is portrayed along the x-direction. (i) For the lowest density of filaments,
visible tracks in the color time overlays were used to create kymographs. These
tracks were deposited by single filaments, as evidenced by the single trail of intensity
in the kymographs. (ii) For intermediate densities of filaments, the dense regions of
the color-time overlay were used to create kymographs. The filaments moving in the
high density regions were moving in both directions, as evidenced by the diagonal
lines in both directions. (iii) For high density filaments, the high density regions of
the color-time overlays were used to create the kymograph. All the filaments appear
to move in the same direction implying that the high density region has polaraligned filaments. All scale bars in the x-direction are 5 μm for all images. All scale
bars in the y-direction were 1 min in time for all kymographs.

gliding trajectory of individual filaments (Fig 2.7.A i). Using these tracks, I created
kymographs (space-time diagrams) of the moving filaments to reveal the direction and
speed of each filament as it glided (Fig 2.7.B). The intensity of the filament was
displayed with distance along the track on the x-axis, and time along the track in the ydirection. The diagonal lines indicated motion of the filaments parallel to the track. For
low densities, the kymographs showed one filament gliding in only one direction (Fig
2.7.B i).
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At intermediate filament densities, the tracks in the time color overlay image were
mixed because many filaments were overlapping in a condensed, active stream of
filaments (Fig 2.7.A ii). The condensed streams that appeared in the overlay image were
used to create a kymograph to reveal the velocity and direction of filaments in the stream.
In the kymograph, tracks moved in both directions (left and right). The width of the line
used to create the kymograph was ~300 nm, which was approximately the diffraction
limit of the microscope. The fact that multiple filaments with opposing directions were
observed within the same diffraction-limited region of the stream implies that these
filaments were organized into a nematic within the stream.
At higher concentrations, the time color overlay was also a mix of colors, appearing
white in some regions, because they were present over almost the entire imaging time
(Fig 2.7.A iii). The condensed streams at higher concentration appeared a bit wider and
better condensed than those at intermediate concentration. Creating a kymograph from
these condensed stream regions, I observed that there are still multiple filaments within a
diffraction-limited region. Unlike the intermediate filament density, I observed that all
the filaments were proceeding in the same direction, creating a polar array of filaments
(Fig 2.7.B iii). Thus, in our system, the microtubules self-organize into nematic or polar
streams as a function of the filament density.

2.5.4 Actin filaments exhibit Isotropic and Nematic states
Using the same time color overlays and kymographs, I examined the direction and
velocity of actin filaments (Fig 2.8). As for microtubules, low actin filament densities
resulted in individual trajectory traces that correspond to the motion of individual actin
filaments (Fig 2.8.A i). These trajectories had a low persistence length, similar to the
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persistence length of actin filaments. Prior work has demonstrated that the persistence
length of gliding trajectories of actin and microtubules are equivalent to the persistence
length of the filaments 114. When I created kymographs from the trajectories, I found that
some filaments moved slower and had frequent pauses (Fig 2.8.B i, top), likely due to
inactive myosin II in the chamber, as described in the methods. Other trajectories moved
faster and did not pause (Fig 2.8.B i, bottom).
At higher actin filament densities, I again saw condensed streams using the timecolor overlay. When the concentration of actin filaments was higher, the persistence of
the trajectories increased significantly, and the direction of the filaments became aligned
(Fig 2.8.A ii). Over time, the filaments in the chamber became more condensed, which
could be seen in comparing color time overlays for an early movie with one from a later
movie in the same chamber. The density of filaments increased within the streams, and
streams coalesced and became more defined (Fig 2.8.A ii Early and Late).
Using kymographs, it was clear that the condensed streams contained filaments
moving in both directions, implying that they were nematic in organization (Fig 2.8.B ii).
Both the early and late movies showed nematic ordering with filaments moving both
directions within the same diffraction-limited region. The main difference was the density
of filaments. Early movies had a fewer filaments within a diffraction-limited region, but
late time kymographs showed more filaments, again implying that the filament density
within the streams increased over time (Fig 2.8.B ii Early and Late).
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Figure 2. 8 Steady states of actin filament organization as a function of increasing
actin filament density. (A) Color time overlays where each frame of a time series is
overlaid as a different color, as indicated by the color scale bar. (i) Lowest
concentrations of actin filaments display an isotropic phase with filaments pointing
in all directions. The concentration (c) is 0.5 μM actin monomers. The filament
density (ρ) is 0.2 filaments per μm2. The surface area fraction of filaments (ϕ) is
0.0008. The color time scale for this image is from 0 to 120 s. (ii) The highest
concentration of actin filaments displays a nematic phase with filaments co-aligning
globally and moving in antiparallel directions throughout the space. The c is 10 μM
tubulin dimers. The ρ is 3.0 filaments per μm2. The ϕ is 0.015. Filament alignment
occurs rapidly, but the local density of the aligned filaments changes over time.
Early images of these samples do not show density fluctuations – only global
alignment. Later imaging of the same sample shows the accumulation of highdensity regions. The color time scale for these time series are from 0 to 120 s. (B) In
order to determine the direction of the filaments within the high-density regions of
the images, I created kymographs where the image along the linear region of
interest is sequentially layered for each time step. The time dimension is portrayed
on the y-axis. The space dimension along the filament is portrayed along the xdirection. (i) For the lowest density of filaments, visible tracks in the color time
overlays were used to create kymographs. These tracks were deposited by single
filaments, as evidenced by the single trail of intensity in the kymographs. Some
filaments were observed to pause because of interactions with some dead myosins
(top). When unlabeled actin filaments were also included, all filaments were
observed to move without pausing (bottom). (ii) For high densities of filaments, the
denser regions of the color-time overlay were used to create kymographs. For early
time movies, a single diffraction-limited region used for the kymograph still
displayed filaments moving in both directions, even though the density was not as
high. For the late time movies, the regions of high density show motion in both
directions and a significantly higher number of filaments passing parallel to the
diffraction-limited region. All scale bars in the x-direction are 5 μm for all images.
All scale bars in the y-direction were 1 min in time for all kymographs.

2.5.5 Actin-Microtubule Composite Active Matter Velocity Distributions
I next combined the actin and microtubules together in the same assay to
determine the interplay between the filaments. I performed a series of experiments with
varying actin and microtubule concentrations and assessed the state of the system at late
times (after allowing the system to evolve into steady state). A particularly interesting
observation was that the velocity of the actin filaments was faster at higher density (Fig
2.9). It was difficult to track the velocity of individual filaments at the highest densities
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within streams, but I was able to track some filaments, and used those for this analysis. I
quantified velocities for actin at 10 µM without microtubules or at 10 µM with 5 µM
microtubules. Interestingly, I found that actin filaments were propelled significantly
faster at the highest actin densities when compared to actin filaments at low density, 0.5
µM without microtubules (Fig 2.2.B, 2.9.A). Using the KS test for significance, the
probability that these velocity distributions were the same is less than 0.01% (p <
0.0001). This was true for both actin alone and in the presence of microtubules.
For actin filaments at low and high densities, normalized probability distributions
were fit to lognormal distributions using equation 2.1. The best fit parameters for the
propulsion speed probability distribution functions can be found in Table 2.5.

Table 2. 5 Best fit parameters for actin propulsion speeds probability distribution
functions
Data Set

A

x0

σ

R2

Actin 0.5 µM Alone

0.021 ± 0.001

-1.07 ± 0.07

0.94 ± 0.05

0.961

Actin 10 µM Alone

0.045 ± 0.004

-0.07 ± 0.06

0.62 ± 0.05

0.861

Actin 10 µM with 5
µM Microtubules

0.040 ± 0.003

-0.18 ± 0.04

0.41 ± 0.04

0.854

Also, normalized cumulative distributions for action filaments were fit to equation
2.2. The best fit parameters for the propulsion speed probability distribution functions can
be found in Table 2.6.
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Table 2. 6 Best fit parameters for actin propulsion speed cumulative distribution
functions
Data Set

x0

σ

R2

Actin 0.5 µM Alone

-1.077 ± 0.001

0.805 ± 0.002

0.999

Actin 10 µM Alone

-0.175 ± 0.003

0.532 ± 0.005

0.995

Actin 10 µM with 5 µM
Microtubules

-0.262 ± 0.003

0.407 ± 0.005

0.985

When I quantified the velocities of microtubules at 5 µM without actin or at 5 µM
with 10 µM actin, I found minimal changes to the microtubule velocity (Fig 2.2.B,
2.9.B). Comparing 0.5 µM to 5 µM microtubules, both without actin, the probability that
they were the same is 4% (KS test, p = 0.04). Comparing 0.5 µM without actin to 5 µM
microtubules with 10 µM actin, the probability that they were the same is 3.5% (KS test,
p = 0.035). Although these results could be significant, more data would need to be taken
to increase the confidence in these differences.
For microtubules at low and high densities, normalized probability distributions
were fit to lognormal distributions using equation 2.1. The best fit parameters for the
propulsion speed probability distribution functions can be found in Table 2.7.
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Table 2. 7 Best fit parameters for microtubule propulsion speed probability
distribution functions
Data Set

A

x0

σ

R2

Microtubules 0.5 µM Alone

0.0220 ± 0.002

-1.0 ± 0.1

0.94 ± 0.08

0.836

Microtubules 5 µM Alone

0.043 ± 0.005

-0.9 ± 0.1

0.74 ± 0.09

0.846

Microtubules 5 µM with 10
µM Actin

0.041 ± 0.003

-0.96 ± 0.04

0.46 ± 0.04

0.927

Also, normalized cumulative distributions for microtubules were fit to equation
2.2. The best fit parameters for the propulsion speed probability distribution functions can
be found in Table 2.8.
Table 2. 8 Best fit parameters for microtubule propulsion speed cumulative
distribution functions
Data Set

x0

σ

R2

Microtubules 0.5 µM
Alone

-1.131 ± 0.005

0.726 ± 0.009

0.990

Microtubules 5 µM
Alone

-0.905 ± 0.009

0.70 ± 0.01

0.982

Microtubules 5 µM with
10 µM Actin

-1.040 ± 0.006

0.41 ± 0.01

0.985

The median velocities for the actin and microtubules show that the velocity is
strikingly increased for actin filaments compared to microtubules (Fig 2.9.C). Such an
increase in velocity should increase the probability of forming aligned states.
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Figure 2. 9 Velocity of actin filaments increases with polymer concentration. (A)
Actin velocities with crowding. (i) Probability distribution functions of the velocity
of trackable actin filaments gliding in the myosin and kinesin gliding assay at 0.5
µM without microtubules (red filled circles), 10 µM without microtubules (blue
filled circles), or 10 µM with 5 µM microtubules (green filled circles). Fits to the
data are lognormal fit equation (Equation 2.1) for 0.5 µM without microtubules
(dark red line), 10 µM without microtubules (dark blue line), or 10 µM with 5 µM
microtubules (dark green line). (ii) Cumulative probability distribution functions of
the velocity of trackable actin filaments gliding in the myosin and kinesin gliding
assay at 0.5 µM without microtubules (red filled circles), 10 µM without
microtubules (blue filled circles), or 10 µM with 5 µM microtubules (green filled
circles). Fits to the data are lognormal fit equation (Equation 2.2) for 0.5 µM
without microtubules (dark red line), 10 µM without microtubules (dark blue line),
or 10 µM with 5 µM microtubules (dark green line). (B) Microtubules velocities with
crowding. (i) Probability distribution functions of the velocity of trackable
microtubule filaments gliding in the myosin and kinesin gliding assay at 0.5 µM
without actin (red filled squares), 5 µM without actin (blue filled squares), or 5 µM
with 10 µM actin (green filled squares). Fits to the data are lognormal fit equation
(Equation 2.1) for 0.5 µM without actin (dark red line), 5 µM without actin (dark
blue line), or 5 µM with 10 µM actin (dark green line). (ii) Cumulative probability
distribution functions of the velocity of trackable microtubule filaments gliding in
the myosin and kinesin gliding assay at 0.5 µM without actin (red filled squares), 5
µM without actin (blue filled squares), or 5 µM with 10 µM actin (green filled
squares). Fits to the data are lognormal fit equation (Equation 2.2) for 0.5 µM
without actin (dark red line), 5 µM without actin (dark blue line), or 5 µM with 10
µM actin (dark green line). (C) Median velocities from the fits to the cumulative
distribution functions for actin (filled bars) and microtubules (outlined bars). Actin
data from 0.5 µM without microtubules (red filled bar), 10 µM without
microtubules (blue filled bar), or 10 µM with 5 µM microtubules (green filled bar).
Microtubule data from 0.5 µM without actin (red filled bar), 5 µM without actin
(blue filled bar), or 5 µM with 10 µM actin (green filled bar). Error bars represent
the uncertainty of the median velocity fit parameter from Equation 2.2. See Tables
2.5–2.8 for all fit parameters with uncertainty and goodness of fits.

2.5.6 Actin-Microtubule Composite Active Matter Phase Diagram
Using the same parameters described above for actin or microtubules alone, I
assessed if each system displayed isotropic, nematic, or polar order in either the
microtubule or actin organizations. I created a phase diagram of the emergent behavior I
observed (Fig 2.10.A).
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In the low-density regions on the phase diagram, both microtubules and actin
were isotropic, which would be expected. The density of each was too low to have
interaction among the same filaments, and the total polymer mass was also very low. For
the highest microtubule and actin filament densities, both filaments became co-aligned
and nematic (Fig 2.10.B). At the highest density, I observed individual, fluorescentlylabeled actin filaments, which were added at a ratio of one fluorescent filament to 99
unlabeled filaments. The labeled actin, serving as tracers, glided along paths of high
microtubule density (Fig 2.10.B). The microtubule bundles were visible within the actin
channel due to imperfect dichroic glass and the high density resulting in high signal.
At low densities of actin, I found that the presence of the actin disrupted the
microtubules’ polar order. Examining the last column of the diagram, when no actin was
present, the microtubules exhibited polar order. When even the lowest density of actin
was introduced to the system, the microtubules were no longer polar, but rather nematic.
This implied that the microtubule-microtubule interactions that cause
polar ordering were disrupted when actin filaments were present, implying that
the microtubules “sense” the presence of the actin filaments. This could mean that the
microtubule-microtubule interactions that lead to polar order are sensitive to even minor
disruption, yet the nematic alignment was more robust.
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Figure 2. 10 State diagram for actin and microtubule composite gliding assays. (A)
The actin filaments (red markers) were used at five different concentrations: 0.5
μM, 5 μM, 6.7 μM, 8.8 μM, and 10 μM corresponding to the following filament
densities (filaments per μm2): 0.2, 1.5, 2.0, 2.7, 3.0 and the following dimensionless
area fractions: 0.0008, 0.008, 0.010, 0.013, 0.015. The microtubules (blue markers)
where used at three different concentrations: 0.5 μM, 2.5 μM, and 5 μM
corresponding to the following filament densities (filaments/μm2): 0.03, 0.17, 0.34
and the following dimensionless area fractions: 0.004, 0.02, 0.04. For each
concentration pair observed, I used the definitions of isotropic, nematic, and polar
described in figure 2.7 and 2.8 to describe the organization of actin filaments or
microtubules. Isotropic organizations are denoted with a filled circle. Polar
organizations are denoted with a single-headed arrow. Nematic organizations are
denoted with a double headed arrow. Some organizational states were difficult to
determine or showed different organizations in different chambers. These were
mixed between isotropic and nematic and are denoted with a double headed wide
arrow. For each location on the state diagram, 2-5 different chambers were made
and 4-9 different 2-5 minute movies were recorded over one hour, as described. (B)
Example alignment of actin and microtubules. (i) Images from a time series of actin
gliding at 10 µM in the presence of (ii) 5 µM microtubules. (iii) Images are overlaid
with actin in red and microtubules in cyan. Short actin filaments that glide along
microtubule bundles are highlighted with an arrow head. Microtubule channel can
be seen through the actin channel due to high signal and imperfect dichroic glass.
Time between frames in second is given under the images, approximately 3 s apart.
Scale bar is 10 µm.
Both actin and microtubules can become entrained with the other filament’s
nematic order. For example, very high concentrations of actin (10 μM) were nematic.
When combined with a low concentration (0.5 μM) of microtubules, the very few, sparse
density of microtubules were observed to co-align with the actin filaments. They did not
form dense streams of microtubules, but rather were recruited by the nematic streams of
actin and co-aligned with them. Another example was when actin was at 5 μM, it was
typically isotropic. Yet, at the highest microtubule density (5 μM), the actin became
entrained in the microtubule nematic streams (Fig 2.10.B).
Interestingly, the entrainment and co-alignment is not perfectly reciprocal – actin
appeared to be less affected by microtubules. There were several examples where one
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type of filament was aligned, but the other stayed isotropic. For instance, at the lowest
actin concentration (0.56 μM), the actin filaments never co-aligned with microtubules,
despite excellent microtubule nematic ordering. I saw the same effect for actin at 5 μM
with microtubules at 2.5 μM. Microtubules were aligned, but actin was isotropic.
Although the actin organization was less sensitive to the microtubule
organization, there was some actin entrainment with microtubules. Examining the 5 μM
actin concentration row, the actin alone preferred to be isotropic. Yet, at the highest
microtubule density, the actin did co-align with the microtubules to participate in the
nematic organization. These results implied that the filaments could sense each other to
cause co-alignment, but only when they were at the highest concentrations.

2.6 Discussion
Here, I present a proof of principle for a composite active matter system
composed of actin-microtubule filament gliding assay. I found that the presence of other
motors on the surface that could not engage the filament of interest had no effect on the
gliding ability of the filaments, making the system potentially useful for future studies
(Fig 2.2). Further, I found a composite buffer condition that allows both actin and
microtubules to glide simultaneously and at about the same velocity. Excitingly, I also
found that methylcellulose has the ability to enable microtubules to interact to drive
alignment into nematic and polar order (Fig 2.6). A recent publication previously showed
that microtubules became nematic with higher methylcellulose but did not report polar
order, as I observe here 115. During the review of this manuscript, another publication
reported that methylcellulose was able to induce large-scale chiral vortices, which would
imply polar order of the filaments. These vortices were mostly observed around defects
53

within the chamber, such as air bubbles 116. These studies appear to be seeing a similar
phenomenon as I present for microtubules, although they did not characterize their
directionality. I found that the methylcellulose was not simply able to align filaments, but
cause polar ordering, similar to that observed with actin in the absence of crowders
previously 67. The effect of methylcellulose on microtubule active matter offers an
opportunity for control and a tuneability not previously controllable for this system.
One of the results of our experiments is the identification of the concentration of
polymer at which the system begins to exhibit orientationally ordered streams. I find that
this transition occurs between concentrations of 0.5 and 2.5 μM for microtubules and 5
and 10 μM for actin. These concentrations correspond to filament densities of 0.03 – 0.17
filaments/μm2 for microtubules and 1.5 – 3 filaments/μm2 for actin. Using this transition
density as a measure of the isotropic-nematic transition point, I find that it is indeed lower
than the Onsager estimate for long thin rods of the corresponding lengths (ρC = 3π / 2LC2)
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which would be 4.7 filaments/μm2 or 15.5 μM for actin and 0.18 filaments/μm2 or 2.7

μM for microtubules if I use the median length of the filaments to make the estimates.
Our findings are consistent with theoretical results on self-propelled rod models 79 and
simulations of filaments on motility assays 118, both of which predict an enhancement of
nematic order and hence a lowering of the transition density due to the self-propulsion of
the filaments. In order to make a quantitative comparison of experiments and the theory
as presented in 79, future work needs to be performed at different filament lengths and
different self-propulsion speeds.
Another interesting, yet unexplained result is that the actin filaments were
observed to glide faster in the presence of higher densities (Fig 2.9). The effect, although

54

present, is less pronounced and therefore reported with lower confidence for
microtubules. It is not clear why the filaments would be able to glide faster at high
densities. One possibility is the saturation of inactive myosins on the surface at high
density. At low density, I often observed filaments moored at locations of inactive
myosin. It is possible that at high density, all such locations were blocked, and the
filaments could move faster. Another possibility is that the actin filaments were straighter
and effectively stiffer when they are at higher density. Straight actin might enhance the
ATP turn-over through increasing the rate of ADP release, increasing the efficiency of
mechanochemical coupling in the actin-myosin system. Future studies could probe the
mechanism of this phenomenon by reducing the motor number, but maintaining high
density of actin filaments to see if velocity stays high when the filament trajectories are
straighter.
Prior simulations use the motor density on the coverslip as a measure of the selfpropulsion or activity in the system 118. In our assays, I used 58 nM kinesin-1 and 530
nM myosin II non-specifically adhered to the surface. I estimated the motor density in
two ways. To find the maximal motor density, I assumed all the motors inserted in the
chamber adhered to the available cover glass on the top and bottom. This estimate
resulted in 1,600 kinesin/μm2 and 15,000 myosin/μm2. These estimates are still less than a
saturating level of ~60,000 motors/μm2, assuming the motors each take up 16 nm2 on the
glass surface. At the lower end, I assume that the concentration of motors in the chamber
was constant and estimated the surface density from the given volume density of motors.
Using this second approximation scheme, I estimate the motor density to be 11
kinesin/μm2 and 47 myosin/μm2. These estimates are consistent with values reported in
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prior works 67,96,119. At these motor densities, using the width of the filament as the motor
capture radius, the simulations predict that the transition should occur at 5x10-5
microtubules/μm2 and 0.05 actin filaments/μm2
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, which is much lower than the values I

find in our experiments. There are many possible reasons why these predicted transition
locations do not match our results, including our estimates of motors on the surface,
estimates of the radius of capture for the filaments, and the length distributions of the
filaments and their inherent semi-flexibility. Future experiments will aim to quantify the
origins of these discrepancies.
A second main result of our experiments is a first look into the emergent
phenomenology when self-propelled filaments of different lengths and stiffnesses interact
with each other. Microtubules appear more susceptible to entrainment by actin in this
system, but actin filaments are not as affected by microtubule polymer. There are a
number of locations on the state diagram where the total polymer mass (microtubules and
actin combined) should be more than enough to cause actin filament alignment, yet the
actin does not align. For instance, actin alone shows nematic ordering when the area
fraction is above 0.015. Yet, when the total polymer mass is above 0.015, such as when
the microtubules are at 2.5 μM, the actin still does not align. Thus, the total polymer mass
is not a good order parameter for actin ordering. On the other hand, the total polymer area
fraction is a good order parameter for microtubule ordering into the nematic phase. In
fact, whenever the total polymer mass is above 0.02, microtubules appear to be ordered in
the system – whether that density to due to actin or microtubules. One plausible reason
for the different behavior of actin and microtubules could be their different stiffness,
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which will significantly change their interparticle interactions. Future experiments will
explore this hypothesis by changing the length of the filaments.
Understanding the physical mechanisms that lead to the phenomenology observed
in the model composite active matter system requires an exploration of the interplay
between self-propulsion speed, length and stiffness of a mixture of two species of selfpropelled rods. While the parameter space of different speeds has been explored in the
literature, and shown to produce unexpected segregation and density fluctuations, the
influence of relative lengths of the active nematogen and their stiffness is as yet
unexplored territory. Given the inherently non-equilibrium nature of the system, I have
no a priori way of predicting the consequence of these properties on the emergent
behavior. I expect that the development of this model experimental system can spur
theoretical investigations into these questions in the context of composite active
materials.
Given the importance of the microtubule and actin cytoskeletal networks in live
cells, it is interesting to speculate on how the work presented here might inform on these
complex processes. I found that the actin appeared to be less influenced by the
microtubules. Although that could mean that the actin ignores the microtubule
cytoskeleton in the cell. The experiments presented here took advantage of steric
interactions, likely enhanced by the crowding agents. In addition, depletion force has a
key role in bundle formation for actin and microtubule filaments. Interestingly, its
corresponding interactions between actin filaments is different from microtubules. The
depletion force forms nematic bundles of actin filaments meaning the resulted
interactions between actin filaments are not sensitive to their polar structure. However,
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the depletion force affects microtubules interactions differently. It is sensitive to the
structural polarity of microtubules and could lead to nematic as well as polar ordering in
microtubule bundles. Also, methylcellulose is a negatively charged molecule that could
affect charge interaction between filaments. Within the cell, there are likely a number of
chemical interactions between the filaments. Indeed, a number of recent in vitro
experiments have shown that microtubule or actin associated proteins can actually bind to
the other cytoskeletal filament as well 101,102. These papers have demonstrated that actin
and microtubule filaments can interact during polymerization at dilute concentrations
101,102

. It would be an interesting further step to repeat these experiments in dense systems

with many more filaments of each type to observe the large-scale co-polymerization and
co-organization.
In summary, I have described first experiments in a composite active matter
system of self-propelled filaments. The phase space available for exploration in this
system includes particle properties (length of filaments, stiffness), activity (modifying
motor concentrations), interactions (altered crowders, ionic strength buffers, and
crosslinkers), and concentration of the different component particles. This system can
serve as a test bed for theoretical ideas that have been proposed in the context of aligning
self-propelled active fluids and serve to play the same role as Janus colloids have played
for non-aligning self-propelled particles.
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CHAPTER 3
DYNAMICS OF THE 3D COMPOSITE NETWORK OF ACTIN AND
MICROTUBULE WITH NEUTRAVIDIN CROSSLINKERS

3.1 Abstract
The cytoskeleton is able to precisely tune its structure and mechanics through
interactions between semiflexible actin filaments, rigid microtubules and crosslinker
proteins. However, the role that each of these components, as well as the interactions
between them, plays in the dynamics of the composite cytoskeleton remains an open
question. Here, I investigate the effect of interaction of actin and microtubule filaments in
the steady-state dynamics of this composite using generic, strong biotin-NeutrAvidin
crosslinkers. I analyzed the data collected by our collaborators using fluorescence
confocal microscopy to reveal the mechanisms in which crosslinking tunes the mobility
of actin–microtubule composites. We show that varying crosslinking motifs have little
impact on the microscale mobility and mechanics. We further examine the role of actin
crosslinking and find non-monotonic dependence of microtubules steady-state dynamics
on actin crosslinking. In fact, the microtubule mobility – dictated by crosslinker-driven
rearrangements of actin filaments –controls composite stiffness. The microrheology
measurements from our collaborators show similar non-monotonic dependence of the
stiffness on the actin crosslinking, corroborating our findings about the dynamics of the
actin-microtubule composites and implying a link between the mechanics and mobility of
the networks.
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3.2 Introduction
Functional dynamic properties of the cytoskeleton are determined by the crosstalk
of biopolymers, actin and microtubule, when physical interaction of these filaments
mediated by auxiliary proteins such as crosslinking proteins. Actin filaments are
semiflexible filaments with a persistence length of 10 µm 17,18, microtubules are rigid
with of 1 mm 14,18,36,120,121. Networks of semiflexible actin filaments play critical roles in
cell polarity and contractile and migratory processes 122,123; while microtubules enable
intracellular trafficking and transport, chromosomal dynamics, and mitotic spindle
alignment during cell division 122,124. Synergistic interactions between these two
filaments, which are mediated by steric and chemical interactions (i.e. entanglements and
crosslinking) 17,123,125,126, establish essential cell asymmetries and enable proliferation,
differentiation, and migration 17,123,127–129 . While crosslinking of both filaments is
ubiquitous in cells, serving important roles in locomotion, membrane reinforcement, and
intercellular cargo transport 120,123,129 there is mounting evidence of crosslinking between
actin and microtubules, mediated by proteins such as tau, MAP2, APC, profilin, and
plectin 88,101,123,130–136. Specifically, actin-microtubule co-crosslinking has been shown to
be important to cortical flow, wound healing, neuronal cone growth, cell migration, and
muscle contraction 122–124,129,131,133,137–140.
To understand the role of actin crosslinking in cells, numerous studies have
investigated the mechanical properties of crosslinked actin networks in vitro 45,126,141–143.
These studies have shown that the majority of crosslinking proteins form isotropic
networks of crosslinked filaments at low and intermediate crosslinker:actin monomer
ratios, R, but form bundles of nematically aligned filaments at high R 142,144–146. Due to
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these structural changes, increasing crosslinker concentrations have been shown to
directly correlate with increased network stiffness and elasticity 16,45,142–144,146–149.
Despite the growing evidence of the importance of actin and microtubule
interactions to cytoskeleton dynamics, mechanics, and function 126,150–154 and its
application in designing biomimetic materials, few studies have investigated composite
networks of actin and microtubules 126,155–157. Here, we use fluorescence microscopy to
examine the steady-state dynamics of crosslinked composite network of equimolar actin
and microtubule filaments. First, we study the effect of varying crosslinking motifs, and
show that it has minor impact on the microscale mobility while all crosslinking motifs
reduce filament mobility. The subtle effect of actin crosslinking on composite mechanics
that this study reveals begs the question as to the role of actin crosslinking in dynamics
and mechanics and its dependence on the crosslinking concentration. We demonstrate
non-monotonic dependence of mobility of the microtubules on the degree to which actin
filaments are crosslinked. Microtubule mobility is slowed the most when the actin
network that scaffolds microtubules is both rigidly crosslinked and sufficiently dense.
Too much crosslinking leads to actin bundling, thereby increasing the actin scaffold mesh
size and thus allowing for more microtubule mobility. Conversely, too few crosslinks
confer a dense but floppy scaffold that is insufficient to markedly suppress microtubule
fluctuations. This careful balance demonstrates the elegant ways that actin crosslinking
can modulate the interactions between actin and microtubules within the cytoskeleton to
enable a myriad of different mechanical responses and processes in cells. More generally,
this work reveals surprising design principles for biomimetic composite materials –
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showing that modest changes to filament interactions can lead to dramatic improvements
in toughness and elasticity.

3.3 Material and Methods
Here I explain the materials and methods for actin microtubule composite
network. Two sets of experiments were conducted by our collaborators on the crosslinked
composite network of actin and microtubule filaments. In all the experiments, the total
amount of equimolar actin and microtubule proteins was held fixed at 5.8 μM. First, a
constant amount of crosslinkers were employed to crosslink different filaments. Then,
different amount of actin crosslinkers were added to the composite while microtubules
were not crosslinked. The steady-state dynamics of these composite networks were
studied using fluorescence confocal microscopy.

3.3.1 Materials for varying crosslinking motifs in actin-microtubule composite
network

Rabbit skeletal actin, biotinylated actin and Alexa-488-labeled actin were
purchased from Cytoskeleton (AKL99, AB07) and Thermofisher (A12373) and stored at
−80 °C in a Ca buffer (2 mM Tris (pH 8.0), 0.2 mM ATP, 0.5 mM DTT, 0.1 mM CaCl2)
Porcine brain tubulin, biotinylated tubulin, and rhodamine-labeled tubulin were
purchased from Cytoskeleton (T240, T33P, TL590M) and stored at −80 °C in PEM-100
(100 mM PIPES (pH 6.8), 2 mM MgCl2, and 2 mM EGTA).
Crosslinked networks were formed using preassembled biotin-NeutrAvidin
complexes optimized previously for stable, isotropic crosslinking of actin networks 45. As
depicted in Fig 3.1, crosslinker complexes are comprised of NeutrAvidin flanked on
62

either side by biotinylated actin and/or tubulin, depending on the desired crosslinking
motif. We incorporated crosslinkers into previously established protocols to form coentangled actin-microtubule composites 155. In short, actin monomers, tubulin dimers, and
crosslinker complexes were added to PEM-100 supplemented with 1 mM ATP, 1 mM
GTP, and 5 μM Taxol. To image composites, 0.13 μM of Alexa-488-labeled actin
filaments and rhodamine-labeled microtubules, as well as oxygen scavenging agents [4.5
mg/ml glucose, 0.5% β-mercaptoethanol, 4.3 mg/ml glucose oxidase, 0.7 mg/ml catalase]
were added (Fig 3.1). The solution was then mixed, pipetted into a ~20 μL sample
chamber, and allowed to incubate at 37 °C for 30 minutes to co-polymerize both proteins.
We prepared six different composite types that varied in their crosslinking motif
as follows (Fig 3.1.A): (1) no crosslinkers are present (None); (2) actin filaments in the
composite are crosslinked to each other (Actin); (3) microtubules in the composite are
crosslinked to each other (Microtubule); (4) both actin and microtubules are crosslinked
but they cannot crosslink to each other (Both); (5) actin and microtubules are crosslinked
to each other but not to themselves (Co-linked); and (6) a composite similar to Both but
in which the densities of actin-actin and microtubule-microtubule crosslinks are both
doubled (Both 2x).
For all presented data at the first part, total protein concentration was held fixed at
5.8 μM with an equimolar ratio of actin to tubulin, and the molar ratio of crosslinker to
protein was fixed at R = 0.02 when
[𝑁𝑒𝑢𝑡𝑟𝐴𝑣𝑖𝑑𝑖𝑛 𝑐𝑟𝑜𝑠𝑠𝑙𝑖𝑛𝑘𝑒𝑟]

𝑅 = [𝐺−𝑎𝑐𝑡𝑖𝑛 𝑚𝑜𝑛𝑜𝑚𝑒𝑟𝑠]+[𝑡𝑢𝑏𝑢𝑙𝑖𝑛 𝑑𝑖𝑚𝑒𝑟𝑠]

Eq. 3.1

The mesh size of actin and microtubule networks comprising each composite are a =
0.3/ca1/2 = 0.85 µm and m = 0.89/ct1/2 = 1.58 µm, respectively, where ca and ct are the
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actin and tubulin concentrations in units of mg/ml 158–160. From these mesh sizes we
calculated the effective composite mesh as ξ = (m -3 + a -3 ) -1/3 = 0.81 μm 155. We
estimated the length between crosslinkers for all three types of crosslinking used in
composites (actin crosslinking, microtubule crosslinking, and actin-microtubule colinking) as follows (Fig 3.1.A). The length between crosslinkers along an actin filament
was determined by lc,a = ½lmon × R−1 where lmon = 2.7 nm is the length that each actin
monomer adds to an actin filament. The ½ prefactor takes into account that each
crosslinker is shared between two filaments. Similarly, the length between crosslinkers
along a microtubule was calculated by lc,m = ½(lring/13) × R−1 where every 13 tubulin
dimers adds lring = 7.8 nm in length to the microtubule. For Actin and Microtubule
composites, lc,a = 67.5 nm and lc,m = 15 nm. In the composite where crosslinkers are
equally distributed between actin-actin links and microtubule-microtubule links (Both), R
remains fixed so there are half as many crosslinkers available to each network. Thus, lc,a
and lc,m both double (i.e. lc,a = 135 nm, lc,m = 30 nm). For composites in which both
networks are linked but R is doubled (Both 2x) lc,a and lc,m remain the same as in the Actin
and Microtubule cases. For Co-linked composites, the length between crosslinkers that
link actin to microtubules was computed as lc,a-m = (lc,a×lc,m)1/2 = 31 nm.
A Nikon A1R laser scanning confocal microscope with a 60x 1.4 NA objective
and QImaging QICAM CCD camera were used to collect 2D time series of composites.
The microscope is outfitted with 488 nm and 561 nm lasers and simultaneously records
separate images for each laser channel (green and red) to separately visualize
Alexa-488-actin (green) and rhodamine-tubulin (red) (Figs 3.1.B, 3.2). Time series of 512
× 512 images (0.41 µm/pixel) in each channel were recorded at 16 fps for 60 seconds.
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For each composite type, two different samples were imaged with 3–5 time series taken
for each sample.
Time series from each channel (green and red) were analyzed separately to
determine the mobility of actin and microtubules in the composites, as previously
described 155. In brief, every 16 frames in the time series were averaged together to create
time series with 1 second frames 155. As demonstrated and described previously 155, we
selected 1 second frames to average out the frame-to-frame shot noise that obscured the
images of the filaments, enhancing the signal to noise without altering the trends in the
data (Fig 3.4); and because the filaments do not significantly change position over that
time (within the resolution of the measurement). From these averaged time series, we
used FIJI/ImageJ to create a single collapsed image for each channel that represented the
standard deviation of each pixel over time (Fig 3.1.B). The average standard deviation
over all pixels was then calculated to give a single standard deviation value for the entire
time series <δ>. This value, which represents the variation in intensity values for each
pixel over time, is a measure of the extent to which filaments in the network fluctuate
over time. To account for differences in overall intensity among different time series, we
also computed the average intensity over all pixels and frames for each time series <I>,
and normalized each standard deviation by this value. The resulting metric <δ>/<I>,
which quantifies the mobility of actin and microtubules in each time series, is presented
in Fig 3.3. We carried out this analysis for all time series collected for each composite
type. We used the Kolmogorov-Smirnov statistical test (KS-Test,
http://www.physics.csbsju.edu/stats/KS-test.html) to compare different data sets.
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Figure 3. 1 Schematic of experiments to probe the role that crosslinking plays in the
mechanics and mobility of crosslinked actin-microtubule composites. (A) Cartoon of
molecular components comprising actin-microtubule composites with varying
crosslinker motifs (None, Actin, Microtubule, Both, Co-linked, Both 2x) described in
the text. The calculated length between crosslinkers for each motif is listed under
each cartoon, where lc,a is the length between crosslinkers along an actin filament,
lc,m is the length between crosslinkers along a microtubule, and lc is the length
between crosslinkers when actin and microtubules are linked to each other. (B)Twocolor laser scanning confocal micrograph of 5.8 μM Co-linked actin-microtubule
composite with ~3% of microtubules and actin labeled with rhodamine (red) and
Alexa-488 (green), respectively. Standard deviation projections of a 60 s video taken
at 1 fps for the microtubule (red) and actin (green) channels. Scale bar is 20 μm.
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From KS-tests, we computed probability values p for finding overlapping data and use
the accepted value of p < 0.05 as the cutoff for determining when two data sets were
significantly different.

3.3.2 Materials for varying actin crosslinking in actin-microtubule composite
network
For the second set of experiments, Rabbit skeletal
actin monomers (G-actin),

biotinylated G-actin and Alexa-488-labeled G-actin are purchased from Cytoskeleton
(AKL99, AB07) and Thermofisher (A12373) and suspended at 1 mg/ ml, 2 mg/ml and
1.5 mg/ml, respectively, in Ca buﬀer G (2 mM Tris pH 8.0, 0.2 mM ATP, 0.5 mM
DTT, 0.1 mM CaCl2) and stored at -80°C. Lyophilized porcine brain tubulin, biotinylated
tubulin, and rhodamine-labeled tubulin are purchased from Cytoskeleton (T240, T33P,
TL590M). Porcine tubulin and biotinylated tubulin are suspended to 5 mg/ml in PEM100 [100 mM PIPES (pH 6.8), 2 mM MgCl2, 2 mM EGTA] and stored at 80 °C.
Rhodamine-labeled tubulin is suspended to 5 mg/ml using a 1 : 10 ratio of rhodaminetubulin : unlabeled- tubulin in PEM-100 and stored at -80 °C.
To crosslink actin filaments within co-entangled actin–microtubule composites,
we incorporate biotin–NeutrAvidin crosslinker complexes prepared using wellestablished and validated protocols described previously 45,141,161. Crosslinker complexes,
tubulin dimers, and G-actin are added to PEM-100 supplemented with 1 mM ATP, 1 mM
GTP, and 5 μM Taxol. To determine filament mobility within composites, 0.13 μM of
Alexa-488-labeled actin filaments and rhodamine-labeled microtubules are added to the
solution 155. To inhibit photobleaching of labeled filaments, oxygen scavenging agents
[4.5 mg/ ml glucose, 0.5% β-mercaptoethanol, 4.3 mg/ml glucose oxidase, 0.7 mg/ml
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catalase] are included. The final mixture is pipetted into a 20 μl sample chamber made
from a glass slide and coverslip separated by 100 μm of double-stick tape and sealed with
epoxy. To polymerize filaments and form the crosslinked network, the sample is
incubated for 30 minutes at 37 °C.
For all presented data, we fix the total protein concentration to 5.8 μM with an
equimolar ratio of actin monomers to tubulin dimers. We vary the crosslinker
concentration to examine actin crosslinker molar ratios of R = 0, 0.005, 0.01, 0.02, 0.04
and 0.08 when R is
𝑅=

[𝑁𝑒𝑢𝑡𝑟𝐴𝑣𝑖𝑑𝑖𝑛 𝑐𝑟𝑜𝑠𝑠𝑙𝑖𝑛𝑘𝑒𝑟]
[𝐺−𝑎𝑐𝑡𝑖𝑛 𝑚𝑜𝑛𝑜𝑚𝑒𝑟𝑠]

Eq. 3.2

The mesh sizes of the actin network and microtubule network within composites are the
same as the previous part.
To determine filament mobility, we use a Nikon A1R laser scanning confocal
microscope with a 60x 1.4 NA objective and QImaging QICAM CCD camera to collect
2D time series of composites. The microscope is outfitted with 488 nm and 561 nm lasers
that simultaneously record separate images in the green and red channels to visualize
Alexa-488-actin (green) and rhodamine-tubulin (red) (Fig 3.2.B). For each crosslinker
ratio, 3–5 time series of 512 x 512 images (0.41 μm /pixel) in each channel are recorded
at 1 fps for 60 seconds for two different samples.
Using FIJI/ImageJ, each time series channel (green and red) is separately
analyzed to determine the mobility of actin and microtubules in the composites, as
previously described 141,161. In short, we create a single projection image of the standard
deviation of each pixel over time. We calculate the average standard deviation over all
pixels for each projection image to obtain a single standard deviation value for the entire
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time series <δ>. This value represents the variation in intensity values for each pixel over
time and is thus a measure of the extent to which filaments in the composite fluctuate
over time. In order to account for diﬀerences in the overall intensity among diﬀerent time
series, we normalize each standard deviation value by the average intensity over all pixels
and frames for each time series <I>. The resulting metric, <δ>/<I>, quantifies the
mobility of actin and microtubules in each time series.

Figure 3. 2 Schematic of experiments to probe the role that crosslinking plays in the
mechanics and mobility of actin crosslinked actin-microtubule composites. (A)
Cartoon of composites of microtubules (red) and actin (green) with increasing
concentrations of actin crosslinkers (blue) defined as the crosslinker:actin ratio R.
(B) Two-color laser scanning confocal image of 5.8 μM total actin-microtubule
composite with R = 0.08. For visualization of filaments, ~3% of tubulin and actin are
labeled with rhodamine (red channel) and Alexa-488 (green), respectively. Standard
deviation projections of a 60 s time series taken at 1 fps for the microtubule (red)
and actin (green) channels. Scale bar is 20 µm.
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3.4 Results and discussion
3.4.1 Steady-state mobility of varying crosslinking motifs in actin-microtubule
composite network
To systematically investigate the role that crosslinking plays in composites of
actin and microtubules we design actin-microtubule composites with four distinct
crosslinking motifs. We use our previously established protocols 155 to create equimolar
co-entangled actin-microtubule composites. We then incorporate biotin-NeutrAvidin
complexes into composites to selectively crosslink the filamentous proteins, keeping the
crosslinker:protein ratio fixed at R = 0.02 155 . We create composites with: crosslinked
actin (Actin), crosslinked microtubules (Microtubule), crosslinkers equally forming actinactin and microtubule-microtubule bonds (Both), and crosslinkers binding actin to
microtubules (Co-linked) (Fig 3.1.A). We compare these composites to a composite
without crosslinkers (None) as well as one in which both filaments are crosslinked but R
is doubled (Both 2x) (Fig 3.1.A). While all composites have the same crosslinker density
R and protein concentration, the length between crosslinkers along actin filaments lc,a,
along microtubules lc,m, and along both filaments lc (for Co-linked) vary for the different
composites, as listed in Fig 3.1.A and described in Methods.
To determine the steady-state mobility of actin and microtubules in each
composite type, we analyze time series of dual-color confocal images, as described in
Methods and previously validated 155. Briefly, for each time series we compute the
average standard deviation of the intensity over time for all pixels <δ> and normalize by
the corresponding average intensity of all pixels over time <I> (Fig 3.3). Higher values
of this mobility metric indicate a more mobile network of filaments that fluctuates more
while lower values imply a more static network.
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Comparing <δ>/ <I> values for actin and microtubules in the same composite,
we find that actin filaments in all composites fluctuate significantly more than
microtubules with an average <δ>/ <I> value that is ~1.5x greater than that for
microtubules (p < 0.03 using KS-Test described in Methods, Fig 3.3). This result, which
is in line with our previous findings for composites without crosslinkers155, is not
surprising given the ~100-fold lower bending rigidity of actin compared to microtubules.
Comparing the mobility of the crosslinked composites to the unlinked composite (None),
we find that all crosslinking motifs reduce the mobility of both filaments by ~1.4x (p ≤
0.04 and p ≤ 0.02 for actin and microtubules, respectively). This outcome corroborates
the results of some other experiments and measurements on the mechanics of this system.
For example, relaxation time is faster for None comparing to crosslinked composites.
Likewise, the measured resistive force during strain for None is substantially smaller than
for crosslinked composites, indicating it is more fluid and mobile 141.
However, the mobilities of both actin and microtubules display minimal variation
between the different crosslinking (p > 0.09 for actin, p > 0.07 for microtubules).
Because the mobility we are measuring is at the submicron scale (each pixel is 0.41 μm)
and in the steady-state (linear) regime, we expect our mobility results to more closely
match the results of microrheology measurements at the submicron and microscopic
scales 141. As described above, at these lengths and force scales there is little difference
between the different crosslinking motifs, with all composites exhibiting similar force,
stiffness and viscosity values. This effect is also seen in the relaxation data in which the
relaxation times for all crosslinked composites are similar 141.
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Lastly, the steady-state mobility measurements for time series with different time
intervals is displayed in Figure 3.4. Here, the time resolution is 62.5 ms (1 frame)
compared to 1 s (16 frames averaged together) in Figure 3.3. As shown, the mobility
measurements and their distributions depend on the time resolution for all of the
composites. However, for smaller time windows the mobility values and spread in the
mobility distributions for both actin and microtubules are enhanced due to noise. Hence,
we use the larger time windows for the mobility analysis and comparison purposes here,
as well as the next section.
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Figure 3. 3 Differences between crosslinking motifs have minimal impact on the
steady-state filament mobility in actin-microtubule composites. (A) For each
composite, a 128×128 image shows the standard deviation of intensity values for
each pixel over time for actin (green) and microtubules (red) in a 60 s time
series. Scale bar is 10 µm and applies to all images. (B) Box-whisker plot of the
steady-state mobility, determined by computing the average standard deviation of
pixel intensities <> normalized by the overall average pixel intensity <I> for each
time series (as described in Methods). For each composite type, <>/<I> is
calculated separately for actin (cross-hatched) and microtubules (solid) and each
data point is computed from 10-12 time series each collected in different regions of
the sample chambers of two different samples. As shown, microtubules are less
mobile than actin filaments in all composites. Further, while crosslinking reduces
the mobility of both filaments, the specific crosslinking motif has little effect.
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Figure 3. 4 Mobility analysis from time series with 62.5 ms time windows. Boxwhisker plot of the steady-state mobility determined by computing the average
standard deviation of pixel intensities <δ> normalized by the overall average pixel
intensity <I> for each time series. Here, we use a time resolution of 62.5 ms (1
frame) compared to 1 s (16 frames averaged together) shown in Fig 3.3. As shown,
the dependence of the mobility of both actin and microtubules on crosslinking motif
is robust to varying time windows used for analysis. However, for smaller time
windows the mobility values and spread in the mobility distributions for both actin
and microtubules are enhanced due to noise.

3.4.2 Steady-state mobility of varying actin crosslinking in actin-microtubule
composite network
To investigate the role that actin crosslinking plays in cytoskeleton composites,
we use previously established protocols to create co-entangled actin–microtubule
composites in which we systematically tune the density of actin crosslinking 155,161. We
use biotin–NeutrAvidin as the crosslinker to create permanent actin-specific crosslinks
devoid of transient unbinding/rebinding events, and we vary the actin crosslinker ratio
from R = 0 to R = 0.08 (Fig 3.2, Methods) 45.
To shed light on the filament fluctuations, we use dual-color confocal time series
to determine the steady-state mobility of both actin and microtubules within composites.
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As described previously, we quantify the mobility as the average standard deviation of
the intensity over time for all pixels <δ>, normalized by the average intensity of all
pixels over time <I> (Fig 3.5). This metric could not necessarily distinguish the acquired
signal of systems with different properties and their motions. However, given the fact that
networks of actin and microtubule filaments are studied, and the results of the response
force and mechanical measurement could help us to understand this metric clearer. The
correlation between force measurement and mobility measurements using average
standard deviation of intensity, <δ>, of this soft material indicates that the observed
mobility of filaments here is associated with “compliance” (or inverse stiffness).
One would expect stiffer networks to correlate with reduced filament mobility,
and actin crosslinking to suppress actin mobility more than microtubules (which remain
unlinked for all R). Fig 3.5, which displays the mobility term <δ>/<I> as a function of R
for both actin and microtubules, shows that actin crosslinking reduces the magnitude and
spread of the mobility of both filaments from that of the R = 0 case. This result is
intuitive as permanent crosslinking leads to stiffer more uniform networks with
suppressed filament fluctuations and less heterogeneity. However, while stiffer
composites do in fact confer reduced mobility, it is surprisingly the mobility of
microtubules rather than actin that correlates with stiffness.
The mean magnitude of <δ>/<I> for microtubules decreases from R = 0 to R =
0.01, is nearly identical for R = 0.01 and 0.02, after which it increases with R.
Interestingly, this non-monotonic behavior is reflected in the mechanical propertied
measurements that is carried out by our collaborators. Figure 3.6 displays the response
force and the stiffness of the composite network for different amounts of actin
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crosslinkers. Average force and average composite stiffness of the composite
demonstrate non-monotonic dependence on crosslinking with a peak at R = 0.02. This
correlation between the dynamics and the mechanical properties suggests that the rigidity
(i.e. reduced mobility) of the microtubules is the primary contributor to elasticity and
stiffness. Crosslinking also reduces the mobility of actin, but surprisingly does not show
the same clear trend as the microtubules.
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Figure 3. 5 Microtubule mobility is tuned by actin crosslinking and dictates the nonmonotonic mechanics of composites. (A) Projection images of the standard deviation
of pixel intensity values in actin (green) and microtubules (red) channels for a 60 s
time series. Time series are acquired using a Nikon A1R laser scanning confocal
microscope with 60 - 1.4 NA objective. Numbers in bottom left of each image
correspond to crosslinking ratio R. Colors outlining images match color scheme in
(B). Scale bar is 25 μm. (B) Box whisker plot of mobility calculated by computing
the standard deviation of pixel intensities over time and space <δ>, normalized by
the average pixel intensity for each time series <I> as described in Methods. As
shown, the mobility as well as the distribution of fluctuations for microtubules
decreases until R= 0.02 after which the mobility increases, with microtubules
becoming more mobile than the actin filaments.
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Figure 3. 6 Mesoscale force response of actin-microtubule composites shows nonmonotonic dependence of stiffness on actin crosslinking. (A) Force, F(x) composites
exert to resist constant speed (v = 10 µm/s) microsphere displacement of 10 µm.
Grey lines are linear fits to the data from 0.25 to 10 µm. (B) Average force over the
full 10 µm bead displacement with error bars denoting standard error across all
trials. Colors match the legend in A and black line and grey panel are average and
error for R = 0. (C) Average composite stiffness <K> = <dF/dx> determined from
slopes of the linear fits shown in A. R = 0 is the solid line 162.

In fact, actin mobility shows no significant dependence on the degree to which
actin is crosslinked, with all distributions overlapping each other. Further, the highest
mobility and largest spread (i.e. heterogeneity) in mobility is measured for R = 0.02,
despite this network exhibiting the stiffest nonlinear mechanical response (Fig 3.6) 162.
Thus, while actin becomes more crosslinked as R increased, which should reduce
its mobility, it appears that it is its ability to suppress microtubule mobility that controls
the elasticity of the composite. This can be understood as actin filaments form a
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scaffolding network interwoven with the network of microtubules. As actin crosslinking
increases the increased rigidity of the actin scaffold reduces the mobility of microtubules.
The robustness of the non-monotonic dependence of microtubule mobility on R,
and its coupling to mechanics, requires a discussion of the mechanism leading to this
surprising behavior. We suggest that as the crosslinking density increases beyond a
critical density, actin filaments begin to form bundles, which increases the mesh size of
the actin scaffold and reduces the connectivity between actin fibers (bundles or single
filaments). This more loosely connected scaffold cannot as effectively suppress
microtubule mobility as a denser network of individual crosslinked filaments. We note
that our confocal images demonstrate that the networks at all R values remain isotropic
and connected, without obvious signs of significant actin bundling. As such, the degree of
bundling is likely on the order of a few filaments, such that a connected network still
forms but with a larger mesh size and fewer connections than a network of individual
crosslinked filaments. Our imaging methods are not sensitive enough to pick up these
subtle microscale changes due to the high density and fluctuations of the labeled
filaments.
To understand the slight difference in the R value at which the minimum of
mobility is achieved, we examine the breadth of the mobility distributions for actin and
microtubules at R = 0.01 and 0.02, crosslinking ratios. The distribution of microtubule
mobility values is narrowest at R = 0.01, indicating that the scaffolding network is the
most uniform and dense, such that microtubules in all regions of the network feel the
same surroundings. The actin mobility distribution is likewise narrower than other R
values suggesting a uniformly crosslinked network. At R = 0.02 the distributions for both
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actin and microtubules are larger than all other crosslinked (R > 0) composites,
suggesting that the composite is the most heterogeneous at this crosslinking density. The
actin mobility, in particular, displays a notably large spread in mobility values. A mixture
of actin bundles and individual crosslinked actin filaments would provide the most
heterogeneous scaffolding network, compared to scaffolds comprised solely of bundles or
single filaments, owing to the wide distribution of actin mobility values.
We note that one previous study examining actin networks crosslinked by
palladin reported a similar non-monotonic dependence in which actin networks appear to
soften for very large R (> 0.1) 142. Authors suggest that increased bundling at these high R
values correspondingly increases the mesh size which gives rise to softer networks 142.
However, in this study the crosslinking density required to see such an effect is an order
of magnitude larger than what we report, and the effect is more subdued for the palladin
result.

3.5 Conclusion
Actin and microtubules form interacting networks within the cytoskeleton,
providing cells with mechanical integrity, and enabling a myriad of mechanical processes
such as locomotion, morphogenesis, intracellular transportation, and division. Many of
these diverse functions are mediated by crosslinking proteins that can bind actin,
microtubules, or both proteins. Further, the role of crosslinking between actin and
microtubules has received much recent attention and is thought to be responsible for
maintaining cell shape and polarity, growth and structure of neurons, and spindle
positioning in mitosis 123,131,132. The design and characterization of composites of flexible
and stiff polymers is also a topic of current interest in materials engineering 163,164, yet
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how crosslinking can tune the mechanical response of these composites has remained
largely unexplored.
Here, we characterize the mobility of composites of actin and microtubules with
distinct crosslinking patterns. First, we create composites in which actin is crosslinked
(Actin), microtubules are crosslinked (Microtubule), both actin and microtubules are
crosslinked (Both), and actin and microtubules are crosslinked to each other (Co-linked).
We use dual-color fluorescence confocal microscopy to measure the mobility of each
composite type. The crosslinking motif has little impact on the microscopic steady-state
filament mobility. Secondly, we study the surprising and diverse roles that actin
crosslinking can play in the steady-state mobility of actin-microtubule composites. We
create composites of actin and microtubules with actin crosslinker ratios of R = 0 – 0.08.
We show that there is an unexpected and robust non-monotonic dependence of filament
mobility on R. We show that it is the synergistic interactions between actin and
microtubules that give rise to emergent behaviors which are largely absent in crosslinked
only actin or crosslinked only microtubule networks.
Our results demonstrate the unique and complex ways that components of the
composite cytoskeleton – such as actin, microtubules, and crosslinkers – work in concert
to tune the mechanical properties of the cell over a wide parameter space with modest
changes to the interactions between constituents. Moreover, our platform and results
provide design principles for biomimetic materials with physical properties that can be
precisely altered by varying the crosslinking motifs as well as the degree of crosslinking.
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CHAPTER 4
DYNAMICS OF THE 3D COMPOSITE NETWORK OF ACTIN AND
MICROTUBULE WITH NEUTRAVIDIN & MAP65 CROSSLINKERS

4.1 Abstract
Actin and microtubule filaments, with their auxiliary proteins, enable the
cytoskeleton to carry out vital processes in the cell by tuning the organizational and
mechanical properties of the network. Despite their critical importance and interactions in
cells, we are only beginning to uncover information about the composite network. The
challenge is due to the high complexity of combining actin, microtubules, and their
hundreds of known associated proteins. Here, I use fluorescence microscopy, fluctuation,
and cross-correlation analysis to examine the role of actin and microtubules in the
presence of an antiparallel microtubule crosslinker, MAP65, and a generic, strong actin
crosslinker, biotin-NeutrAvidin. For a fixed ratio of actin and microtubule filaments, I
vary the amount of each crosslinker and measure the organization and fluctuations of the
filaments. I find that the microtubule crosslinker plays the principle role in the
organization of the system, while, actin crosslinking dictates the mobility of the
filaments. We have previously demonstrated that the fluctuations of filaments are related
to the mechanics, implying that actin crosslinking controls the mechanical properties of
the network, independent of the microtubule-driven re-organization.

4.2 Introduction
The cytoskeleton is composed of interacting biopolymer filaments that regulate
the spatial organization and mechanical properties of the cell. Actin filaments are
82

composed of two protofilaments made from actin monomers, helically twisted with a
diameter of 7 nm and a persistence length of 10 μm 16–18. Actin filaments and their actin
binding proteins (ABPs) govern cell migration, contraction, and cell signaling 165.
Microtubules are composed of tubulin protein dimers that form a lattice of 13
protofilaments that roll into a tube to create a hollow cylinder structure with an outer
diameter of 25 nm and a persistence length of 1 mm 14,36,37. Microtubules, the
microtubule associated proteins (MAPs), and enzymes control intracellular transport,
mitotic spindle formation, and cellular organization. The distinct structures and physical
properties of these cytoskeletal subunits enable the cell to maintain its integrity during
cell growth, differentiation, division, and motility 17.

Characterizing the dynamics and mechanics of composite cytoskeletal networks is
important for both biological and synthetic applications. On the biological front,
intracellular experiments are complex and uncontrolled. Clean, reproducible in vitro
experiments enable the elucidation of fundamental principles of cytoskeletal organization
and mechanics 166–168. From a synthetic materials view, cellular composite networks
inspire the design and fabrication of smart synthetic and biomimetic materials with
tunable mechanical properties 169,170.
Most of the studies of in vitro reconstitution of cytoskeletal filaments have been
conducted in a network of either actin or microtubule filaments. The mechanics and
dynamics of co-entangled and crosslinked actin networks have been characterized in the
presence of various crosslinkers with different structures and strength, such as alphaactinin, fascin, palladin, arp 2/3, arg, filaminA, and biotin-NeutrAvidin 141,142,144–
146,150,151,162,171,172

. It has been shown that actin crosslinkers can increase elasticity and
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stiffness of the network and lead to the formation of actin bundles 16,144,147,148,171.
Microtubule network organization and mechanics have also been explored in the
presence of MAP65, Ase1, PRC1, biotin-NeutrAvidin, and active crosslinkers like
various types of kinesin motors with different movement direction and speed
46,49,98,120,141,159,173–182

. Viscoelasticity measurements have showed that entangled

microtubule networks are soft elastic solids, and added crosslinkers make a stiffer gel of
filaments 124.
Despite their biological relevance, few studies have explored composite networks
of actin and microtubule filaments. These studies have shown that the interactions
between these filaments lead to unexpected emergent properties
102,123,126,132,153,154,156,157,162,183–187

. For example, we have previously shown that actin

filaments, rather than microtubules, govern the microscale elasticity and mobility of
actin-microtubule composite networks comprised of equal molar ratios of actin
monomers and tubulin dimers 141,162,183. We showed that this effect was due to the smaller
mesh size of the network of actin filaments compared to that of the microtubules in the
composite162. Here, I sought to examine networks with more comparable mesh sizes from
similar total filament lengths. Using a fixed ratio of actin to microtubules, I
independently varied the actin and microtubule crosslinkers. I used biotin-NeutrAvidin to
permanently crosslink actin filaments, and MAP65 to transiently crosslink microtubules.
I found that actin crosslinkers tune the mobility of the composite network: actin becomes
less mobile, while microtubules become more mobile. Microtubule crosslinkers, on the
other hand, control the co-localization of actin and microtubule filaments in the
composite network.
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4.3 Materials and Methods
Rabbit skeletal actin, biotinylated actin, and rhodamine-labeled actin were
purchased from Cytoskeleton (AKL99, AB07, AR05) and resuspended at 2 mg/ml, 1
mg/ml, and 1.5 mg/ml, respectively, in Ca Buffer G (2 mM Tris pH 8.0, 0.2 mM ATP,
0.5 mM DTT, 0.1 mM CaCl2) and stored at -80ºC. Lyophilized porcine brain tubulin,
biotinylated tubulin, fluorescent HiLyte 488-labeled tubulin, and fluorescent HiLyte 647
tubulin were purchased from Cytoskeleton (T240, T33P, TL488M, TL670M). Porcine
tubulin and biotinylated tubulin were resuspended to 5 mg/ml in PEM-100 [100 mM
PIPES (pH 6.8), 2 mM MgCl2, 2 mM EGTA] and stored at -80ºC. HiLyte 488 or 647labeled tubulin was resuspended to 5 mg/ml using a ratio of 1:10 fluorescent labeled
tubulin:unlabeled-tubulin in PEM-100 and stored at -80ºC.
Two different types of crosslinkers were used in composite networks of actin and
microtubules. To crosslink actin filaments, biotin-NeutrAvidin crosslinker complexes
were prepared according to previously published protocols 141,162. To crosslink
microtubule filaments, GFP labeled and unlabeled MAP65-1 was used that was expressed
and purified from bacteria as previously described 50,97,98.
Composite networks were made by mixing tubulin, G-actin, and crosslinkers in
PEM-100 solution. For visualization, biotinylated, rhodamine labeled actin filaments
were pre-polymerized in PEM-100 and 2 mM ATP by incubation for 1 hour in room
temperature. To visualize microtubules, all filaments were labeled with HiLyte 488 or
HiLyte 647. Pre-polymerized, rhodamine-labeled actin filaments were prepared at 5 μM
with 1:1 rhodamine labeled actin:unlabeled actin monomer ratio and 0, 0.04, 0.08, or 0.16
biotin-actin:total actin monomer ratio. A mixture of unlabeled and HiLyte 488-labeled or
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HiLyte 647-labeled tubulin (with 3:100 labeled:unlabeled tubulin, 9.1 μM total),
unlabeled actin monomer (1.43 μM final concentration) and pre-polymerized rhodamine
labeled actin filaments (1.43 μM final concentration) were added to the PEM-100 buffer
with 1 mM ATP, 1 mM GTP and 5 μM Taxol. Oxygen scavenging agents (4.5 mg/ml
glucose, 4.3 mg/ml glucose oxidase, 0.7 mg/ml catalase, and 0.5% β-mercaptoethanol,)
were added to the solution to inhibit photobleaching. Additionally, 0.025% Tween was
included to block the chamber surface from protein binding. The mixture was pipetted
into a ~10 μL sample chamber made of a glass slide and cover slip attached via
permanent double stick tape (3M). The ends were sealed by epoxy and the sample
chamber incubated at 37°C for 30 minutes to form the composite network.
At the concentrations of actin and tubulin proteins used, 1.4 μM and 9.1 μM,
respectively, the mesh size of actin and microtubule networks are estimated as A =
0.3/cA1/2 = 1.22 µm and M = 0.89/cT1/2 = 0.89 µm, respectively, where cA and cT are the
actin and tubulin concentrations in units of mg/ml 158,188,189. I can estimate the total
polymer length in our 10 μl experimental chamber from the concentrations and known
geometries of the filaments. For actin, I estimate that there are 27 actin monomers in a 72
nm length of actin filament. Given the concentration of 1.4 μM, I estimate the total
polymer length, when all actin monomers go into polymer form to be 2.4 x 104 m. For
microtubules, I estimate that there are 13 dimers for a 12 nm length of filament. Given
the concentration of 9.1 μM, I estimate the total polymer length, when all tubulin dimers
are polymerized to be 5 x 104 m. These two total polymer lengths are the same order of
magnitude, so I conclude that the total polymer length present is approximately one-toone. In all of the presented data, the total molar concentration of actin and tubulin were
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fixed while the crosslinker concentrations varied. NeutrAvidin:actin molar ratios of R =
0, 0.02, 0.04, and 0.08 were examined for actin crosslinking. For microtubules, three
different percentages of MAP65, 0%, 3%, and 10%, were tested. The % represents the
percentage of tubulin dimers that are bound to MAP65 crosslinkers. The percent bound
was determined from the known equilibrium dissociation constant, as previously
described 49. I specifically use different nomenclature for the amount of actin and
microtubule crosslinkers because this is the nomenclature from prior literature 49,97,141,162
and to make it less confusing about which filament crosslinker I am referring.
I use a Nikon Ti-E inverted microscope with a 60x water immersion objective
(NA = 1.38) with scientific-CMOS camera (Zyla). The pixel size was 108 nm/pixel and
the diffraction limit was around 300 nm, roughly corresponding to 3 pixels. The
microscope can record 2048x2048 images in green and red channels alternatively to
visualize fluorescent HiLyte 488-labeled microtubules and rhodamine labeled actin
filaments. For each experiment at a specified actin and microtubule crosslinker ratio, 5-10
time series were recorded that were 1 to 1.5 minutes each. The exposure time was 60 ms
and 100 ms for the green and red channels, respectively.
To quantify the mobility of the composite network, FIJI/ImageJ was used to
analyze each channel separately, as described previously 141,162. Briefly, the standard
deviation and average of the intensity of an image series were measured. Then the mean
values of each channel were measured and used to calculate <δ>/<I> where <δ> is the
average standard deviation of intensity measurement over the entire time series and <I>
is the average intensity mean over time series. These measurements were calculated for
the actin and microtubule fluorescence channels separately. The value of this ratio
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determined the mobility of actin and microtubule filaments within each composite
network. Figure 4.1 and 4.2 show representative images for actin and microtubule
filaments respectively, in a phase diagram. Pairs of representative images are displayed at
R = 0, 0.2, 0.04, and 0.08 and 0%, 3%, and 10% MAP65 for actin and microtubule
channels, separately. At each data point, a projection image of standard deviation of
intensity (STD), and a projection image of average of intensity (AVG) are shown for a
representative time series. Spatial average of the STD and AVG image generates <δ>
and <I> values for the representative time series. All the images are 125.4 µm×125.4 µm
or 1158 × 1158 pixels.

Figure 4. 1 Image examples for actin filaments in the composite network of actin
and microtubule with NeutrAvidin molecules and MAP65 as actin and microtubule
crosslinkers, respectively. A pair of images is shown for each of 0%, 3%, and 10%
MAP65 and R = 0, 0.02, 0.04, and 0.08 for NeutrAvidin molecules. The % represents
the percentage of tubulin dimers that are bound to MAP65 crosslinkers, while R is
NeutrAvidin:actin molar ratio. Each pair consists of projection image of standard
deviation of pixel intensity value (STD) and projection image of average of pixel
intensity value (AVG). Spatial averaging of STD and AVG images generates <δ>
and <I>, respectively. These values were used to form <δ>/<I> ratio for each time
series. Scale bar is 20 μm and applies to all of the images.
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Figure 4. 2 Image examples for microtubule filaments in the composite network of
actin and microtubule with NeutrAvidin molecules and MAP65 as actin and
microtubule crosslinkers, respectively. A pair of images is shown for each of 0%,
3%, and 10% MAP65 and R = 0, 0.02, 0.04, and 0.08 for NeutrAvidin molecules.
The % represents the percentage of tubulin dimers that are bound to MAP65
crosslinkers, while R is NeutrAvidin:actin molar ratio. Each pair consists of
projection image of standard deviation of pixel intensity value (STD) and projection
image of average of pixel intensity value (AVG). Spatial averaging of STD and AVG
images generates <δ> and <I>, respectively. These values were used to form <δ>/<I>
ratio for each time series. Scale bar is 20 μm and applies to all of the images.

To characterize the co-localization of microtubules and actin filaments, I
calculated the cross correlation between the microtubule and actin fluorescence channels
for the same location and time. For each image of the same region in the chamber
recorded from the actin channel and the microtubule channel, I can calculate the local
normalized cross-correlation value for a region of n pixels. The definition of normalized
cross correlation is:
1

< 𝐼𝑎 ∗ 𝐼𝑚 >= 𝑛 ∑𝑥,𝑦

(𝐼𝑎 (𝑥,𝑦)−𝜇𝑎 )(𝐼𝑚 (𝑥,𝑦)−𝜇𝑚 )
𝜎𝑎 𝜎𝑚
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Eq 4.1

where Ia(x,y) and Im(x,y) are the intensity values for the x and y coordinates of the
selected, corresponding regions of interest over which the normalized cross correlation is
calculated. The parameters μa and μm are the mean intensity values, and σa and σm are the
standard deviations of intensities for the same region. This definition of normalized cross
correlation returned values between -1 and +1, where +1 values denote high correlation
between the actin and microtubule images and were depicted in white, -1 values indicated
anti-correlation between the actin and microtubule images and were depicted in black;
intermediate scaled linearly in grey.
I can use this definition of the normalized cross-correlation function to create
correlation maps, which are images that show where the actin and microtubule images are
highly correlation (white) or anti-correlations (black). I created these maps by sweeping a
square window to select the region over which I calculated the normalized cross
correlation. The interrogation window, defined by characteristic size d, contained (2d +
1)2 pixels. Correlation maps could be created using different window sizes, calculating
the normalized cross correlation (Eq. 1) over the n = (2d + 1)2 pixels, and assigning the
central pixel of the window with the correlation value. The borders of the correlation map
were trimmed by removing d pixels from the borders as this method leaves a frame of
uncalculated pixel values 190.
I used different interrogation window sizes to calculate correlation maps and
determine the optimal window size, d, based on the diffraction limitation of optical
microscopy and the quality of the resulting image. In order to compare between
experiments, I averaged the correlation values from the entire correlation map to give a
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single number for the normalized cross correlation of one set of actin and microtubule
images.

4.4 Results and Discussion
To assess the dynamics of the composite network of actin and microtubule
filaments, I co-polymerized actin filaments and microtubules so as to have similar total
polymer length and mesh sizes. I systematically altered the actin crosslinkers:actin
monomers ratio, R, and the percentage of tubulin dimers bound to MAP65 crosslinkers
(%). These control parameters resulted in altered arrangements of the network structure
and tuned the mobility of the networks.

4.4.1 Composite network without actin crosslinkers
I first looked at the mobility of a composite network of actin and microtubule
filaments with no actin crosslinkers present. To crosslink microtubule filaments, I tested
MAP65 at 0%, 3%, and 10%, and recorded fluorescence images of the actin and
microtubules (Fig 4.3.A). At 0% MAP65, the composite network of actin and
microtubules co-polymerized to form an entangled network, as we have previously
examined 141,162. The microtubule filaments and tracer actin filaments showed little
structure when imaged in wide field epi-fluorescence (Fig 4.3.A i-iii). When MAP65
was introduced to the system (3%), microtubule filaments formed thin, over 10 μm long,
bundles (Fig 4.3.A iv-vi). The bright background in the microtubule channel suggests the
presence of microtubules that remained un-crosslinked. The actin filaments were
uniformly distributed as well, implying that they are unaffected by the microtubule
crosslinking at this concentration.
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At 10% MAP65, the microtubule bundles were denser and longer (Fig 4.3.A viiix). The background in the microtubule channel was lower, implying that most
microtubules were in bundles. Unlike at the lower concentrations, MAP65 at 10%
displayed actin structures. Interestingly, the actin bundles appear to be coincident with
the microtubule structures. The co-localization of actin filaments and crosslinked
microtubule filaments is obvious in the merged channel (Fig 4.3.A ix).
In addition to the organization of the networks, I directly quantified the mobility of the
composite networks, as we have previously measured 141,162. The mobility was deduced
from the average standard deviation normalized by the average intensity, <δ>/<I>, from
time series data of the microtubule and actin fluorescence channels, separately. These
data were taken for several fields within a chamber to perform the averaging (N = 5 - 10
measured time series for each chamber). Interestingly, the mobility of composite
networks with zero actin crosslinking (R = 0) and increasing microtubule crosslinking by
MAP65 at 0%, 3%, and 10% did not depend on the MAP65 crosslinking, despite the
noticeable change to the structure of the composites (Fig 4.3.B).
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Figure 4. 3 Composite networks of microtubule and actin filaments without actin
crosslinkers. (A) Representative images of (i, iv, vii) microtubules, (ii, v, viii) actin
filaments, and (iii, vi, ix) merge channels with microtubules (cyan) and actin (red)
for 0%, 3%, and 10% MAP65 without actin crosslinking (R = 0). Colors outlined
correspond to the colors in part (B). Scale bar is 20 µm. (B) The standard deviation
of pixel intensity over time and space, <δ>, was calculated and normalized by the
average of pixel intensity over time and space, <I>. Box-whisker plot for <δ>/<I>
ratio for 0%, 3%, and 10% MAP65 (N = 7, 8, 6 independent time series) is shown
separately for actin (hashed) and microtubule (solid) networks.

4.4.2 Co-localization of microtubule and actin
I was surprised to observe that actin and microtubules co-localized at high
MAP65 (10%). Although the co-localization appeared obvious, I sought to quantify the
93

amount of co-localization using a cross-correlation between the actin and microtubule
signals in the same location (Fig 4.4, Fig 4.5). Each image was 2048×2048 pixels with a
magnified pixel size of 108 nm; the cross-correlation value for each pixel exists between
+1 to -1. The brightest white points corresponded to highly correlated areas with the
magnitude of +1; the darkest black regions indicate anticorrelation between the images
with a value of -1. Cross correlations between actin and microtubule channels were
calculated using different interrogation window sizes, d, where d is the number of pixels
in both directions around the central pixel (Fig 4.4.B).
I found that the interrogation window size did impact our analysis. If the window
size was too small (d = 1), the data was dominated by shot noise, which is uncorrelated,
by definition (Fig 4.4.B i). Considering the diffraction limit for these images was 250 –
325 nm or ~3 pixels, any calculation for window size below that does not carry physical
information and would be dominated by noise, as shown for the smallest window size.
When d = 5, there are bright patterns that correspond to the co-localized actin and
microtubule bundles, indicating that actin and microtubule channels are highly correlated
at those locations (Fig 4.4.B ii). These bright areas expand at window sizes of 10 and 15
pixels (Fig 4.4.B iii-iv). However, when the window size increased, the resolution of the
structure decreased. The signal from the bundle was smeared out over the window, and
information was lost. Due to this empirical assessment, I chose a window size of d = 5 to
perform all cross-correlation analysis to quantify and compare the actin-microtubule colocalization.
I assessed that the cross correlation was not a result of fluorescence bleed-through
between the actin and microtubule channels. This is obvious from inspection of several
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images where highly fluorescent, non-bundled regions in the microtubule channel are not
bright in the actin channel (Fig 4.4.A, arrows, Fig 4.6). These variations in microtubule
intensity are likely clumps of aggregated tubulin protein that are incapable of forming
filaments. Our tubulin clarification procedure removes most of these aggregates, but
some always remain. In this case, the aggregates were useful to demonstrate that the colocalization I observe was not due to signal bleed through.
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Figure 4. 4 Cross correlation of microtubule and actin channels. (A) Representative
image of (i) microtubule and (ii) actin networks in the same location for R = 0 and
10% MAP65. Scale bar is 20 µm. Bright regions in the microtubule channel (arrow)
are not observed in the actin channel, implying bleed-through is not present. (B)
Calculated cross-correlation maps for the same microtubule and actin images from
(A) for different window sizes, d, when d = 1, 5, 10, 15 (i-vi). Optimal window size
was chosen to be d = 5 (n = 121 pixels) and used throughout to compare different
experiments. (C) Box-whisker plots of the average cross correlations between
microtubule and actin channels averaged over the entire cross-correlation map
created with window size d = 5 pixels for networks with no actin crosslinking (R = 0)
and increasing MAP65 0%, 3%, 10%. (N = 8, 9, 8 independent time series)
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Figure 4. 5 Cross-correlation between actin and microtubule channels. (A) Heat
map plot shows the mean of normalized cross-correlation values for all composite
networks measured with various R and MAP65 percent bound. Color scale indicates
quantitative cross-correlation. (B) Representative merged images of microtubule
(cyan) and actin (red) for all experimental parameters with various R and MAP65
percent bound. Scale bar is 20 µm. (N = 8 – 10 independent measurements)

Figure 4. 6 High intensity microtubule aggregates do not appear in the actin
channels. Representative images of microtubules (i, iii, v, vii, ix, xi) and actin (ii, iv,
vi, viii, x, xii) for the same region in the experimental chamber at different
percentages of MAP65 and R. Arrows denote regions where there is high
fluorescence in the microtubule channel, which are caused by aggregates, without
bleed-through into the actin channel. Scale bar is 20 μm.
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Using the optimal window sizes, I can compare the cross correlation of the actin
and microtubule signals as a function of MAP65 concentration. In the absence of actin
crosslinkers, the cross correlation was an accurate reporter of what was obvious from
images: the actin co-localization increased with MAP65 percent bound (Fig 4.4.C). Given
the dependence on MAP65 concentration, I can think of two possible mechanisms for this
co-localization: (1) actin can bind to MAP65 with a low affinity and is being cocrosslinked into bundles with microtubules, or (2) microtubule bundles are sweeping up
the actin into the large bundles of microtubules. In order to assess these two possible
mechanisms, I performed control experiments to examine the organization of actin in the
presence of MAP65 without microtubules present. I found that in the presence of 10%
MAP65, actin appeared as typical entangled networks with no effect on the actin
structure (Fig 4.7.A). In order to be sure that the MAP65 was not associating with actin
filaments – even weakly – I repeated the measurement using a GFP-labeled MAP65 and
imaged the network in both channels (Fig 4.7.B). I found no obvious association of the
MAP65 with actin and no structure in the MAP65 channel to imply interaction between
the filaments (Fig 4.7.B).
Finally, by closely examining regions where I did observe co-localization
between microtubules and actin, I found that particularly thick microtubule bundles in the
presence of 10% MAP65 could show individual actin filaments within larger bundle
structures (Fig 4.7.C). I used ImageJ/FIJI to create a temporal color code of the time
series for the actin and microtubule channels, which overlaid successive images in
different colors, as given by the time-color scale (Fig 4.7.D). When using a spectrum
color scale, parts of the image that did not move over time appear white (all colors) in the
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temporal color code image. The microtubule bundle was mostly white due to low
fluctuations (Fig 4.7.D i). Most of the actin filaments appeared as rainbows because they
were able to fluctuate (Fig 4.7.D ii). The actin filaments that were co-localized with the
microtubule bundle displayed as white – implying that they did not fluctuate over time,
likely because they were stuck inside the microtubule bundle. Prior work has shown that
the spacing between microtubules within MAP65 driven bundles is 25 – 35 nm 47 , more
than enough space to trap an actin filament of width of 10 nm. Together, these
observations support a mechanism where the actin is swept up into the microtubule
bundles and not being co-crosslinked with microtubules due to an interaction between
MAP65 and actin.
The mechanism for actin-microtubule co-localization mediated by MAP65 is
different from previously reported actin-microtubule interactions mediated by proteins
originally thought to be only actin or microtubule binding partners. In those prior reports,
naturally occurring proteins, such as CLIP-170, mDia 101, or engineered proteins, such as
TipAct 102 served as crosslinkers between individual growing actin or microtubules and
surprisingly altered the growth rates as well as the organization of these filaments.
Another exciting study used tau and fascin to co-organize actin and microtubules 185. In
all of these examples, the experiments showed specific interactions between the filaments
and the crosslinkers. Further, these experiments were performed in quasi-2D, which is
distinct from the work presented here, which is specifically interested in 3D networks of
actin-microtubule composites. Ultimately, these exciting co-crosslinkers can be utilized
to alter the properties of the 3D networks I am creating in this paper.
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Figure 4. 7 Actin and MAP65 do not interact without microtubules. (A) Actin
network with 10% MAP65. Scale bar is 20 µm. (B) Representative image of (i) actin
and (ii) GFP-MAP65. Scale bar is 10 µm. (C) (i) Large, thick bundle of microtubules
in the presence of 10% MAP65. (ii) Actin filaments co-localized within the bundle.
(iii) Merge of microtubules (cyan) and actin (red). Scale bar is 10 µm. (D) Temporal
color code of a 1-minute time series of (i) microtubules and (ii) actin shows that
actin within the microtubule bundle does not fluctuate as much as actin outside of
the bundles. Temporal color code scale uses the spectrum color scale from 0 – 123 s.
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4.4.3 The role of actin crosslinkers in the fluctuation dynamics of actin and
microtubules

We have previously shown that actin network crosslinking has a profound effect
on the mobility and viscoelastic nature of actin-microtubule composite networks 141,162. In
our prior works, the microtubule network was less dense compared to the actin network,
which may have been the reason for the actin’s control over the mechanical properties.
To determine the impact of actin crosslinking by NeutrAvidin when actin and
microtubule mesh sizes are comparable, I prepared co-polymerized actin and microtubule
filaments without MAP65 crosslinkers, and with an increasing ratio of NeutrAvidin:actin
R = 0, 0.02, 0.04, and 0.08. The actin and microtubule networks were imaged directly and
the organization and mobility were measured for each filament type using time series.
I found that the microtubule network of the composite did not appear to have
gross changes in morphology as the actin crosslinking ratio was increased (Fig 4.8.A).
Actin filaments did tend to form a mesh-like network with some clusters of filaments at
the highest tested ratio, R = 0.08, similar to our prior results 141. NeutrAvidin molecules
have four potential binding sites in a tetrahedral arrangement allowing the actin network
to be oriented in a variety of angles when crosslinked. While some actin bundling can
occur, the actin bundles are far less obvious than the microtubule bundles created by the
antiparallel crosslinker, MAP65.
For multiple locations in several chambers, the mobility <δ>/<I> was measured
and compared for networks without microtubule crosslinking and increasing actin
crosslinking (R = 0, 0.02, 0.04, 0.08). In general, I found that the mobility of both actin
and microtubules depended on the actin crosslinking (Fig 4.8.B). This indicated that the
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network mobility and viscoelastic properties were controlled by the actin network and its
crosslinking ratio 141.
Of interest, I found that the microtubule mobility increased, while the actin
mobility decreased (Fig 5.8.B). Perhaps it is not surprising that actin would become less
mobile when crosslinked. Indeed, we have shown that in our prior work 18,19,183.
Strikingly, and distinct from our prior work, microtubule motility significantly increased
as the actin crosslinking increased. The enhanced microtubule mobility may result from
the increased free space when actin filaments become crosslinked, giving microtubules
more space to fluctuate. This implied that the actin was bundling on a scale that was
smaller than we can detect in the microscope, as we previously noted 18,19,183.
In our prior works, the actin mobility is almost always higher than the
microtubule mobility due to the inherent high flexibility of actin filaments compared to
microtubule filaments 18,19,183. These prior works often had equimolar actin monomers
and tubulin dimers, resulting in more actin filaments than microtubules. Specifically, the
number of actin filaments was greater than the number of microtubules due to the fact
that the microtubule requires 13 dimers to nucleate and form a filament, compared to two
actin monomers needed for actin filaments. Here, we purposely chose an actinmicrotubule ratio to result in similar amounts of actin and microtubule polymer length
and mesh sizes. In this study, the tubulin fraction is ~87%. In one prior work, I altered the
relative ratio of actin and tubulin to change the network from 100% actin to 100%
microtubules for entangled networks without crosslinkers. Significant changes in the
mobility and mechanics of the network occurred when the actin and microtubule polymer
mass were similar 183. In that study, entangled networks with high fractions of tubulin had
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low mobilities for actin and microtubules, with actin’s mobility slightly higher than
microtubules 183. Excitingly, I show here that when actin-microtubule filament ratios are
more similar, the mobility of actin decreases as a function of actin crosslinking, and the
microtubule mobility increases.
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Figure 4. 8 Filament fluctuations depend on actin crosslinking. (A) Representative
images of microtubules (i, iv, vii, x) and actin (ii, v, viii, xi). Merged images (iii, vi, ix,
xii) display microtubules (cyan) and actin (red) networks as the actin crosslinking is
increased R = 0, 0.02, 0.04, 0.08 in the absence of microtubule crosslinkers (N = 7, 6,
8, 5 independent time series for increasing R). Colors outlined correspond to the
colors in part (B). Scale bar is 20 μm. Arrows denote regions where there is high
fluorescence in one channel without bleed-through into the other fluorescence
channel. (B) The mobility of the networks was quantified using the <δ>/<I> ratio
where <δ> is the standard deviation of pixel intensity that was averaged over time
and space and then normalized by the mean of pixel intensity, <I>, for (i)
microtubules and (ii) actin as a function of actin crosslinking ratio.

4.4.4 High microtubule crosslinking causes co-localization of actin and
microtubules, while actin crosslinking controls filament mobility

I previously discussed the co-localization of actin and microtubule filaments in
the absence of actin crosslinkers (R = 0) and demonstrated that it was highly correlated at
10% MAP65 (Figs 4.3, 4.4). I wanted to test if the actin crosslinking had further effects
to enhance or negate the actin-microtubule co-localization driven by MAP65. To
investigate this phenomenon, I changed the NeutrAvidin:actin ratio, R, systematically
while maintaining the MAP65 at 10% bound (Fig 4.9). For all actin crosslinker ratios (R
= 0, 0.02, 0.04, 0.08), the microtubules displayed long bundles distributed randomly
through the whole sample in the imaging plane as well as the depth of the experimental
chamber (Fig 4.9.A). As for the entangled networks, actin filaments appeared to colocalize with the microtubule bundles (Fig 4.9.A).
I quantified the co-localization using cross-correlation maps with the optimal
window size of d = 5 (Fig 4.9.B). All the networks had high cross correlation between
actin and microtubules when high MAP65 (10%) was present, and there was no
significant change in the cross correlation due to the actin crosslinking ratio (Fig 4.9.B).
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I measured the mobility of actin and microtubules in composite networks with
high microtubule crosslinking (MAP65 at 10%) as a function of actin crosslinking ratio
(R). As above, I determined the mobility of this crosslinked network by measuring the
mean of standard deviation over time, <δ>, and the mean of intensity over time, <I>,
when the actin crosslinking was R = 0, 0.02, 0.04, and 0.08. For microtubules, the
mobility increased as more actin crosslinkers were added (Fig 4.9.C). For actin filaments,
adding more actin crosslinkers reduced actin filament mobility. The trend for both actin
and microtubules was similar for 10% MAP65 as shown above for 0% MAP65 (Fig
4.8.B). These results imply that the actin crosslinkers have the most influence on network
mobility. From our prior work with actin-microtubule composites, I also know that the
viscoelastic properties of the networks depend on the actin network mobility, implying
that the MAP65 has little effect on the network mechanics.
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Figure 4. 9 Co-localization of microtubule and actin filaments at 10% MAP65. (A)
Representative images of microtubules (i, iv, vii, x), actin (ii, v, viii, xi), and merge
(iii, vi, ix, xii) with microtubules (cyan) and actin (red) composite networks created
in the presence of 10% MAP65 with different actin crosslinking ratios: R = 0, 0.02,
0.04, and 0.08. Bundles of microtubules and co-localization of actin are obvious for
all networks. Color outlines correspond to the data represented in (B) and (C). Scale
bar is 20 μm. (B) Cross correlation of microtubule and actin channels were
computed and displayed in a box-whisker plot. There was no significant difference
in the actin-microtubule co-localization as a function of R (N =8, 8, 10, 10). (C) The
mobility of the (i) microtubules and (ii) actin of composite networks was quantified
using the <δ>/<I> ratio where <δ> is the standard deviation of pixel intensity that
was averaged over time and space and then normalized by the mean of pixel
intensity, <I>, for networks with increasing actin crosslinkers, R (N = 6, 6, 8, 9
independent time series).

I showed that microtubule bundling by MAP65 can significantly affect the
organization of actin and microtubules, specifically causing co-localization (Figs 4.3, 4,
9). Using the GFP-labeled MAP65 protein, I can perform three-color imaging to localize
the microtubules, actin, and MAP65 simultaneously (Fig 4.10.A). For an example
network with 10% MAP65 and R = 0.02 actin crosslinking, I found that the MAP65 and
microtubules exactly correlated their organizations. The actin also correlated with the
microtubules and MAP65, but there were additional actin filament signals outside of the
bundles (Fig 4.10.A ii). Using the temporal color code, it is clear that the actin associated
with the bundles is not as mobile as the actin in the background, also shown in figure 5
(Fig 4.10.B, 4.7.D).
Although the microtubule crosslinker had profound effects on the microtubule and
actin organizations, it had insignificant effects on the mobility of the actin and
microtubule filaments (Fig 4.10.C). This trend continued for all variations of Netravidin
crosslinker (R = 0, 0.02, 0.04, 0.08) and MAP65 percentage bound (0%, 3%, 10%) (Fig
4.10.C). One interesting future avenue would be to explore other microtubule bundling
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agents. It is known that MAP65 crosslinkers reduce the flexural rigidity of microtubule
filaments 191, but other microtubule-associated proteins, such as tau, make microtubules
stiffer 31,37. Future studies using these crosslinking and stiffening associated proteins
could have different results on the mobility.
In order to ensure that these effects on mobility were not caused by inadvertent
effects of the crosslinkers to the wrong filament within the network, I performed control
experiments with actin in the presence of MAP65 (Fig 4.7) and microtubules in the
presence of Neutravidin (Fig 4.11). For each of these tests, I used the higher crosslinker
concentration (10% MAP65 and R = 0.08). The mobility of these networks were
measured and shown as a gray bar (Fig 4.10.C). For microtubules in the presence of
NeutrAvidin, the median mobility is similar to that of microtubules with R = 0 (Fig
4.10.C i-iv), implying that the control network behaves like the composite without actin
crosslinkers (Fig 4.10). Consequently, I can conclude that microtubule filaments and
NeurAvidin molecules do not interact in this composite network. Further, the higher
mobility than control could be due to the increased volume compared to when the other
part of the network is present.
For the samples with actin in the presence of MAP65, without microtubules and
without NeutrAvidin (R = 0), the median and the distribution of mobility exhibited higher
mobility compared to 10% MAP and R = 0 in the presence of microtubule filaments. This
result mirrors the imaging results (Fig 4.7) that suggest that MAP65 and actin do not
associate to form bundles of actin. It implies that great amount of MAP65 could not form
bundles of actin filaments and did not lower the mobility of actin network as was shown
for higher R values. Interestingly, the mobility of the actin in the absence of microtubules
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was significantly higher than observed with microtubules present (Fig 4.10 v-viii). This
could be due to the increased volume to move when the microtubules were absent.
One interesting observation was that, despite the co-localization of actin with
microtubules when the MAP65 was 10% (Fig 4.4, 4.8), the actin mobility is not equal to
the microtubule mobility. This result implied that these co-localized actin filaments did
not dominate the fluctuation dynamics in the actin network. That is corroborated by the
imaging data and the temporal color code data of the actin which shows significant
mobility from the free actin filaments, despite a fraction being immobilized in the
bundles (Fig 4.7.D, 4.10.B).
I also noted that there was a relatively large jump in actin mobility when doubling
the actin crosslinker concentration from R = 0.02 to 0.04. An additional doubling of the
actin crosslinkers (R = 0.08) has no further effect, as if the network mobility has hit a
saturation level (Fig 4.10). This same activity was observed in our recent publication
examining actin crosslinking in composite networks 162.
Unlike actin, the microtubules did not show a discrete jump in the mobility as a
function of actin crosslinking. Instead, the trend of increasing microtubule mobility was
gradual as a function of actin crosslinking (Fig 4.9). Comparing this data to our recent
publication of actin crosslinking in composites without microtubule crosslinking, I see
similar results 162. Namely, the microtubule mobility appears higher than the actin
mobility for R = 0.04-0.08. I conjecture that the mobility changes come from actin
bundles at a level that allows increased microtubule mobility, but is too small to observe
with the resolution of the light microscope.

112

113

Figure 4. 10 Mobility of composite networks of microtubule and actin filaments with
varying crosslinkers. (A) Example three-color image of a network with (i)
microtubules and (ii) actin crosslinked with (iii) 10% GFP-MAP65, and
NeutrAvidin R = 0.02. Three-color image merge showing microtubules (blue),
MAP65 (green), and actin (red). Scale bar is 10 μm. (B) Example mobility of the
images from (A) using ImageJ/FIJI temporal color code function shows (i)
microtubules, (ii) actin, and (iii) MAP65. Microtubules and act both do not move,
which a subset of actin does move outside of the bundles. (C) All mobility
measurements for microtubules (i – iv) and actin (v- viii) as a function of actin
crosslinking (R) and MAP65 binding show an overall dependence on actin
crosslinking but not on MAP65 binding (N = 5 - 10 independent time series).
Horizontal gray bars denote control data of only one type of filament in the
network.

Figure 4. 11 Microtubules in the presence of actin crosslinkers. Representative
image of microtubules in the presence of actin crosslinkers, NeutrAvidin, at R = 0.08
does not show any structure or any evidence of crosslinking. Scale bar is 20 μm.

4.5 Discussion and Conclusions
Composite actin and microtubule networks are important regulators of
intracellular organization and mechanics. I found here that the microtubule crosslinking
and bundling can control the organization of actin-microtubule networks, but the actin
crosslinking controls the dynamics of both filament types, and likely the mechanics of the
network. This result was rather unexpected given that one of the tenants of biological and
soft matter is a relationship between structure and function. In this composite network,
the obvious morphological changes driven by microtubule crosslinking by MAP65 (ie.
the large co-localized actin-microtubule bundles), are not affecting the dynamics nor the
mechanics of the entire network, as might have been predicted.
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Despite the large structural changes, the fluctuation dynamics of the composite
network are controlled only by the actin portion, and the extent of crosslinking of the
actin. Reorganization of the network due to actin crosslinking is difficult to distinguish
given the resolution of fluorescence microscopy, but I expect that the actin filaments are
locally bundled and linked. Despite the lack of obvious change of the organization with
actin crosslinking, the fluctuations of the actin and microtubules change significantly. Of
particular interest is that the microtubules become the more mobile fraction of the
network when the actin filaments are highly crosslinked (R > 0.02). I observed this effect
in a recent publication when R = 0.04 – 0.08, but the apparent change in mobility and the
difference between actin and microtubule mobilities were not as striking in that prior
study as I present here (Fig 4.10). The difference could be due to the increased number of
microtubule filaments compared to our prior work or the higher labeling of the
microtubules revealing a more mobile population. Future work with active crosslinkers
(motors) of either actin or microtubules could reveal exciting mechanical feedback when
included in composite cytoskeletal networks with stable crosslinkers.
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CHAPTER 5
ACTIVE 3D COMPOSITE NETWORK OF ACTIN AND MICROTUBULE WITH
MYOSIN II MOTOR PROTEINS

5.1 Abstract
The cytoskeleton is an active, non-equilibrium network composited of actin and
microtubule filaments as well as their associated proteins such as motor proteins. This
interacting composite network plays a vital role in various cell processes such as cell
division and cell motility. Synergistic interactions of actin and microtubule filaments in
the presence of motor proteins creates a complex system that is poorly understood. Here,
I look at the organization of this active composite network by performing correlation
analysis, and I use the data collected by our collaborators employing confocal
fluorescence microscopy.

5.2 Introduction

The Cytoskeleton is a dynamic composite network of filaments that enables the
cell to actively self-organize its interior to facilitate various essential cell functions like
cellular morphogenesis and mechanosensing. Assemblies of biopolymers such as actin
and microtubules driven by motor proteins underly these dynamics that leads to
morphological changes in a living cell.
To understand the basic mechanisms that governs the activity of motor driven
networks of filaments, various theoretical studies explored the produced contractile or
extensile networks192–200. Organization and dynamics of active network composed of
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actin and myosin II motor proteins was explored extensively in vitro 95,201–203. These
actomyosin networks undergo contractile motion while myosin motors slide actin
filaments against each other 95,201–204. It has been shown that connectivity of the filaments
in an actomyosin network is a key parameter that could control the structure and activity
of this network 202,205,206. Actin crosslinking proteins could tune the connectivity of
actomyosin network. In vitro studies show that long range contraction in the network
only occurs above a threshold connectivity when actin crosslinkers provide globular
contractility across the network 202,205,206. However, below this threshold connectivity,
myosin activity could produce short range contraction that forms smaller clusters 202,206.
The cooperative interaction of actin crosslinkers and myosin motor in the contractile
actomyosin network forms large aggregates 94 as well as aster structures while myosin
motor activity could be controlled spatiotemporally using stimulating light that inactivate
myosin inhibitors 203,207,208. Another recent study on the actomyosin network used
experiment accompanied with simulation to demonstrate that stiffness and connectivity of
filament modulate the deformation of the active network. Semiflexible filaments undergo
contraction at higher filament connectivity, while crosslinking can tune more rigid
filaments to form extensile to contractile networks 206. These results could explain the
fact that active assemblies of more rigid microtubule filaments with motor proteins like
kinesin motors, exhibit either extensile 98,192,193,209–211 or contractile 98,212,213 motions.
As it is discussed above, active actin and microtubule networks were explored
individually, while the effect of introducing a second type of filaments in an actin
network remained an open question. However, the unique interaction of actin and
microtubule filaments regulated the structure and dynamics of the cell and is critical in
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various biological processes such as cell migration and division. I have shown that the
interaction of actin and microtubule filaments in the composite network can produce a
unique network with distinct dynamics and mechanical properties. Hence, exploring the
effect of activity in this composite network could enable us to design multifunctional
materials.
Here, we examine the 3D active composite network of actin, microtubule, and
myosin II motors. Two color confocal fluorescence microscopy was used by our
collaborators to visualize the contractile network, while myosin activity was controlled
by light. To characterize the temporal structural changes in this contractile network, I
used correlation length measurements. I show that active composite network exhibit more
organized and uniform contraction in both actin and microtubule networks while the
length over which the network is correlated decreases over time. In contrast, actin
filaments in active actomyosin network undergo rupturing and turbulent contractions that
is reflected in enhancement in their correlation length measurements at later times.

5.3 Material and Method
5.3.1 Composite network preparation
Actin and microtubule were co-polymerized in the proper optimized buffers, each
at the constant concentration of 2.9 μM, according to previously published protocols
141,162

. Rabbit skeletal myosin II (Cytoskeleton, #MY02) introduced to provide activity to

this composite network at the constant concentration of 0.24 μM. Oxygen scavenging
solution was added to prevent photo damage. Also, 50 μM blebbistatin was added to
inhibit myosin activity until the imaging began 214.
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5.3.2 Microscopy
A Nikon A1R laser scanning confocal microscope was used to image networks
with a 60x 1.4 NA objective (Nikon). Labeled actin and microtubule were visualized
using two color imaging. Actin and Microtubules were imaged using 488 nm laser and
561 nm laser, respectively. The 488 nm light also inactivated the blebbistatin and initiate
myosin activity. Time series were taken for 6 minutes at a frame rate of 2.78 fps. Each
frame is 256×256 pixels or 212 µm ×212 µm 214.

5.3.3 Correlation measurements
To quantify spatial correlation in a two-dimensional image, I used a MATLAB
function 109. Pair autocorrelation functions were tabulated in MATLAB using Fast
Fourier Transform, FFT, as:
𝑔(𝑟⃗) =

𝐹𝐹𝑇 −1 ( |𝐹𝐹𝑇 (𝐼)|2 )
𝑁( 𝑟⃗)

Eq 5.1

Where FFT-1 is a reverse Fast Fourier Transform, N(𝑟⃗) is a normalization due to finite
size of the image. Also, the pixel intensity of the 2D image forms I matrix. To eliminate
the artifacts formed due to periodic nature of FFT, a zero pad is added around the original
image I. N(𝑟⃗) is the autocorrelation of window function W that masks the image. W has 1
value inside the measurement area and has the same size of zero padding as the original
image I.
𝑁(𝑟⃗) = 𝐹𝐹𝑇 −1 ( |𝐹𝐹𝑇 (𝑊)|2 )

Eq 5.2

Basically, this normalization is the total squire area that is considered for the correlation
calculation.
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Figure 5.1 displays an example of spatial correlation measurements for an image
of actin network. The image (Fig 5.1.A) shows the actin network in an active composite
of actin and microtubule filaments. The size of this image is 180×180 pixel or
149μm×149μm.

Figure 5. 1 Correlation measurement. (A) A confocal microscopy image of actin
network in an active actin-microtubule composite network. It is 180×180 pixel or
149μm×149μm. Scale bar is 20 μm. (B) Color-coded map of 2D spatial correlation
⃗⃗), obtained from the image. The spatial correlation function is depicted
function, g (𝒓
for 360×360 pixels. (C) 1D spatial correlation function calculated by angular
averaging for each r value. The normalized result is plotted versus r (μm).
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⃗⃗), is calculated using the MATLAB
The 2D spatial correlation function, g(𝒓
function. Figure 5.1.B displays this map for the image of actin network and it has the size
of 360×360 pixel. The 2D spatial correlation map is expected to be symmetric for
isotropically oriented filaments. Then, g(𝑟⃗) was averaged over all angles for each r value
to create 1D spatial correlation function, G(r). This function is normalized as below
Correlation =

G(r) − 1
𝐺𝑚𝑎𝑥 (𝑟)−1

Eq 5.3

Where Gmax(r) is the maximum value of the G function. The correlation function is
plotted in Fig 5.3.C for different distances, r. The shape and range of the correlation
function could reveal information about the underlying structure of the initial image
109,110,215

. Here, the correlation function is in the range between 1 and 0, and fitted to an

exponential function, 𝑎 × 𝑒𝑥𝑝(−𝑥/𝑏). The exponential coefficient b is considered as the
short-range correlation length for the network of filaments.

5.4 Result and discussion
To evaluate the structure of dynamic composite network of actin and microtubule
filaments, I measure the short-range correlation length of each of the actin and
microtubule network, separately. I look at 3 different time series for active composite
network and compare them with the result of 3 time series of active actin and myosin
network. By starting the imaging, the 488 nm light deactivates the myosin motor
inhibitors, blebbistatin, and initiates their activity. As a result, myosin motors slide the
actin filaments against each other that leads to contraction in the network of filaments. To
characterize this contractile network, I calculate the correlation length of the network for
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frames at 20, 120, 240, and 360 second for each time series. The change in the correlation
length of a network over time could indicate the effect of activity in its structure.

5.4.1 Correlation length measurement of a contractile composite network
To investigate the change of correlation length over time, I look at the network of
filaments for time series i, ii, iii, while actin and microtubule channels are analyzed
separately. The correlation length is measured for four frames of each time series at 20,
120, 240, and 360 second. Fig 5.1 and Fig 5.2 display the network of filaments over time
and the calculated correlation results for actin and microtubule network, respectively.
We examine the 3D composite network of actin and microtubule over the course of six
minutes while myosin motors provide the activity. Although, myosin motors only bind to
actin filaments, it is clear from the careful observation of the time series that the two
networks remain coordinated while microtubules co-localized with actin filaments and
move with them. Particle Image Velocimetry (PIV) analysis conducted by our
collaborator shows similar movement patterns for actin and microtubule networks, while
they both move toward the center of activated region 214. Here, I measure the correlation
length of actin and microtubule networks as described in the Method. Briefly, the 2D
spatial correlation function is calculated for each image using Fast Fourier Transform
(FFT) in a MATLAB code. Then, 1D correlation function for different radii is computed
after angular averaging. To find the correlation length, the normalized correlation is
plotted vs radius and fitted to exponential decay. Here, the actin and microtubule
filaments are randomly oriented in the network. Consequently, their 1D correlation
functions generally show an exponential decay with minimum or no fluctuation before
going to 0 value at grater r values (Fig 5.1.C). The overall trend of correlation
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Figure 5. 2 Actin filaments in a 3D active contractile composite network. (A) Four
different confocal microscopy images of time series i, ii, iii are displayed. The frames
correspond to 20 sec, 2 min, 4 min, and 6 min after the start of imaging, while the
activated myosin motors initiate the contraction in the composite network. Colors
outlined correspond to the colors in part (B). Scale bar is 40 μm and applies to all
the images. (B) Correlation length values of actin network for each of the four
frames of time series i, ii, iii are shown. Myosin activities move and rearrange actin
filaments and forms a denser network with smaller correlation length over the
course of 6 minutes.
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Figure 5. 3 Microtubule filaments in a 3D contractile composite network. (A) Four
different confocal microscopy images of time series i, ii, iii are displayed. The frames
correspond to 20 sec, 2 min, 4 min, and 6 min after the start of imaging, while the
activated myosin motors initiate the contraction in the composite network. Colors
outlined correspond to the colors in part (B). Scale bar is 40 μm and applies to all
the images. (B) Correlation length values of microtubule network for each of the
four frames of time series i, ii, iii are shown. Although, myosin only binds to actin
filaments, the microtubule network moves accordingly. This rearrangement of
microtubules forms a network with smaller correlation length.

measurements indicate smaller correlation length for both of the actin and
microtubule networks over time, that is in a good agreement with the PIV analysis
results. The contraction in an active actin-microtubule composite rearrange and move the
filaments and creates networks with smaller mesh size. Hence, these structural changes

124

due to the contraction are mirrored in the correlation length measurements of both actin
and microtubule networks.

5.4.2 Correlation length measurement of contractile composite network
To determine the effect of actin and microtubule interaction in the dynamics of
this active composite network, a control experiment was designed. The microtubule
filaments are removed in the new active actomyosin network while all of the other
reagents and conditions remain the same. Fig 5.4 shows four different frames of this
active actomyosin network for time series i, ii, iii. The reorganization of actin network is
more drastic and rupturing in the control experiment and the networks undergo more
obvious structural changes over six minutes. Myosin activity creates bright regions that
contains bundles of actin filaments and leaves large voids in the network. As the
filaments are not confined on a surface and the network is imaged at the middle of each
sample, these bundles could move out of the plane of view. Thus, large bundles of actin
filaments enter and then exit the plane of view due to myosin activity. The computed
correlation length for active actomyosin network is displayed in Fig 5.4.B. The
correlation length of actin network increases over time for the time series while the time
series iii undergo significant raise. This bundle formation alters the structure of actin
network and consequently, affects the correlation measurements. It seems that the results
correspond to the characteristic length between the brighter areas made of bundles of
actin rather than individual filaments. The contraction empowered by myosin motors
shapes the denser areas of actin filaments. These aggregates grow over time and then
spread even further apart while they move out of the plane of view.
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Figure 5. 4 Actin filaments in a 3D active actomyosin network. (A) Four different
confocal microscopy images of time series i, ii, iii are displayed. The frames
correspond to 20 sec, 2 min, 4 min, and 6 min after the start of imaging, while the
activated myosin motors initiate the contraction in the actin network. Colors
outlined correspond to the colors in part (B). Scale bar is 40 μm and applies to all
the images. (B) Correlation length values of actin network for each of the four
frames of time series i, ii, iii are shown. Structural changes fueled by myosin activity
forms bundles of actin filaments that enter and exit the plane of view. The
correlation measurements correspond to the rearrangement of these bright areas,
while an enhancement in the calculated correlation length is observed.

126

5.4.3 Discussion
The comparison between the active actin-microtubule and active actomyosin
networks indicates that composite network has a slower, controlled network-wide
contraction. This organized contraction dynamics is reflected in the decreasing
characteristic length of both actin and microtubule networks over time. In contrast, actin
network contraction leads to network rupturing when the actin bundles have turbulent
motion over time. These results show that microtubule in the active actomyosin network
could control the organization of actin network and slow down its activity 214.
Previous studies have shown the role of filament connectivity and stiffness in the
actomyosin contraction 205,206. For more rigid actin bundles, increasing crosslinker
density can cause extensile to contractile transition in the actomyosin network 206. Here,
by introducing rigid microtubule filaments to the active actomyosin network, the
structure and dynamics of the network is regulated, while slower and more organized
contractile network created. This composite provides a platform to explore the interplay
of rigidity and connectivity between flexible actin filaments and rigid microtubules.
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CHAPTER 6
OVERVIEW
Self-organization and dynamics of composite network of actin and microtubule
filaments were discussed in this thesis. Interactions of these two biopolymers in the
cytoskeleton enable the cell to fulfill various key cell functions such as cell motility and
cell division. Hundreds of known enzymes and auxiliary proteins cooperate to regulate
the interaction of actin and microtubules at different parts of cells and facilitate their
functions. Studying its underlying mechanism can transform our understanding of cell
biology and material science. In addition, it could be exploited to design multifunctional
smart materials that can be customized accordingly.
Actin and microtubule filaments are the main elements in these composite
networks. Different characteristics of these filaments such as their rigidity and median
length could determine the mechanics and dynamics of the composite network. Using
filaments with different persistence length would be an interesting next experiment to
design. The density ratio of actin and microtubules filaments could also affect the
viscoelastic properties of the composites. Moreover, various molar ratios of actin and
microtubule can control the final median length of each filament and form a composite
network with distinct structure. Introducing some auxiliary proteins that could regulate
actin and microtubule filaments polymerization as well as severing enzymes also could
enable us to control the length of these filaments in the composite.
To tune the interaction of actin and microtubule filaments, various types of
crosslinkers could be employed. Each type of crosslinkers has a specific size and strength
that could produce distinct higher order structures of filaments by forming branches or
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bundles. The ratio of crosslinkers to total protein is another parameter that could be
investigated.
Motor proteins can provide activity to these composite networks and generate
force by consuming energy. Different types of myosin and kinesin motors can interact
with actin and microtubule filaments while the directional movement and the amount of
generated force varies depending on the characteristic of certain motors. The density of
the motors and their molar ratio could dictate the activity and structure of the active
composite network. There are studies that investigated the cooperative role of
crosslinkers and motor protein in the network of filaments. Here in the active composite
network, we can introduce actin and microtubule specific crosslinkers and explore the
interplay between them. In addition, the activity of the network could be controlled by the
amount of ATP present in the composite network. A certain type of ATP that is called
caped ATP, is initially inactive and being exposed to the UV light could activate it.
Employing this ATP could allow us to locally activate the motors in the composite
network using UV light. As a result, the motor proteins could switch from passive
crosslinkers to force generating agents that slide the filaments along each other in a
controlled manner in desired areas.
To visualize the network of filaments and quantify the viscoelastic characteristic
of actin-microtubule composite network, we can use different type of fluorescence
microscopy and optical tweezers microrheology. Various analytical methods such as
differential dynamic microscopy (DDM), Particle Image Velocimetry (PIV) and
correlation measurements could be employed to assess the dynamics and the structural
changes in an active composite network of filaments.
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There are many different aspects that could be studied to reveal the physical
properties of the composite network of interacting actin and microtubule filaments.
Further research on the cytoskeletal composite networks in the presence of their associate
proteins and motors can provide a deeper understanding of the mechanisms that cells use
to regulate their activity and organization.
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APPENDIX A
PROTOCOL FOR ACTIN, MYOSIN II, MICROTUBULE, AND KINESIN-1
GLIDING ASSAY

Myosin II

Actin Buffer 10X
[Final]
250mM
250mM
10mM
40mM

Formula Weight
68.05 g/mol
74.55 g/mol
380.35 g/mol
95.21 g/mol

Chemical
Imidazole
KCl
EGTA
MgCl2

0.68g
0.746g
0.152g
1600uL
pH to 7.4
ddH2O to 40mL

Myosin Buffer 10X
[Final]
250mM
3M
10mM
40mM

Formula Weight
68.05 g/mol
74.55 g/mol
380.35 g/mol
95.21 g/mol

Chemical
Imidazole
KCl
EGTA
MgCl2

Myosin Buffer 1X
0.5 mL of 10X Myosin Buffer Concentrate
50 μL of 1 M DTT
Add ddH2O to 5 mL
Actin Buffer 1X
1 mL of 10X Actin Buffer Concentrate
100 μL of 1 M DTT
Add ddH2O to 10 mL
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0.34g
4.47g
0.076g
800uL
pH to 7.4
ddH2O to 20mL

3.4g
3.73g
0.76g
8mL
pH to 7.4
ddH2O to 200mL

Deadhead Myosin Spindown
4.4 μL of 18 mg/mL myosin……………………Final 200 μg/mL of myosin stock
17.4 μL of 2.3 mg/mL F-actin…….……Final 100 μg/mL of unlabeled actin stock
4 μL of 0.1 M ATP……………………………………………….Final 1 mM ATP
374.2 μL of Myosin Buffer 1X ..………………..Myosin Buffer 1X to total 400 μL
Centrifuge at 95,000 rpm for 20 minutes at 4 °C to pellet deadheads. Remove supernatant
and dilute to desired concentration.
Myosin Dilution
Spun down myosin is diluted in Myosin Buffer, usually to 200 μg/mL.

Kinesin-1
1. Take kinesin stock from -80 °C and thaw it on ice.
2. Add PEM-100 and DTT to kinesin stock to make 580 nM solution.
3. Centrifuge diluted myosin solution at 90,000 rmp for 10 minutes at 4 °C to
remove aggregates!

Prepare spin-coated coverslips
1. Make the setting of the spin coater for 3500 rpm for 30 seconds
2. Put the coverslip on the stage
3. Pipette 50 μl of 0.1% nitrocellulose at the middle of the coverslip
4. Press start!
Store the coverslips in a clean lidded container and use them within 2 weeks!

Methylcellulose
To make 3% methylcellulose:
3
weight
methylcellulose =
100
volume
Add 0.12 gram of 88000 MW methylcellulose to 4ml ddH2O and store at 4 °C overnight
to dissolve!
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Actin polymerization

10x F - Buffer
1 ml
Imidazole (1M)……………………………………….Final 100 mM
2.5 ml
KCl (2M)…………………………..………..……….….0.5 M
100 µl
MgCl2 (1M)…………………………………….….……..10 mM
100 µl
EGTA (200mM)……………………………………….……….2 mM
6300 µl
ddH2O
---------------------------------------Total
10 ml
10x G – Buffer
200 µl
Tris (1M)………………………………………………Final 20mM
40 µl
CaCl2 (0.5 M)……………………………………………………..2mM
9760 µl
ddH2O
------------------------------------Total
10 ml
1x out of 10x G – Buffer
5 µl
10x G – Buffer
1 µl
DTT (10mM)
44 µl
ddH2O
---------------------------------Total
50 µl
•
•
•
•
•
•

Final labeled actin concentration is 50 µM in this protocol.
Final phalloidin concentration is 16 µM in this protocol.
Concentration of phalloidin should be 1/3 of the concentration of actin.
Labeled actin to total actin concentration is typically 1/10 to 1/3 in labeled actin
filaments.
Reconstitute Cytoskeleton G-actin powder to 10mg/ml. Aliquot and drop freeze,
then store at -80 °C. (for both labeled and unlabeled G-actin).
Reconstitute phalloidin with methanol to 100 µM. Store at -20 °C.
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Labeled F-actin
1.5 µl
red G-actin (220 µM)……………………………….….……Final 50 µM
3 µl
unlabeled G-actin (220 µM)……………………………..…….… 50 µM
3.2 µl
phalloidin in Methanol (100 µM)…………………………………16 µM
1 µl
ATP (40 mM)………………………………………………………2 mM
2 µl
10x F-Buffer
9.3 µl
1x G-Buffer
----------------------------------------------------------------20 µl total

Unlabeled F-actin
4.5 µl
unlabeled G-actin (220 µM) )……………………………..………Final 50 µM
3.2 µl
phalloidin in Methanol (100 µM) )………………………..….…………16 µM
1 µl
ATP (40 mM) )………………………………………………..…………2 mM
2 µl
10x F-Buffer
9.3 µl
1x G-Buffer
----------------------------------------------------------------20 µl total
Add everything except the phalloidin and put it on ice for 30 minutes to polymerize. Then
put it on room temperature for another 30 minutes. After that, add phalloidin and leave it
on ice for 1 hour. It is ready, should be stored at 4 °C.
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Microtubule polymerization
Making Cytoskeleton Taxol stabilized microtubule 11% labeled
Unlabeled Cytoskeleton Tubulin: The stock comes in a pellet that needs 200 µl PEM-100
added to it to be at 5mg/ml (on ice). Aliquot and drop freeze from stock. Keep at -80 °C.
Labeled Cytoskeleton Tubulin: add 4 µl PEM-100 to resuspend pellet to 5 mg/ml before
use (on ice). Aliquot and drop freeze from stock. Keep at -80 °C.
1. Turn on large Sorvall Discovery M120 centrifuge, set to °C. Make sure vacuum is
on.
2. Thaw/resuspend tubulin on ice. Transfer 2 µl labeled + 16 µl unlabeled = 18 µl
total
3. Using the small S120AT2-0449 rotor in deli fridge, centrifuge at 90,000 rmp for
10 minutes. Thaw aliquot of 100 mM GTP for next step.
4. Discard pellet and transfer sup to a 1.5 mL epp. Tube. Add 0.2 µl 100 mM GTP
(1 mM GTP final).
5. Incubate for 20 min at 37 °C.
6. Add 0.45 µl 2 mM Taxol (50 µM Taxol final).
7. Incubate for 20 minutes at 37 °C.
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Gliding assay for actin, myosin, microtubule, and kinesin:

Blocking buffer
BSA 10mg/ml
5 µl
1x Actin buffer
95 µl
-----------------------------------Total
100 µl
Diluted labeled actin filament
Labeled actin filament
Unlabeled actin filament
Deoxy
Actin buffer 1x
Diluted labeled microtubule filament
MTs
Taxol
PEM-100
Motility buffer
Actin buffer 10x
10 µl
KCl (1M)
3.7 µl
ATP (100mM)
2 µl
DTT (1M)
1 µl
Deoxy
2 µl
Methylcellulose (3%) 16.7 µl
ddH2O
53.6 µl
Taxol
1 µl
-----------------------------------Total
80 µl

1. Make 10 µl chamber with nitrocellulose coated coverslip
2. Mix 1 µl Kinesin 580 nM and 9 µl of HMM 200 µg/ml, then flow it into the
chamber (incubate 5 min)
3. Add 10 µl blocking buffer
4. Add 10 µl diluted microtubule filament solution
5. Add 10 µl diluted actin filament solution
6. Add 10 µl motility buffer
7. Image the chamber
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APPENDIX B
IMAGEJ/FIJI MACRO FOR MEASURING MEAN OF STANDARD DEVIATION
AND AVERAGE OF PIXEL INTENSITY OVER TIME FOR TIME SERIES
/*
This Imagej/Fiji macro provides measurements for steady-state
dynamics of actin microtubule filaments in a composite network.
It splits a time series to actin(green) and red (microtubule)
channels and analyzes each separately.
It measures standard deviation of pixel intensity over time,
delta, and its average over all pixels, <delta>.
Also, it measures average of pixel intensity over time, I, and
its average over all pixels, <I>. We use the results of each
channel of a time series to make <delta>/<I> ratio for that
channel. Each original time series has over 900 frames. I measure
the above values for original time series first (*-all.tif). Then
I make a new time series with frames that are temporal average of
intensity of all of the frames that are in 1 sec. Here there are
16 frames/sec so the movie (*-1sec.tif) has [# original
frames/16] frames. "Measure" command gives the mean of intensity
over all pixels for a time collapsed frame, then the results are
saved as csv file.
*/
dir1 = getDirectory("Choose Source Directory ");
list = getFileList(dir1);
for (i=1; i<=9; i++){
open("Time sequence"+i+".nd2");
title=getTitle();
title=replace(title, ".nd2", "");
selectWindow("Time sequence"+i+".nd2");
run("Show Info...");
saveAs("Text", dir1+"meta data "+title+".txt");
//Split the channels
run("Enhance Contrast", "saturated=0.35");
run("Enhance Contrast", "saturated=0.35");
run("Split Channels");
/*
Here are the measurements for "-all" time series
Here C1 is always green channel, C2 is red channel.
delete some frames then save "all" tif time series for
each channel!
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*/
selectWindow("C1-"+title+".nd2");
run("Delete Slice");
run("Delete Slice");
saveAs("Tiff", dir1+title+"-green-all.tif");
selectWindow("C2-"+title+".nd2");
run("Delete Slice");
run("Delete Slice");
saveAs("Tiff", dir1+title+"-red-all.tif");
//find average of intensity for each time series, then save
it
selectWindow(title+"-green-all.tif");
run("Z Project...", "projection=[Average Intensity]");
run("Enhance Contrast", "saturated=0.35");
run("Select All");
run("Measure");
saveAs("Tiff", dir1+"AVG_"+title+"-green-all.tif");
close();
selectWindow(title+"-red-all.tif");
run("Z Project...", "projection=[Average Intensity]");
run("Enhance Contrast", "saturated=0.35");
run("Select All");
run("Measure");
saveAs("Tiff", dir1+"AVG_"+title+"-red-all.tif");
close();
//find standard deviation of intensity for each time
series, then save it
selectWindow(title+"-green-all.tif");
run("Z Project...", "projection=[Standard Deviation]");
run("Enhance Contrast", "saturated=0.35");
run("Select All");
run("Measure");
saveAs("Tiff", dir1+"STD_"+title+"-green-all.tif");
close();
selectWindow(title+"-red-all.tif");
run("Z Project...", "projection=[Standard Deviation]");
run("Enhance Contrast", "saturated=0.35");
run("Select All");
run("Measure");
saveAs("Tiff", dir1+"STD_"+title+"-red-all.tif");
close();
// Here are the measurements for "-1sec" time series
//average each 16 frames to make 1sec frames, same it under
the name AVG_..
selectWindow(title+"-green-all.tif");
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run("Grouped Z Project...", "projection=[Average Intensity]
group=16");
run("Enhance Contrast", "saturated=0.35");
saveAs("Tiff", dir1+"AVG_"+title+"-green-1sec.tif");
selectWindow(title+"-red-all.tif");
run("Grouped Z Project...", "projection=[Average Intensity]
group=16");
run("Enhance Contrast", "saturated=0.35");
saveAs("Tiff", dir1+"AVG_"+title+"-red-1sec.tif");
//now find standard deviation and average of intensity of
//AVG_ time series that are basically 1sec time series.
selectWindow("AVG_"+title+"-green-1sec.tif");
run("Z Project...", "projection=[Standard Deviation]");
run("Enhance Contrast", "saturated=0.35");
saveAs("Tiff", dir1+"STD_AVG_"+title+"-green-1sec.tif");
selectWindow("AVG_"+title+"-green-1sec.tif");
run("Z Project...", "projection=[Average Intensity]");
run("Enhance Contrast", "saturated=0.35");
saveAs("Tiff", dir1+"AVG_AVG_"+title+"-green-1sec.tif");
selectWindow("AVG_"+title+"-red-1sec.tif");
run("Z Project...", "projection=[Standard Deviation]");
run("Enhance Contrast", "saturated=0.35");
saveAs("Tiff", dir1+"STD_AVG_"+title+"-red-1sec.tif");
selectWindow("AVG_"+title+"-red-1sec.tif");
run("Z Project...", "projection=[Average Intensity]");
run("Enhance Contrast", "saturated=0.35");
saveAs("Tiff", dir1+"AVG_AVG_"+title+"-red-1sec.tif");
//measure the mean of intensity over all pixels of the
resulted image
selectWindow("STD_AVG_"+title+"-green-1sec.tif");
run("Select All");
run("Measure");
selectWindow("AVG_AVG_"+title+"-green-1sec.tif");
run("Select All");
run("Measure");
selectWindow("STD_AVG_"+title+"-red-1sec.tif");
run("Select All");
run("Measure");
selectWindow("AVG_AVG_"+title+"-red-1sec.tif");
run("Select All");
run("Measure");
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saveAs("Results", dir1+"Results_"+title+".csv");
close();
close();
close();
close();
close();
close();
close();
close();
}
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APPENDIX C
PROTOCOL FOR CROSSLINKED ACTIN-MICROTUBULE COMPOSITE
NETWORK WITH PRE-POLYMERIZED LABELED FILAMENTS

Crosslinked Actin-Microtubule Co-Polymerization Protocol –
Anderson Lab
**Pre-polymerized Labeled filaments
Shea N. Ricketts
Updated February 22, 2019 by SNR
Reagents
Dark-Tubulin, 45.5 uM = 5 mg/ml, from Cytoskeleton cat #T240, in -80°C *keep on
ice, lasts for ~2 hrs on ice. Do not refreeze again in the -80°C.
Rhodamine-Tubulin, 45.5 uM = 5 mg/ml, from Cytoskeleton cat #TL590, in -80°C
*keep on ice until thawing for rhodamine microtubule (R-MT) polymerization.
Polymerize the same day aliquot is pulled from -80°C. Do not refreeze again in the 80°C.
Biotin Tubulin, 45.5 µM = 5 mg/ml, from Cytoskeleton cat #T333P, in -80°C *keep on
ice, lasts ~2 hrs if properly kept on ice Do not refreeze again in the -80°C.
Dark Actin, 46.5 µM = 2 mg/ml, from Cytoskeleton cat #AKL99, in -80°C *keep on ice,
last up to 1 week if properly kept on ice (as ice melts, replenish ice). Do not refreeze
again in the -80°C.
488-Alexa Actin, 34.9 µM = 1.5 mg/ml, from Thermofisher cat #A12373, in -80°C
*keep on ice, last up to 1 week if properly kept on ice (as ice melts, replenish ice). Do
not refreeze again. Do not refreeze again in the -80°C.
Biotin Actin, 23.3 µM = 1 mg/ml, from Cytoskeleton cat #AB07, in -80°C
GTP 100 mM, pH 7.0, in -20°C *keep on ice after thawing, can be refrozen and used
again.
ATP 100 mM, pH 7.0, in -20°C *keep on ice after thawing, can be refrozen and used
again.
Taxol 2 mM stock in DMSO, aliquot and freeze in -20°C *keep on bench after
thawing, can be refrozen and used again. Put back in -20°C once Taxol dilutions are
made (PEM-Taxol and 200 µM Taxol).
Neutravidin, 83.3 µM, from Thermo Fisher cat #31000, in -20°C *keep on ice, last up
to 1 week if properly kept on ice (as ice melts, replenish ice). However aliquot is at 5
µl so will likely be used up within 1-2 days. Do not refreeze again in the -20°C.
Free Biotin, 1.02 mM, from Sigma cat #B4501, in 4°C *take a 5 µl sample from the
stock solution.Keep on ice, last up to 1 week if properly kept on ice (as ice melts,
replenish ice).
488 Labeled 4.5 µm Microspheres
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Oxygen Scavenging system: 4.5 mg/ml glucose, 4.3 mg/ml glucose oxidase, 0.7
mg/ml catalase
0.5% β-mercaptoethanol
Buffers
PEM-100
100 mM PIPES, pH to 6.8 with HCl
2 mM MgCl2
2 mM EGTA
*Stored at room temperature and is viable for 1 years.
1 x G-buffer
2.0 mM Tris pH 8
0.2 mM ATP
0.5 mM DTT
0.1 mM CaCl2
*Stored at -20°C and is viable for 1-2 years.
Dilutions
PEM-Taxol
198 μl PEM-100
2 μl 2 mM Taxol *Thaw Taxol
*Make fresh every time before use, keep at room temp, good for 1 day.
200 uM Taxol
18 μl DMSO
2 μl 2 mM Taxol *Thaw Taxol
*Make fresh every time before use, keep at room temp, good for 1 day.
10 mM GTP, 1:10 dilution
90 µl PEM-100
10 µl 100 mM GTP
*Keep on ice during use, store in -20°C, can freeze/thaw.
10 mM ATP, 1:10 dilution
90 µl PEM-100
10 µl 100 mM ATP
*Keep on ice during use, store in -20°C, can freeze/thaw.
1% (v/v) Tween
495 ul PEM
5 µl Tween 20
Vortex and quick spin to mix
*Store at room temperature and use repeatedly. Good for 1 year.
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8.33 µM Neutravidin, 1:10 dilution
9 µl PEM-100
1 µl 83.3 µM Neutravidin
*Keep on ice during use, good for the day’s use
51 µM Free Biotin, 1:20 dilution
19 µl PEM-100
1 µl 1.02 mM (1020 µM) Neutravidin
*Keep on ice during use, good for the day’s use
PEM-100
Fill 50 ml tube with 40 ml sterile DI water
Measure out and add 1.893 grams of PIPES
Qualitatively transfer to 50 ml tube
100 µl of 1 M EGTA (final will be 2 mM)
100 µl 1 M MgCl2 (final will be 2 mM)
pH to 6.8 with pH meter (in 290)
If pH is too high add HCl *typically PEM is too basic with a pH between ~7.4-8.
Usually add 3-5 drops of HCl. Do so carefully as to not fall below 6.8 and have to add
KOH.
If pH is to low add KOH
Fill remaining volume to 50 ml in 50 ml tube using sterile DI water.
Sterile Filter into new 50 ml tube.
Label “PEM-100 pH 6.8 yourinitials, Date”
*Store at room temperature, in your drawer.
Tubulin Storage Protocol
Keep on ice during entire process prior to flash freezing and storage.
Dark Unlabeled Tubulin
Obtain unlabeled 1 mg lyophilized porcine tubulin (Cytoskeleton Cat #T240) from the
4°C and put on ice.
Add 200 µl PEM-100 to 1 mg lyophilized tubulin to bring up to 5 mg/ml volume.
Pipette to mix, make sure you got all tubulin from sides or lid. Do so by pipetting the
fluid on the sid or lid and depositing it into the solution at the bottom of the tube. To
avoid bubbles pipette slowly.
Let sit on ice for 10 minutes to allow tubulin to go into solution.
Rhodamine Labeled Tubulin
Obtain Rhodamine labeled 20 µg lyophilized porcine tubulin (Cytoskeleton Cat
#TL590) from 4°C and put on ice
Add 4 µl PEM-100 to 20 µg lyophilized rhodamine tubulin to bring up to 5 mg/ml
volume
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Pipette to mix, make sure you got all tubulin from sides or lid. Do so by pipetting the
fluid on the sid or lid and depositing it into the solution. To avoid bubbles pipette
slowly
Let sit on ice for 10 minutes to allow tubulin to go into solution
Biotinylated Tubulin
Obtain biotin 20 µg lyophilized porcine tubulin (Cytoskeleton Cat) from 4°C and put on
ice
Add 4 µl PEM-100 to 20 µg lyophilized rhodamine tubulin to bring up to 5 mg/ml
volume
Pipette to mix, make sure you got all tubulin from sides or lid. Do so by pipetting the
fluid on the sid or lid and depositing it into the solution. To avoid bubbles pipette
slowly *Do NOT vortex
Let sit on ice for 10 minutes to allow tubulin to go into solution
Aliquots from Dark and Rhodamine Tubulin
Mix labeled and unlabeled tubulin for desired labeling ratio. No labeling ratio has
MT’s that are too bright. Currently we use a 1:10 ratio rhoadmine-labeled:unlabeled
tubulin (the 1:20 ratio was too dim).
Add 36 µl of dark tubulin directly to the 4 µl rhodamine tubulin tube to create 40 µl
total.
Let sit for 10 minutes on ice to allow rhodamine tubulin and dark tubulin to go into
solution Aliquot rhodamine tubulin into 5 µl (8 aliquots)
Label each aliquot tube “R” *Once the rhodamine tubulin has been polymerized, add
to label “R-MT” with the data
Aliquot remaining volume of unlabeled tubulin into 5 µl (32 aliquots)
Label each aliquot tube “5 mg/ml DT” DT stands for dark tubulin
Flash Freeze with liquid nitrogen and store at -80°C *Flash freezing is absolutely
necessary for tubulin to remain functional
Aliquots from Dark, Biotinylated and Rhodamine Tubulin
Mix labeled, unlabeled and biotinylated tubulin for desired labeling ratio and
crosslinking ratio. Currently the labeling ratio for MT’s is 1:10 labeled:unlabeled
tubulin. This means that we are going to keep the total tubulin volume fixed at 40 µl
along with the 4 µl rhodamine tubulin tube. The volume of biotinylated tubulin will
vary depending on the crosslinking ratio and so will the volume of unlabeled tubulin.
Depending on the crosslinking ratio refer to the chart and add the correct volumes
directly to the 4 µl rhodamine tubulin tube to create 40 µl total.
Crosslinked Ratio “R=X”

0.005

0.01

0.02

0.04

Unlabeled Tubulin, 5 mg/ml (µl)

35.6

35.2

34.4

32.8

Biotinylated Tubulin, 5 mg/ml (µl)

0.4

0.8

1.6

3.2
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Rhodamine Tubulin, 5 mg/ml (µl)

4

4

4

4

Total Tubulin Volume (40 µl)

40

40

40

40

Let sit for 10 minutes on ice to allow rhodamine tubulin, dark tubulin, and biotinylated
tubulin to go into solution Aliquot the biotinylated rhodamine tubulin into 5 µl (8
aliquots)
Label each aliquot tube with the correct ratio and an R so you know that this is
labeled tubulin. ‘R–R=0.0X” *Once the biotinylated rhodamine tubulin has been
polymerized, add to label “R–R=0.0X MT” with the data
Flash Freeze with liquid nitrogen and store at -80°C *Flash freezing is absolutely
necessary for tubulin to remain functional
Actin Storage Protocol
Keep covered on ice during entire process prior to flash freezing and storage
Dark Unlabeled Actin
*Reconstitute to 2 mg/ml (46.6uM)
Spin down the powder
Add 100 ul of DI to 1 mg of actin
This gives 10mg/ml Dark Actin
Reconstitute to working concentration (2mg/ml) in G1
Aliquot into 25 ul aliquots
Drop freeze in Liquid N2
Store in -80°C freezer.
Alexa-488-labeled Actin
*Reconstitute 1.5 mg/ml (34.9uM)
Alexa-488-labeled actin arrives in solution
Measure the volume received
Read the concentration from the data sheet
Add appropriate amount of 1x G-buffer to reconstitute to 1.5 mg/ml
Aliquot out the 1.5 mg/ml Alexa-488 actin into 5ul aliquots
Flash freeze in liquid nitrogen and store at -80°C.
Biotinylated Actin
*Reconstitute to 1 mg/ml (23.3uM)
Spin down the lyophilized biotinylated actin
Add 2 ul of DI to lyophilize biotinylated actin
This gives 10 mg/ml biotinylated actin.
Then reconstitute to 1 mg/ml in GX1 buffer
Aliquot out the 1 mg/ml biotinylated actin into 5 µl aliquots
Flash freeze in liquid nitrogen and store in -80°C
Crosslinker Solution for Microtubules
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Goal is to make the 10 µl crosslinker solution with neutravidin, free biotin and
biotinylated tubulin.
Make sure to adjust the volume to be greater, ie 10x and 20x.
Refer to chart to see crosslinking volumes
Crosslinked Ratio “R=X”

0.005

0.01

0.02

0.04

Crosslink volume adjustment

20x

20x

20x

6x

PEM-100 (µl)

8.82

7.65

5.28

7.17

Neutravidin, 8.33 µM 1:10 dilution (µl)

0.7

1.39

2.79

1.67

Biotinylated Tubulin, 5 mg/ml (µl)

0.25

0.51

1.02

0.61

Free Biotin, 51 µM 1:20 dilution (µl)

0.23

0.45

0.91

0.55

Incubate in bath sonicator for 90 minutes with ice packs to keep from over-heating.
This is added to the actin to polymerize networks with crosslinkers and the volume
increase is taken into account in the final sample volumes
Crosslinker Solution for Actin
Goal is to make the crosslinker solution with neutravidin, free biotin and biotinylated
actin.
Make sure to adjust the volume to be greater, ie 10x and 20x.
Refer to chart to see crosslinking volumes
Crosslinked Ratio “R=X”

0.005

0.01

0.02

0.04

Crosslink volume adjustment

20x

20x

20x

6x

PEM-100 (µl)

8.58

7.16

4.31

6.59

Neutravidin, 8.33 µM 1:10 dilution
(µl)

0.70

1.39

2.79

1.67

Biotinylated Actin, 1 mg/ml (µl)

0.50

1.00

1.99

1.19

Free Biotin, 51 µM 1:20 dilution (µl)

0.23

0.45

0.91

0.55

Incubate in bath sonicator for 90 minutes with ice packs to keep from over-heating.
This is added to the actin to polymerize networks with crosslinkers and the volume
increase is taken into account in the final sample volumes
Pre-polymerized 488-Alexa Labeled Actin Filaments Protocol:
Goal is to create a 5 µM 10 µL solution with 50% dark and 50% labeled actin filaments
that can then be diluted and added to the sample chamber for force and image
measurements.
6.74 µl PEM-100
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0.72 µl 488-Alexa Labeled Actin 1.5 mg/ml (34.9 µM)
0.54 µl Dark Actin 2 mg/ml (46.5 µM)
2.00 µl 10 mM ATP (ATP in PEM-100)
Mix by pipetting and allow to polymerize for one hour
Pre-polymerized Biotinylated 488-Alexa Labeled Actin Filaments Protocol:
Goal is to create a 5 µM 10 µL solution with dark, labeled, and biotinylated actin
filaments that can then be diluted and added to the sample chamber for force and image
measurements.
Make a 1:5 dilution of Biotinylated Actin 1 mg/ml (2 µl PEM-100 and 2 µl Biotinylated
Actin) *for all crosslinked ratios greater than or equal to R = 0.01
Make a 1:10 dilution of Biotinylated Actin 1 mg/ml (9 µl PEM-100 and 1 µl Biotinylated
Actin) *for all crosslinked ratios less than or equal to R = 0.01
Depending on the crosslinking ratio refer to the chart to create a 10 µl solution.
Crosslinked Ratio “R=X”

0.005

0.01

0.02

0.04

PEM-100 (µl)

6.55

6.34

6.36

6.18

488-Alexa Labeled Actin, 1.5
mg/ml (µl)

0.71

0.70

0.69

0.67

Unlabeled Actin, 2 mg/ml (µl)

0.53

0.53

0.52

0.51

Biotinylated Actin, 1 mg/ml (µl)

0.21 (1:10 dilution)

0.43 (1:10
dilution)

0.43 (1:5 dilution)

0.64 (1:5 dilution)

2.00 µl 10 mM ATP (ATP in PEM-100)
Mix by pipetting and allow to polymerize for one hour
R-Tubulin pre-polymerization Protocol:
Goal is to create a 37 µM 5 µl solutio n that can be diluted and added to the sample
chamber for force images and measurements. *For crosslinked microtubules, to create
biotinylated rhodamine microtubules use the same protocol just with the correct R–
R=0.0X tube.
Thaw R-aliquot in your hand and put on ice. Once you start the rest of the protocol, the
R-aliquot needs to be stored at room
Add 0.55 uL 10 mM GTP to the thawed R-aliquot (for a final concentration of 1 mM).
Incubate in water bath at 37°C for 20-30 minutes to polymerize microtubules. (NOT
above 37°C, slightly below is fine.
Add 0.6 uL of 200 uM Taxol (final Taxol concentration ~20 μM). This brings the
tubulin concentration to 37 µM
Incubate at 37°C for 20-30 minutes to equilibrate the Taxol. Taxol is NOT a
permanent binder, do not dilute taxol lower than 5 μM as the KD value is ~2 µM.
Label polymerized Rhodamine tubulin “R-MT” with the date.
*Store 5 µl stock on lab bench (room temperature) and wrap in foil. DO NOT put
polymerized microtubules on ice; MT’s are unstable in cold - even with Taxol.
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**The 5 µl stock can be used for up to a week. Dilutions will not last and should not
be kept after several hours.
***If MT’s are too entangled and clumpy or too long, shear microtubules with a
Hamilton syringe for 3 up-down passes and image again.
Labeled Protein Dilutions
Make dilutions right before adding to the sample chamber. When proteins are
diluted, they may depolymerize if not added to more proteins.
Labeling dilutions determined via trial and error from confocal imaging. Goal is to be
able to see each filament without having to adjust several parameters during
acquisition.
488-Alexa Pre-polymerized Actin (1:2)
2 µl PEM-100
2 µl pre-polymerized 488-labeled actin filaments, cut tips
*Make fresh each time immediately prior to making the final sample.
488-Alexa Pre-polymerized Biotinylated Actin (1:2)
2 µl PEM-100
2 µl pre-polymerized biotinylated 488-labeled actin filaments, cut tips
*Make fresh each time immediately prior to making the final sample.
Rhodamine-Tubulin (R-MT’s) (1:10)
9 µl PEM-Taxol
1 µl R-Mt’s polymerized
*Make fresh each time immediately prior to making the final sample.
Rhodamine-Tubulin (R-MT’s) (1:10)
9 µl PEM-Taxol
1 µl biotinulated R–R=0.0X Mt’s polymerized
*Make fresh each time immediately prior to making the final sample.
FOR IMAGING AND FORCE MEASUREMENT:
Make a Glu/Goc/Bead solution
The glu/goc solution is critical to prevent photobleaching, beads are needed for force
measurements.
6 µl PEM-Taxol
2 µl 488-Labeled 4.5 µm microspheres, make sure all spheres are suspended in
buffer, vortex if not.
1 µl Glu
1 µl Goc
Mix the solution by vortexing and quick spin.
*Make fresh each time immediately prior to making the final sample. The
glu/goc/bead solution MUST be the last solution that is made prior to making the
final sample chamber as glu/goc starts reacting once mixed.
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**If just imaging, replace 2 µl microsphere with PEM-Taxol.
Final Sample Chamber at 5.8 µM volumes for 20 uL final volume
rough calculations on data sheet in binder “Crosslinked AMT Calculations for 5.8 µM”
→ Crosslinked solution R=0.0X Microtubules
→ Crosslinked solution R=0.0X Actin
→ Polymerized 488-Alexa labeled actin filaments (takes 1 hour)
→ Polymerized rhodamine microtubules (takes 40 min to 1 hour)
→ Polymerized biotinylated 488-Alexa labeled actin filaments (takes 1 hour)
→ Polymerized biotinylated rhodamine microtubules (takes 40 min to 1 hour)
→ Final Sample
Make 20 µl final sample chamber, see below *For these networks, the total protein
concentration is at 11.6 µM and a tubulin fraction of 0.5 (actin fraction of 0.5).
Pipet to mix, gently. Cut tips when adding actin and tween to final sample.
Pipet 20 µl into sample chamber (made via 2 layers of double sticky tape, coverslip
and slide).
Seal sample chamber with epoxy, label sample on slide with date and AMT ratio.
Incubate sealed sample at 37°C for 30 minutes. Use the oven in 292. MAKE sure
temperature does not rise above 37°C or else your AMT network will crash and
burn and you will be sad.
AMT network, no crosslinkers: 0.5 AMT → 2.9 µM actin + 2.9 µM tubulin in PEM-100
9.6 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
1.2 µl Dark Tubulin, 5 mg/ml or 45.5 µM
1.2 µl Dark Actin, 2 mg/ml or 46.5 µM
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1 µl 1:10 R-MT dilution (in PEM-Taxol)
1 µl 1:2 Pre-polymerized 488-labeled Actin (in PEM-100)
1 µl beads/glu/gloc
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
AMT network, Crosslink Actin R=0.02: 0.5 AMT → 2.9 µM actin + 2.9 µM tubulin in
PEM-100
8.7 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
1.2 µl Dark Tubulin, 5 mg/ml or 45.5 µM
1.1 µl Dark Actin, 2 mg/ml or 46.5 µM
1 µl 20x Crosslinker Actin Solution
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1 µl 1:10 R-MT dilution (in PEM-Taxol)
1 µl 1:2 Pre-polymerized 488-labeled Actin (in PEM-100)
1 µl beads/glu/gloc
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0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
AMT network, Crosslink Microtubules R=0.02: 0.5 AMT → 2.9 µM actin + 2.9 µM
tubulin in PEM-100
8.7 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
1.1 µl Dark Tubulin, 5 mg/ml or 45.5 µM
1.2 µl Dark Actin, 2 mg/ml or 46.5 µM
1 µl 20x Crosslinker Microtubule Solution
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1 µl 1:10 R-MT dilution (in PEM-Taxol)
1 µl 1:2 Pre-polymerized 488-labeled Actin (in PEM-100)
1 µl beads/glu/gloc
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
AMT network, co-crosslink R=0.02: 0.5 AMT → 2.9 µM actin + 2.9 µM tubulin in PEM100
*For this network the Microtubule ratio is R=0.01 and the Actin ratio is R=0.01. Here the
crosslink solution is made separately
7.8 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
1.1 µl Dark Tubulin, 5 mg/ml or 45.5 µM
1.1 µl Dark Actin, 2 mg/ml or 46.5 µM
1 µl 20x Crosslinker Microtubule Solution
1 µl 20x Crosslinker Actin Solution
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1 µl 1:10 R-MT dilution (in PEM-Taxol)
1 µl 1:2 Pre-polymerized 488-labeled Actin (in PEM-100)
1 µl beads/glu/gloc
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)

AMT network, co-crosslink R=0.04: 0.5 AMT → 2.9 µM actin + 2.9 µM tubulin in PEM100
*For this network the Microtubule ratio is R=0.02 and the Actin ratio is R=0.02. Here the
crosslink solution is made separately
7.8 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
1.1 µl Dark Tubulin, 5 mg/ml or 45.5 µM
1.1 µl Dark Actin, 2 mg/ml or 46.5 µM
1 µl 20x Crosslinker Microtubule Solution
1 µl 20x Crosslinker Actin Solution
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2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1 µl 1:10 R-MT dilution (in PEM-Taxol)
1 µl 1:2 Pre-polymerized 488-labeled Actin (in PEM-100)
1 µl beads/glu/gloc
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
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APPENDIX D
PROTOCOL FOR CROSSLINKED ACTIN-MICROTUBULE COMPOSITE
NETWORK USING MAP65 AND NEUTRAVIDIN (PRE-POLYMERIZED
LABELED FILAMENTS)

Crosslinked Actin-Microtubule Co-Polymerization Protocol – Ross Lab
**Pre-polymerized Labeled filaments
Leila Farhadi
Updated Aug 5, 2019 by Leila F
Reagents
Dark-Tubulin, 45.5 uM = 5 mg/ml, from Cytoskeleton cat #T240, in -80°C *keep on
ice, lasts for ~2 hrs on ice. Do not refreeze again in the -80°C.
HiLyte Fluor 488-Tubulin, 45.5 uM = 5 mg/ml, from Cytoskeleton cat #TL488, in -80°C
*keep on ice until thawing for HiLyte Fluor 488 microtubule (G-MT) polymerization.
Polymerize the same day aliquot is pulled from -80°C. Do not refreeze again in the 80°C.
Biotin Tubulin, 45.5 µM = 5 mg/ml, from Cytoskeleton cat #T333P, in -80°C *keep on
ice, lasts ~2 hrs if properly kept on ice Do not refreeze again in the -80°C.
Dark Actin, 46.5 µM = 2 mg/ml, from Cytoskeleton cat #AKL99, in -80°C *keep on ice,
last up to 1 week if properly kept on ice (as ice melts, replenish ice). Do not refreeze
again in the -80°C.
Rhodamine Actin, 34.9 µM = 1.5 mg/ml, from Cytoskeleton cat #AR05, in -80°C
*keep on ice, last up to 1 week if properly kept on ice (as ice melts, replenish ice). Do
not refreeze again. Do not refreeze again in the -80°C.
Biotin Actin, 23.3 µM = 1 mg/ml, from Cytoskeleton cat #AB07, in -80°C
GTP 100 mM, pH 7.0, in -20°C *keep on ice after thawing, can be refrozen and used
again.
ATP 100 mM, pH 7.0, in -20°C *keep on ice after thawing, can be refrozen and used
again.
Taxol 2 mM stock in DMSO, aliquot and freeze in -20°C *keep on bench after
thawing, can be refrozen and used again. Put back in -20°C once Taxol dilutions are
made (PEM-Taxol and 200 µM Taxol).
Neutravidin, 83.3 µM, from Thermo Fisher cat #31000, in -20°C *keep on ice, last up
to 1 week if properly kept on ice (as ice melts, replenish ice). However, aliquot is at 5
µl so will likely be used up within 1-2 days. Do not refreeze again in the -20°C.
Free Biotin, 1.02 mM, from Sigma cat #B4501, in 4°C *take a 5 µl sample from the
stock solution. Keep on ice, last up to 1 week if properly kept on ice (as ice melts,
replenish ice).
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Oxygen Scavenging system: 4.5 mg/ml glucose, 4.3 mg/ml glucose oxidase, 0.7
mg/ml catalase
0.5% β-mercaptoethanol
Buffers
PEM-100
100 mM PIPES, pH to 6.8 with HCl
2 mM MgCl2
2 mM EGTA
*Stored at room temperature and is viable for 1 years.

1 x G-buffer
2.0 mM Tris pH 8
0.2 mM ATP
0.5 mM DTT
0.1 mM CaCl2
*Stored at -20°C and is viable for 1-2 years.
Dilutions
PEM-Taxol
198 μl PEM-100
2 μl 2 mM Taxol *Thaw Taxol
*Make fresh every time before use, keep at room temp, good for 1 day.
200 uM Taxol
18 μl DMSO
2 μl 2 mM Taxol *Thaw Taxol
*Make fresh every time before use, keep at room temp, good for 1 day.
10 mM GTP, 1:10 dilution
9 µl PEM-100
1 µl 100 mM GTP
*Keep on ice during use, store in -20°C, can freeze/thaw.
10 mM ATP, 1:10 dilution
9 µl PEM-100
1 µl 100 mM ATP
*Keep on ice during use, store in -20°C, can freeze/thaw.
1% (v/v) Tween
495 ul PEM
5 µl Tween 20
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Vortex and quick spin to mix
*Store at room temperature and use repeatedly. Good for 1 year.
8.33 µM Neutravidin, 1:10 dilution
9 µl PEM-100
1 µl 83.3 µM Neutravidin
*Keep on ice during use, good for the day’s use
51 µM Free Biotin, 1:20 dilution
19 µl PEM-100
1 µl 1.02 mM (1020 µM) Neutravidin
*Keep on ice during use, good for the day’s use
PEM-100
Fill 50 ml tube with 40 ml sterile DI water
Measure out and add 1.893 grams of PIPES
Qualitatively transfer to 50 ml tube
100 µl of 1 M EGTA (final will be 2 mM)
100 µl 1 M MgCl2 (final will be 2 mM)
pH to 6.8 with pH meter (in 290)
If pH is too high add HCl *typically PEM is too basic with a pH between ~7.4-8.
Usually add 3-5 drops of HCl. Do so carefully as to not fall below 6.8 and have to add
KOH.
If pH is to low add KOH
Fill remaining volume to 50 ml in 50 ml tube using sterile DI water.
Sterile Filter into new 50 ml tube.
Label “PEM-100 pH 6.8 your initials, Date”
*Store at room temperature, in your drawer.
Tubulin Storage Protocol
Keep on ice during entire process prior to flash freezing and storage.
Dark Unlabeled Tubulin
Obtain unlabeled 1 mg lyophilized porcine tubulin (Cytoskeleton Cat #T240) from the
4°C and put on ice.
Add 200 µl PEM-100 to 1 mg lyophilized tubulin to bring up to 5 mg/ml volume.
Pipette to mix, make sure you got all tubulin from sides or lid. Do so by pipetting the
fluid on the sid or lid and depositing it into the solution at the bottom of the tube. To
avoid bubbles pipette slowly.
Let sit on ice for 10 minutes to allow tubulin to go into solution.
HiLyte Fluor 488-Labeled Tubulin
Obtain labeled 20 µg lyophilized porcine tubulin (Cytoskeleton Cat #TL488) from 4°C
and put on ice. Add 4 µl PEM-100 to 20 µg lyophilized rhodamine tubulin to bring up
to 5 mg/ml volume. Pipette to mix, make sure you got all tubulin from sides or lid.
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Do so by pipetting the fluid on the sides or lid and depositing it into the solution. To
avoid bubbles pipette slowly. Let sit on ice for 10 minutes to allow tubulin to go into
solution.
Aliquots from Dark and HiLyte Fluor 488- Tubulin
Mix labeled and unlabeled tubulin for desired labeling ratio. No labeling ratio has
MT’s that are too bright. Currently we use a 1:10 ratio HiLyte Fluor 488labeled:unlabeled tubulin (the 1:20 ratio was too dim).
Add 36 µl of dark tubulin directly to the 4 µl HiLyte Fluor 488 tubulin tube to create
40 µl total.
Let sit for 10 minutes on ice to allow labeled tubulin and dark tubulin to go into
solution. Aliquot HiLyte Fluor 488-labeled tubulin into 5 µl (8 aliquots)
Label each aliquot tube “G” *Once the 488 tubulin has been polymerized, add to
label “G-MT” with the data.
Aliquot remaining volume of unlabeled tubulin into 5 µl (32 aliquots)
Label each aliquot tube “5 mg/ml DT” DT stands for dark tubulin.
Flash Freeze with liquid nitrogen and store at -80°C *Flash freezing is absolutely
necessary for tubulin to remain functional.
Actin Storage Protocol
Keep covered on ice during entire process prior to flash freezing and storage.
Dark Unlabeled Actin
*Reconstitute to 2 mg/ml (46.6uM)
Spin down the powder
Add 100 ul of DI to 1 mg of actin
This gives 10mg/ml Dark Actin
Reconstitute to working concentration (2mg/ml) in G1
Aliquot into 25 ul aliquots
Drop freeze in Liquid N2
Store in -80°C freezer.
Rhodamine-labeled Actin
*Reconstitute 1.5 mg/ml (34.9uM)
Spin down the powder
Add 2 ul of DI to 20 ug of actin
This gives 10mg/ml Dark Actin
Reconstitute to working concentration (1.5mg/ml) in G1
Aliquot into 5ul aliquots
Drop freeze in Liquid N2
Store in -80°C freezer.
Biotinylated Actin
*Reconstitute to 1 mg/ml (23.3uM)
Spin down the lyophilized biotinylated actin
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Add 2 ul of DI to lyophilize biotinylated actin
This gives 10 mg/ml biotinylated actin.
Then reconstitute to 1 mg/ml in GX1 buffer
Aliquot out the 1 mg/ml biotinylated actin into 5 µl aliquots
Flash freeze in liquid nitrogen and store in -80°C

Crosslinker Solution for Actin
Goal is to make the crosslinker solution with neutravidin, free biotin and biotinylated
actin.
Make sure to adjust the volume to be greater, ie 10x and 20x.
Refer to chart to see crosslinking volumes
Crosslinked Ratio “R=X”

0.02

0.04

0.08

PEM-100 (µl)

8.60

7.20

4.39

Neutravidin, 8.33 µM 1:10 dilution (µl)

0.69

1.37

2.75

Biotinylated Actin, 1 mg/ml (µl)

0.49

0.98

1.96

Free Biotin, 51 µM 1:20 dilution (µl)

0.22

0.45

0.90

Incubate in bath sonicator for 90 minutes with ice packs to keep from over-heating.
This is added to the actin to polymerize networks with crosslinkers and the volume
increase is taken into account in the final sample volumes
Pre-polymerized Rhodamine Labeled Actin Filaments Protocol:
Goal is to create a 5 µM 10 µL solution with 50% dark and 50% labeled actin filaments
that can then be diluted and added to the sample chamber for force and image
measurements.
6.74 µl PEM-100
0.72 µl Rhodamine Labeled Actin 1.5 mg/ml (34.9 µM)
0.54 µl Dark Actin 2 mg/ml (46.5 µM)
2.00 µl 10 mM ATP (ATP in PEM-100)
Mix by pipetting and allow to polymerize for one hour
Pre-polymerized Biotinylated Rhodamine Labeled Actin Filaments Protocol:
Goal is to create a 5 µM 10 µL solution with dark, labeled, and biotinylated actin
filaments that can then be diluted and added to the sample chamber for force and image
measurements.
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Crosslinked Ratio “R=X”

0

0.02

0.04

0.08

PEM-100 (µl)

6.74

6.37

5.99

5.23

Rhodamine Labeled Actin, 1.5
mg/ml (µl)

0.72

0.69

0.66

0.6

Unlabeled Actin, 2 mg/ml (µl)

0.54

0.52

0.49

0.45

Biotinylated Actin, 0.2 mg/ml (µl)
(1:5 dilution)

0

0.43

0.86

1.72

ATP 10 mM

2.00

2.00

2.00

2.00

Mix by pipetting and allow to polymerize for one hour

Labeled Protein Dilutions
Make dilutions right before adding to the sample chamber. When proteins are
diluted, they may depolymerize if not added to more proteins.
Labeling dilutions determined via trial and error from confocal imaging. Goal is to be
able to see each filament without having to adjust several parameters during
acquisition.
Rhodamine Pre-polymerized Actin (1:2)
2 µl PEM-100
2 µl pre-polymerized Rhodamine actin filaments, cut tips
*Make fresh each time immediately prior to making the final sample.
Rhodamine Pre-polymerized Biotinylated Actin (1:2)
2 µl PEM-100
2 µl pre-polymerized biotinylated Rhodamine actin filaments, cut tips
*Make fresh each time immediately prior to making the final sample.
Make a Glu/Goc/Bead solution
The glu/goc solution is critical to prevent photobleaching
6 µl PEM-Taxol
2 µl 488-Labeled 4.5 µm microspheres, make sure all spheres are suspended in
buffer, vortex if not.
1 µl Glu
1 µl Goc
Mix the solution by vortexing and quick spin.
*Make fresh each time immediately prior to making the final sample. The
glu/goc/bead solution MUST be the last solution that is made prior to making the
final sample chamber as glu/goc starts reacting once mixed.
**If just imaging, replace 2 µl microsphere with PEM-Taxol.
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Final Sample Chamber, volumes for 20 uL final volume
rough calculations on data sheet in binder “Crosslinked Calculations for 1.43 µM actin,
9.1 µM MT”
→ Crosslinked solution R=0.0X Actin
→ Polymerized Rhodamine labeled actin filaments (takes 1 hour)
→ Dark actin
→ MAP65
→ Dark and labeled Tubulin
→ Final Sample
Make 20 µl final sample chamber, see below
Pipet to mix, gently. Cut tips when adding actin and tween to final sample.
Pipet 20 µl into sample chamber (made via 2 layers of double sticky tape, coverslip
and slide).
Seal sample chamber with epoxy, label sample on slide with date and AMT ratio.
Incubate sealed sample at 37°C for 30 minutes. MAKE sure temperature does not
rise above 37°C or else your AMT network will crash and burn, and you will be
sad.
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Composite network: R=0, 0% MAP65
8.44 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
0 µl Crosslinker Actin Solution
0 µl MAP65, 4.66 µM
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.56 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0, 3% MAP65
7.11 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.8 µl Dark Tubulin, 5 mg/ml or 45.5 µM
0 µl Crosslinker Actin Solution
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.33 µl MAP65, 4.66 µM
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.56 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0, 10% MAP65
3.96 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
0 µl Crosslinker Actin Solution
4.48 µl MAP65, 4.66 µM
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.56 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0.02, 0% MAP65
7.46 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM
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2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
1 µl Crosslinker Actin Solution
0 µl MAP65, 4.66 µM
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.54 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0.02, 3% MAP65
6.13 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.8 µl Dark Tubulin, 5 mg/ml or 45.5 µM
1 µl Crosslinker Actin Solution
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.33 µl MAP65, 4.66 µM
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.54 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0.02, 10% MAP65
2.99 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
1 µl Crosslinker Actin Solution
4.48 µl MAP65, 4.66 µM
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.54 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0.04, 0% MAP65
7.49 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
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1 µl Crosslinker Actin Solution
0 µl MAP65, 4.66 µM
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.51 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0.04, 3% MAP65
6.16 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.8 µl Dark Tubulin, 5 mg/ml or 45.5 µM
1 µl Crosslinker Actin Solution
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.33 µl MAP65, 4.66 µM
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.51 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0.04, 10% MAP65
3.01 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
1 µl Crosslinker Actin Solution
4.48 µl MAP65, 4.66 µM
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.51 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0.08, 0% MAP65
7.54 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
1 µl Crosslinker Actin Solution
0 µl MAP65, 4.66 µM
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
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1 µl glu/gloc
0.46 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0.08, 3% MAP65
6.21 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.8 µl Dark Tubulin, 5 mg/ml or 45.5 µM
1 µl Crosslinker Actin Solution
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.33 µl MAP65, 4.66 µM
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.46 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
Composite network: R=0.08, 10% MAP65
3.06 µl PEM-100 (**always add PEM-100 as the remainder to fill volume to 20µL)
2.80 µl Dark Tubulin, 5 mg/ml or 45.5 µM
2 µl 10 mM GTP (in PEM-100)
2 µl 10 mM ATP (in PEM-100)
1.20 µl lab/dark 1:10 HiLyte Fluor -488 Tubulin
1 µl Crosslinker Actin Solution
4.48 µl MAP65, 4.66 µM
1 µl 1:2 Pre-polymerized Rhodamine Actin (in PEM-100)
1 µl glu/gloc
0.46 µl Dark Actin, 2 mg/ml or 46.5 µM
0.5 ul 1% Tween
0.5 ul 200 uM Taxol (in DMSO)
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